Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFGE8,Lactadherin,39093,-0.105082286816625,0.00389460231883854,-0.112715707361548,-0.0974488662717011,1.14288906824524e-156
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS15,Enteropeptidase,39023,-0.185626642611618,0.00797514458648033,-0.20125792600112,-0.169995359222117,8.99349060368583e-118
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCG,Pro-glucagon,38727,-0.25188205202916,0.0109591836452538,-0.273362051973857,-0.230402052084462,6.76840445128805e-115
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYY,Peptide YY,36391,-0.1717708789232,0.00832226097349301,-0.188082510431247,-0.155459247415154,4.21667454732853e-93
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,39253,0.220462207026064,0.0111052989230759,0.198695821136835,0.242228592915292,1.28142122117359e-86
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIP,Gastric inhibitory polypeptide,36420,-0.077084545152117,0.00392456357398641,-0.0847766897571304,-0.0693924005471037,1.26364692130787e-84
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9,Complement component C9,36796,0.0909689417520257,0.00480623405666317,0.0815487230009659,0.100389160503086,7.87024531763796e-79
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,36791,-0.0669208501623685,0.00361701852507877,-0.0740102064715229,-0.0598314938532141,1.87925327347209e-75
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES1,Liver carboxylesterase 1,39095,-0.123559451978548,0.00724053107181923,-0.137750892879314,-0.109368011077782,1.07916883525337e-64
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,39255,-0.0573651184601137,0.00336520805403452,-0.0639609262460214,-0.0507693106742061,1.4502586256489e-64
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF9,Protein turtle homolog A,36792,-0.123922340182657,0.00748558208341072,-0.138594081066142,-0.109250599299171,6.25345238902716e-61
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1A,Meprin A subunit alpha,36743,-0.102881406282243,0.00650167794882876,-0.115624695061947,-0.0901381175025382,7.15297979826302e-56
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOF,Apolipoprotein F,36796,0.036337812440583,0.00231616209893116,0.031798134726678,0.0408774901544881,5.78776311233431e-55
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,39147,0.0448023795890511,0.00290162236231108,0.0391151997589214,0.0504895594191808,2.21197484865698e-53
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPY,Pancreatic prohormone,39064,-0.139369016754975,0.00907164489175144,-0.157149440742808,-0.121588592767142,7.21554440840487e-53
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RB,Interleukin-17 receptor B,38886,0.0745627455635382,0.00488064441504552,0.064996682510049,0.0841288086170274,2.67999688892436e-52
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY1,Aminoacylase-1,39106,-0.0848777376822652,0.0056195344236718,-0.095892025152662,-0.0738634502118685,3.57142317478895e-51
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA2,Apolipoprotein A-II,36796,0.0646780213670533,0.00431062551092904,0.0562291953656324,0.0731268473684742,1.82714820779944e-50
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPA,Apolipoprotein(a),36552,0.233318340126001,0.0159359103872388,0.202083955767012,0.264552724484989,3.79310589398119e-48
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG2,Secretogranin-2,39178,-0.0404116856961035,0.00282334347333838,-0.0459454389038468,-0.0348779324883603,3.58155156196619e-46
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,39162,0.0362007600822675,0.00255956389259172,0.0311840148527878,0.0412175053117473,3.95117530524189e-45
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSE,Cathepsin E,36500,-0.0658482874644431,0.00477084827720512,-0.0751991500877651,-0.0564974248411211,5.06751790092177e-43
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,39023,-0.0444520575630641,0.00323280701037099,-0.0507883593033913,-0.038115755822737,9.15650844972863e-43
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS8,Prostasin,39039,-0.0496408653270037,0.00364487118628386,-0.05678481285212,-0.0424969178018873,5.42184266433474e-42
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHBG,Sex hormone-binding globulin,36796,0.0622657425510168,0.00467122355677863,0.0531101443797307,0.0714213407223029,2.86844523816024e-40
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,36430,-0.145728379785512,0.0109383848258422,-0.167167614044163,-0.124289145526862,3.20169666398831e-40
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH1,Somatotropin,39086,0.216784512260295,0.0163748129707796,0.184689878837567,0.248879145683023,8.67845278104302e-40
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRP,Agouti-related protein,39291,-0.0630016359701592,0.00476311628048814,-0.072337343879916,-0.0536659280604025,1.00848837585194e-39
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPM,Carboxypeptidase M,39189,-0.0411464745853875,0.00313053506925844,-0.047282323321134,-0.0350106258496409,3.01943688308711e-39
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39165,0.0451937181859116,0.00348966573474333,0.0383539733458147,0.0520334630260085,3.69254034825094e-38
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR3,Anterior gradient protein 3,38714,-0.0693966779382409,0.00535884353111867,-0.0799000112592335,-0.0588933446172483,3.78277624946279e-38
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFASC,Neurofascin,39291,-0.0324388008483889,0.00251652095202263,-0.0373711819143533,-0.0275064197824246,7.99735039062766e-38
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSD,Cathepsin D,38007,-0.0458514233029579,0.00357597280285853,-0.0528603299965606,-0.0388425166093552,1.9927580699959e-37
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPY,Pro-neuropeptide Y,39255,-0.0752633630655523,0.00594781664288086,-0.0869210836855988,-0.0636056424455058,1.61704457209827e-36
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF21,Fibroblast growth factor 21,39237,-0.13712253595325,0.0108704724481364,-0.158428661951598,-0.115816409954903,2.66692580149332e-36
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39106,-0.0372574713136186,0.00299117178594424,-0.0431201680140693,-0.0313947746131679,1.93407904961555e-35
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO3,Beta-enolase,36420,-0.0681940054744353,0.00547217021265962,-0.0789194590912482,-0.0574685518576225,1.94959217442519e-35
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FURIN,Furin,39147,-0.0381187819580789,0.00307177897804997,-0.0441394687550569,-0.032098095161101,3.43518865404609e-35
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,38672,-0.0616143174250651,0.00497815895082817,-0.0713715089686883,-0.0518571258814419,5.19004571199014e-35
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPH,Hephaestin,36792,-0.0292655276141417,0.00236734194965995,-0.0339055178354752,-0.0246255373928082,6.59017077959841e-35
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,38832,-0.0560952003157596,0.00456997912889932,-0.0650523594084023,-0.0471380412231169,1.81342377067982e-34
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MET,Hepatocyte growth factor receptor,39118,0.0216076159126882,0.0017692077819634,0.01813996866004,0.0250752631653365,3.81676882034095e-34
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,38864,-0.0323970577652934,0.00265520598557817,-0.0376012614970266,-0.0271928540335602,4.43462094102567e-34
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,38625,-0.110269104537635,0.00906936762640392,-0.128045065085387,-0.0924931439898832,7.51172022698e-34
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC13,Mucin-13,38741,-0.0555815292750943,0.00460307139877382,-0.064603549216691,-0.0465595093334976,2.05439107112899e-33
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,39246,0.0679326360346731,0.0056455023981281,0.056867451334342,0.0789978207350041,3.35709297529516e-33
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,36728,-0.0913974279427965,0.00770108337216344,-0.106491551352237,-0.0763033045333562,2.55477876952387e-32
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,39093,-0.0565755764993319,0.0047965412031612,-0.0659767972575278,-0.0471743557411359,5.70032040878761e-32
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,36791,-0.0338873869822383,0.00288704062933617,-0.0395459866157372,-0.0282287873487394,1.18127235920101e-31
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM1,Isthmin-1,39099,-0.0423748252980837,0.00362133310320806,-0.0494726381803715,-0.0352770124157959,1.70875137600525e-31
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL2,C-C motif chemokine 2,38960,-0.0544634973230755,0.00467784967091849,-0.0636320826780758,-0.0452949119680753,3.39164610694411e-31
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,39099,-0.0424174446469918,0.00367109942720987,-0.0496127995243232,-0.0352220897696605,9.41776855399457e-31
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,38951,-0.0750866210963208,0.00653078705581,-0.0878869637257084,-0.0622862784669332,1.82220702792923e-30
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MME,Neprilysin,39023,-0.0814509774930486,0.00717301621820066,-0.0955100892807219,-0.0673918657053753,9.21719237208173e-30
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,38832,-0.0866925276211048,0.00769357169721749,-0.101771928147651,-0.0716131270945585,2.47305735271711e-29
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA1,Glutathione S-transferase A1,39079,-0.0869786602818019,0.00775327560433564,-0.1021750804663,-0.071782240097304,4.31212198006568e-29
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,39147,-0.02542336509264,0.002280243689026,-0.0298926427231309,-0.020954087462149,9.30587674567158e-29
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA2,Carboxypeptidase A2,39166,-0.0649888529451022,0.00585892036743475,-0.0764723368652744,-0.0535053690249301,1.75565557226014e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3B,Protein FAM3B,39023,-0.0356229933908631,0.00323901272404214,-0.0419714583299857,-0.0292745284517405,4.98058366784716e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBKS,Ribokinase,38750,-0.049012013562504,0.00447187881442107,-0.0577768960387693,-0.0402471310862387,7.59740618132085e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSZ,Cathepsin Z,39103,-0.0307787073771887,0.00281999064805856,-0.0363058890473835,-0.0252515257069939,1.24391601337144e-27
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP1,Neuropilin-1,39182,0.0274676634770255,0.00252358515215044,0.0225214365788107,0.0324138903752404,1.7249391685697e-27
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCS1,Neuronal calcium sensor 1,39255,-0.0274964286287546,0.00254529815980101,-0.0324852130219646,-0.0225076442355446,4.17463188497071e-27
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,36490,-0.0467811326364319,0.00433573861940048,-0.0552791803304569,-0.038283084942407,5.05235771785947e-27
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA3,Glutathione S-transferase A3,38727,-0.0746879232644631,0.00696801762282086,-0.088345237805192,-0.0610306087237342,1.04139725238236e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELE,E-selectin,39283,-0.0483312297898419,0.00452398118902832,-0.0571982329203374,-0.0394642266593464,1.50842973974778e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOE,Apolipoprotein E,36806,-0.0698465480538506,0.00654075595970501,-0.0826664297348724,-0.0570266663728288,1.65144662935595e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,36731,-0.0535804087164947,0.00502849679617042,-0.0634362624369887,-0.0437245549960007,2.1207134189837e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,38795,-0.0727640125446774,0.00683247593081575,-0.0861556653690763,-0.0593723597202785,2.17473001061198e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,39237,-0.0412214151731988,0.00389060901365214,-0.048847008839957,-0.0335958215064406,3.86391104885358e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAST,Gastrin,36747,-0.112006375697858,0.0105981289312946,-0.132778708403196,-0.0912340429925209,5.32843793233806e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EZR,Ezrin,39241,-0.0231100332840002,0.00218751786147586,-0.0273975682924929,-0.0188224982755075,5.34366301130337e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",36420,-0.054963358378758,0.00521662873914093,-0.0651879507074743,-0.0447387660500418,7.54169312331335e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPB1,Beta-ureidopropionase,36792,-0.0879210642381729,0.00839724191287614,-0.10437965838741,-0.0714624700889357,1.49740158698859e-25
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,36500,-0.0466657984627528,0.00446232036884287,-0.0554119463856848,-0.0379196505398207,1.71575517348792e-25
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,36500,-0.0720222906426059,0.00691145689930262,-0.0855687461652391,-0.0584758351199728,2.52588838937604e-25
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,38841,-0.0516679219081004,0.00496606297853669,-0.0614014053460323,-0.0419344384701685,2.8923535218734e-25
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39224,-0.0283969607720477,0.00274643608894698,-0.0337799755063838,-0.0230139460377116,5.63474567444108e-25
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KITLG,Kit ligand,39106,0.0349054950750713,0.00338458348204127,0.0282717114502704,0.0415392786998722,7.42221275832777e-25
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,38987,-0.0662721888512417,0.00642650719215931,-0.0788681429478739,-0.0536762347546094,7.49222647844931e-25
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,38987,-0.0552550607837867,0.00536424531004261,-0.0657689815914702,-0.0447411399761032,8.45439198387187e-25
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP2,Neuropilin-2,39093,0.0266021488514986,0.00259635525056617,0.0215132925603889,0.0316910051426083,1.48243279634956e-24
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39023,-0.0400603150908614,0.00393907216158905,-0.047780896527576,-0.0323397336541469,3.22844677087569e-24
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH,Parathyroid hormone,36421,-0.0735308774447651,0.00726000071975837,-0.0877604788554915,-0.0593012760340387,5.12096508971485e-24
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THOP1,Thimet oligopeptidase,39042,-0.027853314337072,0.00277467572818334,-0.0332916787643113,-0.0224149499098327,1.22452915785153e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPL,Lipoprotein lipase,39106,0.0428756180444071,0.00429289686689748,0.0344615401852881,0.0512896959035262,2.0389590567271e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM20A,Pseudokinase FAM20A,36792,-0.0255012297322794,0.00256523040112377,-0.030529081318482,-0.0204733781460768,3.33991759336986e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSF,Cathepsin F,39147,-0.0363835463886941,0.00367482027762743,-0.0435861941328439,-0.0291808986445444,4.84594341159025e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS2,Thrombospondin-2,39093,-0.0324676833704188,0.0032953237869824,-0.0389265179929043,-0.0260088487479333,7.81190964255203e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKB,Creatine kinase B-type,36791,0.0514415716152792,0.00528112669480114,0.041090563293469,0.0617925799370894,2.41395456281037e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHR,Growth hormone receptor,36500,-0.0253405354418106,0.00260680980952362,-0.0304498826684769,-0.0202311882151443,2.93875948162775e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUSB,Beta-glucuronidase,39153,-0.0514741170909972,0.00535287240364947,-0.0619657470021502,-0.0409824871798443,7.87727773875992e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,39062,-0.0435723292100625,0.00454975856290232,-0.052489855993351,-0.034654802426774,1.15180012818206e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,39099,-0.0240304407521378,0.00251383927072677,-0.0289575657227623,-0.0191033157815133,1.3634607268732e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACHE,Acetylcholinesterase,36500,-0.0284482660740885,0.00298496996174496,-0.0342988071991087,-0.0225977249490684,1.84778964228353e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN1,CCN family member 1,38994,-0.065134823433186,0.00684018241818837,-0.0785415809728352,-0.0517280658935368,1.94350625615919e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELN,Elastin,36792,-0.0289503098618847,0.00304591067519851,-0.0349202947852738,-0.0229803249384956,2.35670794759345e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR37,Prosaposin receptor GPR37,38832,-0.0552630786809751,0.00583995413468189,-0.0667093887849517,-0.0438167685769986,3.43166914294829e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15,Interleukin-15,39099,-0.0279934870942432,0.00296552422557178,-0.0338059145763639,-0.0221810596121225,4.27116194151105e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,36792,-0.0553424704366076,0.00586214559422609,-0.0668322758012908,-0.0438526650719245,4.33135202511358e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,36731,-0.0323487469583755,0.00342857747413214,-0.0390687588076745,-0.0256287351090765,4.57148338224156e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,36791,-0.0458411296577854,0.00487954934524108,-0.0554050463744579,-0.0362772129411129,6.69881378028833e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,36747,0.0311796762984195,0.00332460438509193,0.0246634517036393,0.0376959008931997,7.79920573277292e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDUA,Alpha-L-iduronidase,39255,-0.0390390298815694,0.00416709399025883,-0.0472065341024767,-0.0308715256606621,8.36446015333194e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",39023,-0.0696511675810738,0.00745121859005931,-0.0842555560175901,-0.0550467791445576,1.01908189434908e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,36500,-0.0190534398866364,0.00204783458478973,-0.0230671956728243,-0.0150396841004485,1.57017278447463e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,38832,-0.0459556680834301,0.00496286741436394,-0.0556828882155835,-0.0362284479512768,2.31896624444399e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCTN3,Tectonic-3,36792,-0.0248661810596938,0.00268853092741463,-0.0301357016774264,-0.0195966604419611,2.61769997139196e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREG1,Protein CREG1,38905,-0.0316485696335337,0.00342711114580982,-0.0383657074793209,-0.0249314317877464,2.92791416266054e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA4,Apolipoprotein A-IV,36806,-0.02954509360481,0.0032083056360812,-0.0358333726515292,-0.0232568145580909,3.79434140988e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEG1,Protein HEG homolog 1,36500,-0.0226316955040293,0.00246432493615486,-0.0274617723788928,-0.0178016186291658,4.80606397756604e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,39093,0.0254501321280741,0.00278019813183797,0.0200009437896717,0.0308993204664765,6.16663221357268e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,38727,-0.0521115369740576,0.00571015571933558,-0.0633034421839553,-0.0409196317641599,7.99731310612706e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,39023,-0.0548804259334976,0.00604737819078631,-0.0667332871874388,-0.0430275646795565,1.27328848632851e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MVK,Mevalonate kinase,38841,-0.0654705312095504,0.00722710645343115,-0.0796356598582754,-0.0513054025608253,1.47619487883577e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39099,0.0317905619777772,0.00353475735845751,0.0248624375552005,0.0387186864003539,2.6671989529751e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFM,Afamin,36806,-0.015538289076103,0.001728682847511,-0.0189265074572246,-0.0121500706949815,2.84994523653327e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,39063,-0.0160082432226414,0.00178673886715004,-0.0195102514022555,-0.0125062350430273,3.63506625584358e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP5,Retinol-binding protein 5,39023,-0.0458596483901648,0.00512251629522785,-0.0558997803288114,-0.0358195164515182,3.8699720945858e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,38727,-0.0483686255419701,0.00541114641739341,-0.0589744725200611,-0.037762778563879,4.39394023233485e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,39023,0.0330719857887992,0.00370150206848928,0.0258170417345602,0.0403269298430382,4.54342089345509e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMNL1,Formin-like protein 1,38741,-0.0490006968345555,0.0055316823375209,-0.0598427942160965,-0.0381585994530145,9.038944890307e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS1,Protein MTSS 1,36743,-0.0892641446529073,0.0100767755143583,-0.10901462466105,-0.069513664644765,9.17029913135604e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTG,Protogenin,39255,-0.0199801079855952,0.00226341291521708,-0.0244163972994207,-0.0155438186717697,1.18470919568206e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,38922,-0.0374328751960639,0.00424229334870683,-0.0457477701595293,-0.0291179802325985,1.22693285436979e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLB1,Beta-galactosidase,38987,-0.0338501510084379,0.00383937251969978,-0.0413753211470495,-0.0263249808698263,1.30684887552423e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,39099,-0.042164893551775,0.00478853426124155,-0.0515504207038084,-0.0327793663997415,1.44234443998254e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,39140,0.0360014088572203,0.00409563899034669,0.0279739564361408,0.0440288612782998,1.64999789907473e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK14,Kallikrein-14,39255,0.0360174888965479,0.00410147435365145,0.0279785991633911,0.0440563786297048,1.77897145197177e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,39086,-0.038917008461549,0.00443538668549251,-0.0476103663651143,-0.0302236505579837,1.90114969000724e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FEN1,Flap endonuclease 1,38727,-0.0499601060128093,0.00569552312742598,-0.0611233313425642,-0.0387968806830544,1.94636199660769e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCXR,L-xylulose reductase,39147,-0.0431650447179985,0.00492362345346197,-0.052815346686784,-0.033514742749213,2.02671976924126e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHK,Ketohexokinase,36420,-0.0513054564515799,0.00587777167022755,-0.0628258889252259,-0.039785023977934,2.89840795917979e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,39183,-0.0246758803157894,0.00283039451370723,-0.0302234535626556,-0.0191283070689233,3.11328359734802e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HJV,Hemojuvelin,36767,-0.0349775202988966,0.00401217883194097,-0.0428413908095009,-0.0271136497882923,3.17923061357762e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,36500,-0.0307329517859387,0.00352693077656915,-0.0376457361080142,-0.0238201674638632,3.30194589526954e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,38824,-0.113653020418187,0.0131189681585819,-0.139366198009008,-0.0879398428273668,5.04800002806969e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,39023,-0.062364005283529,0.00723794976567468,-0.0765503868242514,-0.0481776237428066,7.59236405001383e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL27,C-C motif chemokine 27,39106,-0.0486842541199663,0.00566509156005228,-0.0597878335776687,-0.0375806746622638,9.22640131968793e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPC,C-type natriuretic peptide,39099,-0.0356667298221202,0.00417250822299047,-0.0438448459391815,-0.0274886137050588,1.36954306725352e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF19,Fibroblast growth factor 19,39162,-0.0596013039495207,0.00699013440460249,-0.0733019673825416,-0.0459006405164999,1.6480518546895e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA14,Carbonic anhydrase 14,39255,0.0272226083125898,0.00319823046521507,0.0209540766007682,0.0334911400244113,1.86922567541602e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG2,Desmoglein-2,39093,0.020624937764478,0.0024293725146764,0.0158633676357122,0.0253865078932437,2.25843566439812e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,36614,-0.0197516769132182,0.00233135626794504,-0.0243211351983904,-0.0151822186280459,2.67071974123104e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS4,Thrombospondin-4,39131,-0.0343104188091612,0.00407720815891769,-0.0423017468006399,-0.0263190908176825,4.26748286269499e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,39079,-0.0747591152617203,0.00889299072921424,-0.0921893770909802,-0.0573288534324603,4.5940120296861e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN2,Matrilin-2,39117,-0.0226703564062945,0.00270366952490766,-0.0279695486751135,-0.0173711641374755,5.51025452464826e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,36430,-0.0341067865217665,0.00407869984814986,-0.0421010382241402,-0.0261125348193928,6.80260572889134e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,36792,-0.0222985064017754,0.00267155864158645,-0.0275347613392848,-0.0170622514642659,7.73289665577795e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADIPOQ,Adiponectin,36806,0.0500779015958243,0.00601609556930213,0.0382863542799922,0.0618694489116565,9.35322547821301e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIP2,Cysteine-rich protein 2,38987,-0.0271292771080382,0.00326375016919837,-0.033526227439667,-0.0207323267764094,1.01774707629928e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3F,Semaphorin-3F,39106,-0.0191918356140973,0.00231884852844586,-0.0237367787298512,-0.0146468924983434,1.37324346342866e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXT,Oxytocin-neurophysin 1,39241,-0.104273330683772,0.0126331594695433,-0.129034323244077,-0.0795123381234672,1.65592697921372e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH15,Cadherin-15,39205,-0.0405874537185025,0.00492192659028507,-0.0502344298354613,-0.0309404776015438,1.76574583317937e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBC,Inhibin beta C chain,39093,-0.030718477745417,0.00374906007180223,-0.0380666354861494,-0.0233703200046847,2.73420413764905e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,36391,-0.0456641685064466,0.00558031032004453,-0.0566015767337339,-0.0347267602791593,3.03258021446163e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMPD3,AMP deaminase 3,36747,-0.0525411714457865,0.00642375528939289,-0.0651317318129966,-0.0399506110785764,3.12363556631571e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,38832,-0.0271969536378132,0.00333574669894204,-0.0337350171677396,-0.0206588901078868,3.82369146969861e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAN,Neurocan core protein,39241,0.0271473475509421,0.00333626365679841,0.0206082707836172,0.033686424318267,4.35775602798413e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,36731,-0.0382697574998236,0.00475415180603362,-0.0475878950396495,-0.0289516199599977,9.02095067085212e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,36500,0.0219559064896923,0.00273222529405269,0.016600744913349,0.0273110680660356,1.01103039959547e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCLY,Selenocysteine lyase,39211,-0.0358397014287065,0.00449710578458487,-0.0446540287664928,-0.0270253740909201,1.70448509520256e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIT,Vitrin,36792,-0.0266141098307008,0.00334155047044035,-0.0331635487527639,-0.0200646709086377,1.79560096993804e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH17,Cadherin-17,39106,-0.0480653998267776,0.00603851489738733,-0.0599008890256567,-0.0362299106278984,1.84380784051293e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,36391,-0.0405101351971131,0.00511219255175933,-0.0505300325985613,-0.0304902377956648,2.48925487740886e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,39147,-0.0155741548104086,0.00197124693370285,-0.0194377988004662,-0.011710510820351,2.96227426082295e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH2,Cadherin-2,39106,-0.0251267956465745,0.0031812687772564,-0.031362082449997,-0.0188915088431519,3.01785898615927e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,38977,-0.0264615743841616,0.00335832330634345,-0.0330438880645948,-0.0198792607037284,3.51260541124526e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL11,Eotaxin,39291,-0.0271019465117078,0.0034563776687773,-0.0338764467425113,-0.0203274462809043,4.7552776915674e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,39023,-0.0426665313712733,0.00544436151793526,-0.0533374799464264,-0.0319955827961201,4.92618933290228e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES3,Carboxylesterase 3,39023,-0.0490645663038581,0.00626297596771876,-0.0613399992005869,-0.0367891334071293,5.03528930461643e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,36420,-0.0257002798513952,0.00328093809691078,-0.0321309185213404,-0.0192696411814501,5.13690292401216e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLK1,Protein delta homolog 1,39283,-0.0398379572755804,0.00509389191356221,-0.0498219854261623,-0.0298539291249985,5.59015700120163e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,36806,0.0181639223234766,0.00232274129921318,0.0136113493770188,0.0227164952699345,5.68826713967395e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,39057,0.0336089467402637,0.00430665472205681,0.0251679034850324,0.0420499899954951,6.38868213081047e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMBS,Porphobilinogen deaminase,39255,-0.0303171721035025,0.00390197892677901,-0.0379650507999893,-0.0226692934070156,8.36236554019788e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,39106,-0.0294398625861671,0.00380416392912643,-0.0368960238872549,-0.0219837012850793,1.06586346959178e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,36500,-0.0151942402333293,0.00196995111930684,-0.0190553444271707,-0.0113331360394879,1.32079465084199e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,39255,-0.0235855733370907,0.00308655874357875,-0.0296352284745051,-0.0175359181996764,2.27532341393374e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,39099,-0.0343829277006202,0.00451820388492901,-0.0432386073150811,-0.0255272480861594,2.90403580446933e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGLN1,Egl nine homolog 1,39099,-0.0371451561877957,0.00488323229281186,-0.0467162914817069,-0.0275740208938844,2.97636357000499e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBN,Nibrin,38841,-0.0359076616723204,0.00472339870237328,-0.0451655231289721,-0.0266498002156688,3.086529434856e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORD,Sorbitol dehydrogenase,39190,-0.0475340143726256,0.00626014436125891,-0.059803897320693,-0.0352641314245581,3.30264913118375e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,39023,-0.0235623217076647,0.00312759593403859,-0.0296924097383804,-0.0174322336769491,5.21084595287238e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,39283,0.0195861359650294,0.00260142859989061,0.0144873359092438,0.024684936020815,5.39585544754862e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL16,Pro-interleukin-16,39291,-0.0282229099642014,0.0037505365820407,-0.0355739616650012,-0.0208718582634017,5.56115828642225e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,39162,0.0138144328032251,0.0018370770769647,0.0102137617323743,0.0174151038740759,5.79053660718942e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39206,-0.0392766623035056,0.00525188407946847,-0.0495703550992638,-0.0289829695077474,7.91876743265054e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,36747,-0.0213325693808015,0.00285979067978212,-0.0269377591131745,-0.0157273796484286,9.24190629227033e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,39099,-0.0430080089566367,0.00578593724318595,-0.0543484459532811,-0.0316675719599922,1.11635101545266e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,39053,-0.0360641642000577,0.00487092991547521,-0.0456111868343891,-0.0265171415657262,1.39115890485448e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR2,Cadherin-related family member 2,39023,-0.0491204889712474,0.006646150580295,-0.0621469441086256,-0.0360940338338692,1.53542394546375e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",38832,-0.0611858100800147,0.00831835648486595,-0.0774897887903519,-0.0448818313696774,2.00051123516641e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,36743,-0.0399987348002767,0.00545732576342577,-0.0506950932965912,-0.0293023763039622,2.45031433309561e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUOM,Fucose mutarotase,36500,-0.0425442146601221,0.00580916033642573,-0.0539301689195165,-0.0311582604007277,2.55954093614065e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP2,Retinol-binding protein 2,39023,0.0508682101664829,0.00694881766492315,0.0372485275432335,0.0644878927897322,2.59621583115778e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,36767,-0.038741801971104,0.00529247238692924,-0.0491150478494853,-0.0283685560927227,2.62317553693356e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM2,Paralemmin-2,36747,-0.0252364359680798,0.00345725061273508,-0.0320126471690406,-0.018460224767119,3.05618302416993e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2AP,CD2-associated protein,39106,-0.0420954124797404,0.00578219714935521,-0.0534285188924766,-0.0307623060670042,3.49665075989441e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,39283,0.0162246156529718,0.00222893441716749,0.0118559041953236,0.0205933271106201,3.52287176913646e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOA,Elongin-A,39023,-0.0339292621446193,0.00467293158816359,-0.04308820805742,-0.0247703162318187,4.03476685778947e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO1,R-spondin-1,38987,0.0232521500485893,0.00320315010495294,0.0169739758428815,0.029530324254297,4.0848054398711e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,36791,-0.0177183181044788,0.00244573202135311,-0.0225119528663309,-0.0129246833426267,4.58339363629955e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,38741,-0.0373240934081754,0.00516377662463825,-0.0474450955924664,-0.0272030912238845,5.13764743551765e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,36500,-0.0271947394412178,0.00376213661111591,-0.0345685271990049,-0.0198209516834306,5.16296673129505e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,39165,0.0380238338603519,0.00526151416613324,0.0277112660947307,0.048336401625973,5.17915330017665e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KEL,Kell blood group glycoprotein,38741,-0.0233589032891438,0.00323290129057017,-0.0296953898186613,-0.0170224167596263,5.24012016968377e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKLR,Pyruvate kinase PKLR,39114,-0.0419701785292424,0.00582617082697484,-0.0533894733501131,-0.0305508837083717,6.13267688282878e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL5,Fc receptor-like protein 5,39093,0.0367471012494732,0.00510739760100368,0.026736601951506,0.0467576005474404,6.54310360906327e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADM,Pro-adrenomedullin,39255,-0.0170447711350022,0.00238884365320011,-0.0217269046952744,-0.01236263757473,1.00989534463751e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,39071,-0.0552517757878082,0.00774356045250726,-0.0704291542747224,-0.040074397300894,1.0101747652594e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,39029,0.0412652704431363,0.00578516374036342,0.029926349512024,0.0526041913742486,1.02684514479643e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MENT,Protein MENT,36500,0.0143866554224783,0.00202631831253345,0.0104150715299128,0.0183582393150439,1.31524729875995e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39023,0.0127945202882744,0.00180336448319908,0.00925992590120421,0.0163291146753446,1.35268990804432e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,39255,-0.0832113123490941,0.0117709932709755,-0.106282459160206,-0.0601401655379821,1.62544775354732e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39117,-0.0171031504184387,0.00242287667166009,-0.0218519886948925,-0.012354312141985,1.74902945029097e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,39099,-0.0456377471437847,0.00646837378922833,-0.0583157597706723,-0.0329597345168972,1.79363755070849e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,38727,-0.0530783855153949,0.00755487076824433,-0.0678859322211538,-0.038270838809636,2.22220978183073e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRP,Gastrin-releasing peptide,36420,-0.0328595759234477,0.00470730967383436,-0.0420859028841631,-0.0236332489627324,3.08827062308659e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,38832,-0.0237430123725235,0.00340540707434321,-0.0304176102382362,-0.0170684145068108,3.25187607590401e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB1,Carboxypeptidase B,39283,-0.0364250323557765,0.00522534294511842,-0.0466667045282086,-0.0261833601833444,3.27829662638376e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSO,Cathepsin O,39291,-0.0187873877141037,0.00271973923968494,-0.0241180766238862,-0.0134566988043212,5.11503276511036e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,39023,-0.0344251487785201,0.00499027514567235,-0.0442060880640379,-0.0246442094930023,5.46547881744046e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,38987,-0.0466062607879779,0.00675612861082038,-0.0598482728651858,-0.0333642487107699,5.46901783092131e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,39093,-0.0268840135236799,0.00389757093126647,-0.0345232525489622,-0.0192447744983976,5.49580604595563e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMB1,Laminin subunit beta-1,36420,-0.0190317987158089,0.0027633926245652,-0.0244480482599567,-0.0136155491716611,5.96480157173656e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,38727,-0.0346562054279041,0.00503969330215131,-0.0445340043001206,-0.0247784065556875,6.37197235715256e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYNU,Kynureninase,39291,-0.028441934119092,0.0041435129569033,-0.0365632195146225,-0.0203206487235616,6.94095185084307e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39093,0.0152195073598503,0.00221918961993843,0.010869895704771,0.0195691190149296,7.24487227603792e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,39145,0.0180560221341193,0.00263537362005939,0.0128906898388029,0.0232213544294357,7.59194533883564e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAT,Catalase,36616,-0.0328274380486899,0.00480190279403863,-0.0422391675250056,-0.0234157085723742,8.49404549167616e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39147,-0.0216701751295111,0.00317127441193147,-0.0278858729768968,-0.0154544772821254,8.61370458428463e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN2,Calsyntenin-2,39291,-0.0244638182149804,0.00358082644105884,-0.0314822380394557,-0.0174453983905051,8.69365541390424e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",36792,-0.0425082868466549,0.00623246381879879,-0.0547239159315005,-0.0302926577618093,9.47836276811884e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,38741,-0.0313316104032208,0.00460048392108742,-0.0403485588885522,-0.0223146619178895,1.00985470685573e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,39131,-0.0217373286856928,0.00319416685284571,-0.0279978957172704,-0.0154767616541152,1.04577122415513e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,36747,-0.0392644897387177,0.00576986908222702,-0.0505734331398827,-0.0279555463375527,1.05451340721353e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OCLN,Occludin,36767,-0.0266227575899962,0.003921907500014,-0.0343096962900237,-0.0189358188899688,1.18492107354382e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3D,Protein FAM3D,36743,-0.0516005170685158,0.00760200312104593,-0.0665004431857659,-0.0367005909512658,1.18881731393103e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A14,Protein S100-A14,36767,-0.0315870730726998,0.00467591251322081,-0.0407518615986126,-0.022422284546787,1.4867856182202e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP5,Platelet glycoprotein V,36500,0.0222004284260887,0.00328758328528809,0.015756765186924,0.0286440916652533,1.51350793290992e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS4,Galectin-4,39095,-0.0324348586654371,0.00481733638807381,-0.0418768379860618,-0.0229928793448125,1.72207629500457e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,36646,-0.0194710396745347,0.00290252540029529,-0.0251599894591135,-0.013782089889956,2.0518193470986e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,39076,-0.0506597769474965,0.00755722162454678,-0.0654719313316082,-0.0358476225633848,2.10654913993604e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,39291,0.0158061611327469,0.00235894765019851,0.0111826237383578,0.020429698527136,2.14877946455309e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,36500,-0.022645175643609,0.00338132944064053,-0.0292725813472644,-0.0160177699399535,2.21559676751847e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39106,-0.016982231356166,0.00255743328797675,-0.0219948006006004,-0.0119696621117316,3.23537405370347e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPF,Centromere protein F,36538,-0.0326196881771833,0.00491679367345072,-0.0422566037771467,-0.0229827725772199,3.39199069205016e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,36792,-0.0355557271359381,0.0053598591046875,-0.0460610509811256,-0.0250504032907506,3.40393591540264e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,36806,0.0157655162729694,0.00237708171703442,0.0111064361075819,0.0204245964383569,3.4362893527913e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK13,Kallikrein-13,38736,-0.0254322324463587,0.00383894003525013,-0.032956554915449,-0.0179079099772685,3.59645742659631e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,36725,-0.0251704685096564,0.00380976981201489,-0.0326376173412056,-0.0177033196781072,4.08120192063299e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",36420,-0.0223242528544637,0.00338272356621729,-0.0289543910442496,-0.0156941146646778,4.29145263208452e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,39106,-0.0468947541572225,0.00711294323532727,-0.060836122898464,-0.0329533854159811,4.4556137467814e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39165,0.0257948393175639,0.0039294613533047,0.0180930950650867,0.0334965835700411,5.38975924320186e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,38741,-0.0163984216876142,0.00249837243168721,-0.0212952316537211,-0.0115016117215072,5.4246666795055e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR4,Complement factor H-related protein 4,36763,0.0429423692828027,0.00654504351236888,0.0301140839985597,0.0557706545670457,5.54697421923341e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVR,Poliovirus receptor,39241,-0.022272793378188,0.00339613901571676,-0.0289292258489929,-0.0156163609073832,5.61720668551507e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT2,Angiopoietin-2,39255,-0.0224621815124042,0.00344621266117597,-0.0292167583283091,-0.0157076046964993,7.34994521183422e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,39229,-0.035620715746219,0.00546857572102958,-0.046339124159437,-0.024902307333001,7.55947233659113e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,36731,-0.0288202848128607,0.00442445446592463,-0.0374922155660729,-0.0201483540596484,7.59672883022839e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDN1,Endothelin-1,36420,-0.0165538743870417,0.00254819522956317,-0.0215483370369855,-0.0115594117370979,8.54174697967552e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,38684,-0.0516028875452847,0.00796105765717375,-0.0672065605533453,-0.0359992145372241,9.3428846325577e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,39291,0.0170159288783156,0.00262649501698115,0.0118679986450326,0.0221638591115987,9.54007568921502e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXN,Paxillin,38741,-0.0304772153015606,0.00470822315690835,-0.039705332689101,-0.0212490979140203,9.89609933330796e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,38727,-0.0420000061687624,0.006491351906712,-0.0547230559059179,-0.0292769564316069,1.00970194645085e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSNL1,Visinin-like protein 1,36747,-0.0224078729472652,0.00346371776381393,-0.0291967597643405,-0.0156189861301899,1.02008642307275e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN1,Perilipin-1,38741,-0.0204654066651295,0.00316543618456299,-0.026669661586873,-0.0142611517433861,1.04267642905085e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL2,Chordin-like protein 2,39106,-0.0330776047588743,0.0051174348173482,-0.0431077770008767,-0.0230474325168718,1.05271473737333e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGR1,Prostaglandin reductase 1,36792,-0.0468607958158754,0.0072663545509429,-0.0611028507357235,-0.0326187408960273,1.16587927137784e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,39083,0.0184471271415521,0.0028625072546452,0.0128366129224475,0.0240576413606567,1.19551954662023e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA1,Carbonic anhydrase 1,38788,-0.0348304020562746,0.00540604330401999,-0.0454262469321537,-0.0242345571803954,1.20831720982327e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,36792,-0.0332687990911461,0.00517625528943817,-0.0434142594584449,-0.0231233387238472,1.34542670732262e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BECN1,Beclin-1,36420,-0.0354489624859583,0.00551903194226236,-0.0462662650927925,-0.0246316598791241,1.38396531772848e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,36538,-0.0253551171007566,0.00395329428339181,-0.0331035738962045,-0.0176066603053086,1.47104502925896e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN3,Ataxin-3,36747,-0.0358169156851969,0.00558875664124653,-0.0467708787020401,-0.0248629526683537,1.5183176587677e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,39283,0.0147855399971212,0.00230980481323297,0.0102583225631846,0.0193127574310578,1.58606344774629e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',36747,-0.0237072287179581,0.00370344279411064,-0.030965976594415,-0.0164484808415013,1.5929277334803e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,36224,-0.0185911638843787,0.00291366364218008,-0.0243019446230516,-0.0128803831457057,1.82592384294264e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,36731,-0.030908522860037,0.00486044398050794,-0.0404349930618325,-0.0213820526582414,2.0966742474123e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,36791,-0.0134238158931159,0.00211137966846086,-0.0175621200432992,-0.00928551174293265,2.11488546300024e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,36531,-0.0252990038253554,0.00398700897896809,-0.0331135414241328,-0.0174844662265779,2.29464184061234e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLA,Alpha-galactosidase A,36466,-0.0219031050905668,0.00345447839220493,-0.0286738827392884,-0.0151323274418451,2.36843668418657e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLVRB,Flavin reductase,39093,-0.0372469837699805,0.00587537961241466,-0.0487627278103133,-0.0257312397296478,2.36998032458737e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",39106,0.0448338527735778,0.00708109004114751,0.0309549162929286,0.0587127892542269,2.49600422724985e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,36731,-0.032973839674507,0.00521558715876263,-0.0431963905056818,-0.0227512888433322,2.664319387878e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AREG,Amphiregulin,39023,-0.0266275055793038,0.00422827449091894,-0.0349149235815049,-0.0183400875771027,3.10843305163133e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WDR46,WD repeat-containing protein 46,36731,-0.0207926989468208,0.00330244398701137,-0.0272654891613631,-0.0143199087322785,3.15035519364838e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN8,Tetraspanin-8,36743,-0.0561457019032624,0.00892143731881839,-0.0736317190481464,-0.0386596847583783,3.20762316591515e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR5,Complement factor H-related protein 5,36628,0.0236473182628625,0.00376168167410258,0.0162744221816214,0.0310202143441035,3.35559820341854e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,39023,-0.049541586527655,0.00789215690721074,-0.0650102140657881,-0.034072958989522,3.53831555943866e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG1,Arginase-1,38996,-0.0295053162870348,0.00470857799495796,-0.0387341291571524,-0.0202765034169172,3.79757891518391e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCOF1,Treacle protein,36792,-0.0175512180121508,0.00280178983063306,-0.0230427260801916,-0.01205970994411,3.86405622829351e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,39291,0.0143955114676398,0.00230000428814472,0.00988750306287616,0.0189035198724035,3.9792823039562e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,36470,-0.0162601999550638,0.00259804810778711,-0.0213523742463265,-0.0111680256638011,4.00980601134959e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,38727,-0.0349932150183698,0.0056124563982505,-0.0459936295589407,-0.0239928004777988,4.64222347080845e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN1,Dynactin subunit 1,39255,-0.0369358017628165,0.00593261598860923,-0.0485637291004906,-0.0253078744251424,4.91253803931886e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN8,Septin-8,36718,-0.0179984708612968,0.00289055003280564,-0.0236639489255959,-0.0123329927969978,4.91319326677211e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC4,Syndecan-4,39106,0.0258199640723244,0.00414857306276638,0.0176887608693023,0.0339511672753465,4.97889574979845e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,36391,-0.0388089113874252,0.00623720526335655,-0.051033833703604,-0.0265839890712463,5.05970249029533e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSTN,Growth/differentiation factor 8,38832,-0.0294168311936365,0.0047287566800277,-0.0386851942864908,-0.0201484681007822,5.07653085599408e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,38727,-0.0363210650052989,0.00585275220483945,-0.0477924593267842,-0.0248496706838136,5.58593594389012e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTNB,Dystrobrevin beta,36712,-0.0248793714524833,0.00401151234680283,-0.0327419356522168,-0.0170168072527498,5.74620332597419e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,36791,-0.0202271134940176,0.00326446302867964,-0.0266254610302297,-0.0138287659578055,5.96163011398258e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RFC4,Replication factor C subunit 4,36731,-0.0120799103132127,0.00195979252032668,-0.015921103653053,-0.00823871697337243,7.31082761349182e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,36420,-0.0337047972250744,0.00547147210476123,-0.0444288825504064,-0.0229807118997424,7.49217877225844e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH9,Myosin-9,36791,-0.0624964467099452,0.0101629206231605,-0.0824157711313399,-0.0425771222885506,8.00392436404747e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,36743,-0.0444060783432786,0.00722365730304393,-0.0585644466572447,-0.0302477100293125,8.11342789582818e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,38727,-0.0306338607246875,0.00498820291141196,-0.0404107384310549,-0.02085698301832,8.39520217009211e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,39237,-0.0150258903215039,0.00244750660627074,-0.0198230032697946,-0.0102287773732132,8.49410567762918e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,39099,-0.028345397089314,0.00461829143480164,-0.0373972483015252,-0.0192935458771028,8.58321320463619e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC4A1,Band 3 anion transport protein,36791,-0.0261250663718689,0.00425799443920978,-0.0344707354727201,-0.0177793972710177,8.73523955758694e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,36796,-0.0340749805791936,0.00555828305833049,-0.0449692153735214,-0.0231807457848659,9.01595975142205e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,38741,-0.0288961074679343,0.00473201838886802,-0.0381708635101156,-0.019621351425753,1.04366540993046e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD1,Polycystin-1,36792,-0.0145444598463498,0.00238190773673304,-0.0192129990103466,-0.00987592068235305,1.04939297396328e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,36747,-0.0255989279669544,0.00419396794832089,-0.0338191051456634,-0.0173787507882455,1.0658311910322e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,39023,-0.030281577019551,0.00497794004006461,-0.0400383394980776,-0.0205248145410244,1.20672597508782e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,39072,-0.0159582108206035,0.00262418906803194,-0.0211016213939461,-0.0108148002472609,1.22142126149974e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA4,Carbonic anhydrase 4,39283,0.0129669471901607,0.00213246866608811,0.00878730860462796,0.0171465857756934,1.22464861271774e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDA,Cytidine deaminase,36778,-0.02569723764038,0.00422805233264522,-0.0339842202123646,-0.0174102550683953,1.25276954832271e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX2,Peroxiredoxin-2,36608,-0.0337048883623042,0.00554580370723884,-0.0445746636284923,-0.0228351130961161,1.25516246862209e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39106,-0.0351757593457677,0.00579692823397483,-0.0465377386843584,-0.023813780007177,1.32577859043097e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,36430,-0.0391121311276871,0.00644493989529149,-0.0517442133224585,-0.0264800489329158,1.32695745476326e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDT,D-dopachrome decarboxylase,36791,-0.0221870046522903,0.00365630022755399,-0.0293533530982961,-0.0150206562062845,1.33003066228657e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLR,Low-density lipoprotein receptor,39119,-0.0288836112051921,0.00476683815537824,-0.0382266139897335,-0.0195406084206507,1.39946017442512e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,36747,-0.0158373477060609,0.00261684307136653,-0.0209663601259394,-0.0107083352861825,1.46955079116207e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAN,Brevican core protein,38987,0.0183917534979015,0.00304336551195571,0.0124267570944683,0.0243567499013347,1.54605853451627e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,36796,0.0140845849782947,0.00233208813986407,0.00951369222416116,0.0186554777324283,1.58858129627518e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREH,Trehalase,36791,-0.0415338450961548,0.00687709792334154,-0.0550129570259042,-0.0280547331664054,1.58889328196404e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",36767,-0.0225627268074427,0.00377386746597039,-0.0299595070407447,-0.0151659465741407,2.30901560945304e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39086,-0.0619316416508456,0.0103993382721407,-0.0823143446642414,-0.0415489386374499,2.6523663160392e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPO,Erythropoietin,39099,-0.0414184568549004,0.00697807481824318,-0.055095483498657,-0.0277414302111437,2.9928500028978e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR3,Small proline-rich protein 3,36747,-0.0352010144540178,0.00593790240190672,-0.046839303161755,-0.0235627257462807,3.14127784304796e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D17,TBC1 domain family member 17,38741,-0.0238077044066301,0.00401730302933278,-0.0316816183441223,-0.0159337904691378,3.16700780085427e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F7,Coagulation factor VII,39133,-0.01616969698502,0.00272966599532705,-0.021519842335861,-0.010819551634179,3.2155904302011e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,36391,-0.0363988451341244,0.0061493362894302,-0.0484515442614076,-0.0243461460068412,3.32075196802164e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,38987,-0.0123729325790562,0.00209347009512875,-0.0164761339655086,-0.0082697311926039,3.48932909966954e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,36500,0.0209236799845933,0.00354169650293119,0.0139819548388482,0.0278654051303384,3.55602288169152e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTBS,Di-N-acetylchitobiase,36657,-0.01474676279583,0.00249864156679781,-0.0196441002667537,-0.00984942532490631,3.68409949042864e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC1,Stanniocalcin-1,39241,-0.0225232440710397,0.00382118230656897,-0.0300127613919149,-0.0150337267501645,3.84115005108829e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA9,Serpin A9,38950,-0.0390917650563679,0.0066350844647507,-0.0520965306072793,-0.0260869995054565,3.90438485630638e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,38841,0.0214182065850157,0.00364290366537011,0.0142781154008903,0.0285582977691411,4.20432347543963e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",36791,-0.0226260205133973,0.00385126209479714,-0.0301744942191997,-0.0150775468075949,4.33345793549117e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EEF1D,Elongation factor 1-delta,36792,-0.0489006678287649,0.00833008261246953,-0.0652276297492051,-0.0325737059083246,4.45488892639848e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,38907,-0.019235169717539,0.00328471751081961,-0.0256732160387454,-0.0127971233963326,4.84153689177864e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NADK,NAD kinase,39106,-0.0285079190624001,0.00486979978988679,-0.0380527266505782,-0.018963111474222,4.8968137417392e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39099,-0.0325322666759369,0.00556773555812579,-0.0434450283698634,-0.0216195049820103,5.23158095686835e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4R,Reticulon-4 receptor,39255,-0.0176201276950789,0.00302063950988566,-0.0235405811344548,-0.011699674255703,5.54505974475433e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPL,N-acetylneuraminate lyase,36792,-0.023383165659956,0.00401473977968176,-0.0312520556281323,-0.0155142756917798,5.8706096269486e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,36747,-0.0407057718360438,0.00698960324855333,-0.0544053942032083,-0.0270061494688793,5.89107475392451e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,38951,-0.0124519278526079,0.00213886554849289,-0.0166441043276539,-0.00825975137756179,5.94196512631747e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB6,Integrin beta-6,38841,-0.0157315422907697,0.00270975256845674,-0.0210426573249449,-0.0104204272565945,6.54625025688744e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL4,Myosin light chain 4,36420,-0.0274452518560429,0.00472965757314492,-0.0367153806994069,-0.0181751230126788,6.67911568706324e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,36420,-0.0127613172729183,0.0022011348323132,-0.0170755415442521,-0.00844709300158437,6.88853536537483e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPA33,Cell surface A33 antigen,39023,-0.069205341702062,0.01196288332997,-0.0926525930288032,-0.0457580903753207,7.39399862925319e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG4A,Cysteine protease ATG4A,38727,-0.0310969236900102,0.00537670448706411,-0.0416352644846559,-0.0205585828953646,7.45703703108584e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA2,Carbonic anhydrase 2,39057,-0.0356138150345129,0.00618355039111086,-0.0477335738010902,-0.0234940562679356,8.60230365660084e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,39099,0.0180673359374977,0.00316273867944127,0.0118683681257929,0.0242663037492026,1.13367097426307e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,38713,-0.0366268603760092,0.00642579841507841,-0.0492214252695629,-0.0240322954824556,1.22104828684866e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL5,Insulin-like peptide INSL5,36743,-0.0501522411420091,0.0088154344145023,-0.0674304925944336,-0.0328739896895846,1.30459973002038e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH2,Neutral ceramidase,38987,-0.0270278147427364,0.00475730457510707,-0.0363521317099463,-0.0177034977755266,1.36112748416839e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZU1,Azurocidin,38608,-0.0397104696834478,0.00699426089243587,-0.0534192210326221,-0.0260017183342735,1.39188403137534e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,39100,-0.0492635098951428,0.00868420203717615,-0.0662845458880081,-0.0322424739022776,1.43056824195427e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD84,SLAM family member 5,39099,0.0161168170741704,0.00284216879072031,0.0105461662443586,0.0216874679039822,1.44875553291099e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,39095,-0.0207042031416352,0.00365826883857819,-0.0278744100652484,-0.0135339962180219,1.54491963696484e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,38987,-0.0163566673667228,0.00289370696257875,-0.0220283330133772,-0.0106850017200684,1.60988749731059e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP4,Bone morphogenetic protein 4,38960,-0.0235672260509578,0.00417140415377637,-0.0317431781923595,-0.0153912739095561,1.63618862307174e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,39291,-0.0171644368996974,0.0030381560888976,-0.0231192228339367,-0.0112096509654581,1.63639205702892e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,39099,-0.0387485607223429,0.00686092501319311,-0.0521959737482013,-0.0253011476964844,1.65496315338702e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C19orf12,Protein C19orf12,38741,-0.03364121454073,0.00596163650297062,-0.0453260220865525,-0.0219564069949076,1.702085915901e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,38727,-0.0291605651508577,0.00516769989880012,-0.0392892569525059,-0.0190318733492094,1.70307973459672e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PZP,Pregnancy zone protein,36806,0.0279148184425883,0.00494899587019438,0.0182147865370073,0.0376148503481693,1.73106627155383e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,39241,0.0229326251869044,0.00407104047364987,0.0149533858585506,0.0309118645152581,1.80086423886504e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,36631,-0.0284427816704783,0.00505349800695684,-0.0383476377641137,-0.0185379255768429,1.85787859670959e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SBSN,Suprabasin,36774,0.0174239243010122,0.00309743823245321,0.0113529453654039,0.0234949032366205,1.89066468946109e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH1,Cadherin-1,38578,-0.0206984939142733,0.00368265533885627,-0.0279164983784315,-0.013480489450115,1.9382164102117e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39165,-0.0217733860102752,0.00387970568667924,-0.0293776091561665,-0.0141691628643839,2.03325729794538e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL3,Myosin light chain 3,36420,-0.0371777239568678,0.00662916720108254,-0.0501708916709896,-0.024184556242746,2.08752616048881e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMN,Protein amnionless,38841,-0.0244565222260873,0.00436901184629807,-0.0330197854448315,-0.0158932590073431,2.209948703981e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,39139,0.0251526257115445,0.00449534658559774,0.0163417464037729,0.0339635050193161,2.24076185133163e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,36747,-0.0241828187278472,0.00432190690408745,-0.0326537562598586,-0.0157118811958358,2.24595112813285e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML2,Trem-like transcript 2 protein,39093,0.0169598973633506,0.00303137246121601,0.0110184073393672,0.022901387387334,2.24690094014225e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,39241,-0.0340563384494401,0.00609760942834027,-0.046007652928987,-0.0221050239698931,2.37391717647949e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,38727,-0.0221781026204384,0.00397872892753341,-0.0299764113184039,-0.0143797939224729,2.53041576528871e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK4,Dickkopf-related protein 4,38958,-0.0228568961889,0.00410114580366654,-0.0308951419640864,-0.0148186504137135,2.54243242886918e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,36747,-0.0155039090830798,0.00278741377198808,-0.0209672400761765,-0.0100405780899832,2.7183671747859e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPPK1,Epiplakin,36420,-0.0377739986353759,0.00679267580127105,-0.0510876432058672,-0.0244603540648846,2.73727999607197e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39023,-0.0275785540464271,0.00498325675071667,-0.0373457372778318,-0.0178113708150225,3.17756953453514e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL13,C-C motif chemokine 13,39260,-0.0346227302138482,0.00626110674683437,-0.0468944994376435,-0.0223509609900528,3.25793585583062e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,39099,-0.0286352686569917,0.00518069783712551,-0.0387894364177577,-0.0184811008962258,3.30535091017779e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD6,Programmed cell death protein 6,39106,0.0351397053665216,0.00636659483319818,0.0226611794934532,0.0476182312395901,3.457326658842e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDI2,Protein DDI1 homolog 2,36500,-0.0377053782395597,0.00683401432858256,-0.0511000463235816,-0.0243107101555379,3.51000260325375e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,38987,-0.0261394540900047,0.00474333612145813,-0.0354363928880626,-0.0168425152919468,3.63097688529457e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G1B,Phospholipase A2,39264,0.0203809750700424,0.00369898384716771,0.0131309667295937,0.0276309834104911,3.6482702074375e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100P,Protein S100-P,38832,-0.0263529976185698,0.0047883261061687,-0.0357381167866605,-0.0169678784504791,3.78242242701986e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA1,Carboxypeptidase A1,39283,-0.0295858675290933,0.00537615089878946,-0.0401231232907207,-0.019048611767466,3.78970808049691e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAA4,Serum amyloid A-4 protein,36806,-0.0165090866971164,0.00300453658376068,-0.0223979784012874,-0.0106201949929455,3.98727997499976e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,38987,-0.0270136945239079,0.00491727858123017,-0.036651560543119,-0.0173758285046967,4.00119124170831e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",38741,-0.0254024650078574,0.0046258835420553,-0.0344691967502858,-0.016335733265429,4.0535046451736e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36155,-0.0248052549729939,0.00452525447981814,-0.0336747537534374,-0.0159357561925503,4.30014083812703e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA4,Kallistatin,36607,-0.0116926784193526,0.00213394558974499,-0.0158752117752528,-0.00751014506345244,4.34947581871503e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39149,0.0150454434572912,0.00274689964168247,0.00966152015959352,0.0204293667549888,4.38818299924921e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPOCK1,Testican-1,38987,0.0126566935904566,0.00231116016892596,0.00812681965936171,0.0171865675215515,4.41143521109374e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPQ,Carboxypeptidase Q,36784,-0.018851689000645,0.00344640044921376,-0.025606633881104,-0.012096744120186,4.58498553996902e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39117,0.0165793809987325,0.00303253191308138,0.010635618449093,0.022523143548372,4.64448741077156e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,38987,-0.0264894958096751,0.00486713165172212,-0.0360290738470505,-0.0169499177722998,5.33477002356084e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",36792,-0.0376996093299266,0.00692825977915871,-0.0512789984970777,-0.0241202201627755,5.38186529938105e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMCN2,Hemicentin-2,36478,-0.0280258873488893,0.00516716968245217,-0.0381535399264955,-0.017898234771283,5.94084657961406e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIT,Citron Rho-interacting kinase,36421,-0.0224584551849973,0.00414391237607789,-0.03058052344211,-0.0143363869278847,6.08266399279821e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GLB2,Endophilin-B2,36747,-0.0327188838578664,0.00603890204694425,-0.0445551318698772,-0.0208826358458557,6.13462674128864e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",38841,-0.0295711777878766,0.00547636906582941,-0.0403048611569023,-0.018837494418851,6.77404497003672e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS2,Trypsin-2,39165,-0.0252300058760159,0.00467499054384244,-0.0343929873419471,-0.0160670244100847,6.88484460495582e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,36767,-0.0274143237628183,0.00507970807023986,-0.0373705515804885,-0.0174580959451482,6.90271011135585e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39165,-0.0203841120881127,0.00378411131281928,-0.0278009702612384,-0.0129672539149869,7.27979871263434e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39023,-0.0191678488159881,0.00356030513087729,-0.0261460468725076,-0.0121896507594687,7.40292315967206e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI2,Serpin I2,36743,-0.0281344399256271,0.00522651564736845,-0.0383784105944693,-0.0178904692567849,7.45302476489586e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,38841,-0.0348173737741265,0.00648561599343403,-0.0475291811212572,-0.0221055664269958,8.06223829337322e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,38939,-0.0145463438916613,0.00271050033272931,-0.0198589245438107,-0.00923376323951185,8.13921922870028e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,39147,0.0134973532856429,0.00251522516378408,0.00856751196462613,0.0184271946066597,8.15577003993152e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,36500,-0.0260262854214785,0.00485509401819918,-0.0355422696971489,-0.0165103011458081,8.43976408589473e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",38727,-0.0406744702661544,0.00759515486087151,-0.0555609737934625,-0.0257879667388462,8.66763079544879e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",36363,-0.0323647763909503,0.00606455387213507,-0.0442513019803351,-0.0204782508015656,9.63005037163008e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,36806,0.00898836841244926,0.00168560883479562,0.00568457509624985,0.0122921617286487,9.85436865024021e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39073,-0.0354925051317433,0.00666103720939663,-0.0485481380621607,-0.0224368722013259,1.00507407452554e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR,GMP reductase 1,39291,-0.0239644204626356,0.00449974612840046,-0.0327839228743005,-0.0151449180509707,1.01959694959849e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2,Complement C2,39145,0.0115262435166461,0.00216547062543356,0.00728192109079634,0.0157705659424959,1.03657840663279e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,38727,-0.0326689685754439,0.0061441434968689,-0.044711489829307,-0.0206264473215809,1.06964547405933e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDCP1,CUB domain-containing protein 1,38987,-0.0242255664296396,0.00455639377372555,-0.0331560982261417,-0.0152950346331375,1.07091794682212e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP2,Dipeptidase 2,39023,0.0140561105413167,0.0026538092271392,0.00885464445612388,0.0192575766265095,1.19640338980164e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORT1,Sortilin,39086,-0.0180198890195957,0.00340594590842906,-0.0246955430001167,-0.0113442350390748,1.23526585908095e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLB,Beta-klotho,38741,0.0353411973727077,0.00670010889999528,0.022208983928717,0.0484734108166985,1.34821376738211e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN3,Contactin-3,39093,-0.015684388118497,0.00297444098609895,-0.021514292451251,-0.0098544837857431,1.36005416112632e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,39106,-0.0157304602246147,0.0029837953366066,-0.0215786990843636,-0.00988222136486572,1.36813157219006e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,39147,-0.0127300969655599,0.00241970058981923,-0.0174727101216056,-0.0079874838095142,1.45190555451079e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB6,Heat shock protein beta-6,39255,-0.0179572489812689,0.00341390144631154,-0.0246484958160395,-0.0112660021464983,1.45954757007482e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,39099,-0.044193439106342,0.00840357825210466,-0.0606644524804671,-0.0277224257322169,1.4689168344445e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,39086,-0.0328920709044125,0.00625519241060787,-0.0451522480292039,-0.020631893779621,1.47309091620045e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,36430,-0.0153628925161438,0.00292502199885512,-0.0210959356338998,-0.00962984939838772,1.52720642868474e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,39095,0.0161931822133829,0.00309787916972851,0.0101213390407151,0.0222650253860508,1.74384776934402e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,39255,0.0279329925834288,0.00534578565618179,0.0174552526973125,0.0384107324695451,1.76202627223351e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,39099,-0.0295389606774287,0.00565790002307363,-0.040628444722653,-0.0184494766322044,1.80459013807423e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,36762,0.00686986880849628,0.00131649288672986,0.00428954275050576,0.0094501948664868,1.83362322579497e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAXX,Protein PAXX,36500,-0.0219185066213408,0.00420589738804903,-0.0301620655019169,-0.0136749477407647,1.90398479563308e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,36430,-0.0155919914061568,0.00299443444005516,-0.021461082908665,-0.00972289990364874,1.94957487074852e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",36743,0.0490529939564192,0.00942983130761481,0.0305705245934942,0.0675354633193442,2.00292553151405e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C4BPB,C4b-binding protein beta chain,39147,0.0187310522014864,0.00360747877742724,0.011660393797729,0.0258017106052438,2.10394074878602e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX,Glutaredoxin-1,39013,-0.0265516093162071,0.00511418166213304,-0.0365754053739879,-0.0165278132584264,2.11007997219439e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,36747,-0.0417526453370003,0.00805443073133784,-0.0575393295704225,-0.0259659611035782,2.2068637738429e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,36747,-0.0308657728592138,0.00595981992377728,-0.0425470199098172,-0.0191845258086103,2.26468536963116e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,38727,-0.0233676436087989,0.00452062400308687,-0.0322280666548492,-0.0145072205627486,2.38248102003973e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA3,Carbonic anhydrase 3,39253,-0.0283652485463052,0.00549091773760708,-0.0391274473120151,-0.0176030497805953,2.42338697449408e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,39106,-0.0163903002339226,0.00317773337960152,-0.0226186576579415,-0.0101619428099036,2.52919410220253e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL3,Follistatin-related protein 3,39037,-0.0140684225632607,0.0027289703906661,-0.0194172045289663,-0.00871964059755514,2.56525598905977e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,39023,-0.0500825667997987,0.00971509026182908,-0.0691241437129837,-0.0310409898866137,2.56639564891988e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,36747,-0.0361343719435591,0.00701990344175234,-0.0498933826893936,-0.0223753611977245,2.67984922641877e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",39106,-0.0341079244836016,0.00663877712315336,-0.0471199276449822,-0.021095921322221,2.8158056360476e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,38832,-0.0190713495696442,0.00371453070344592,-0.0263518297483982,-0.0117908693908901,2.8681356430552e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADD1,Alpha-adducin,36500,-0.0322874944892777,0.00629239673970088,-0.0446205920990914,-0.0199543968794639,2.92181970270658e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39101,-0.0268704737101309,0.00524618179450419,-0.0371529900273591,-0.0165879573929027,3.06144530071444e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCA,Calcitonin,38951,-0.0285080883237462,0.00556754380442157,-0.0394204741804125,-0.0175957024670799,3.08629023977321e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,39137,0.0145990334223879,0.00285154229274623,0.00901001052860531,0.0201880563161705,3.0974401195124e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN4,Cerebellin-4,39255,-0.0144212736156429,0.00282058982046962,-0.0199496296637633,-0.00889291756752239,3.2112709999537e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF23,Fibroblast growth factor 23,39234,-0.0269790645517835,0.00528737082545259,-0.0373423113696706,-0.0166158177338964,3.39103070917114e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4D,Semaphorin-4D,39241,0.0139137461520555,0.00273776108524237,0.00854773442498046,0.0192797578791305,3.77537933290901e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39211,0.0157417384647298,0.0031006606113791,0.0096644436664268,0.0218190332630329,3.88135407077524e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,38475,-0.017437873066422,0.00343707137078055,-0.0241745329531518,-0.0107012131796921,3.95419033264032e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAT,Tissue-type plasminogen activator,39234,-0.0229069039783236,0.00451684990600873,-0.0317599297941007,-0.0140538781625465,3.9942414721804e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGFR,Opioid growth factor receptor,39023,-0.0150860162121514,0.0029776221391781,-0.0209221556049404,-0.00924987681936229,4.10035969545694e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD27,CD27 antigen,39147,0.0179665467204261,0.00354764031137046,0.01101317171014,0.0249199217307121,4.1453217813476e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39023,-0.0451812197605631,0.00892308387007444,-0.062670464145909,-0.0276919753752172,4.16654754165852e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,36500,-0.0182909491070811,0.00361647531517104,-0.0253792407248164,-0.0112026574893459,4.30352748196141e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,39023,-0.00952095777778929,0.00189149078496923,-0.013228279716329,-0.0058136358392496,4.86937316886021e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",36430,-0.0163939363606925,0.0032593246594327,-0.0227822126931806,-0.0100056600282044,4.97618698953159e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,36796,0.0115704564387189,0.00230645423070641,0.00704980614653434,0.0160911067309035,5.33039695323077e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,39255,-0.0147287249217282,0.00295560247141881,-0.0205217057657091,-0.00893574407774738,6.31796608304696e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,39136,-0.0151032094451123,0.00303278887633106,-0.0210474756427212,-0.00915894324750342,6.42868101931868e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLF4,Krueppel-like factor 4,36363,-0.0180411268124658,0.00362720260523466,-0.0251504439187257,-0.0109318097062058,6.6511190830483e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,38741,-0.0173492701364657,0.00349072073768115,-0.0241910827823208,-0.0105074574906107,6.76584673030656e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,38987,-0.013143993937475,0.00264943166954004,-0.0183368800097735,-0.00795110786517653,7.08702573237222e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,36747,-0.0393653342438039,0.00794497062420768,-0.054937476667251,-0.0237931918203569,7.33430907943251e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMMT,MICOS complex subunit MIC60,36731,-0.0197768478172683,0.00399163231673626,-0.0276004471580714,-0.0119532484764652,7.34091467434166e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELL,L-selectin,36806,0.0101883232079835,0.0020597231820186,0.00615126577122703,0.01422538064474,7.65268887034046e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA1,Apolipoprotein A-I,36806,0.0122726625544439,0.00248786349671546,0.00739645010088159,0.0171488750080062,8.19766662002431e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",38994,-0.0336444566845719,0.00682624035855387,-0.0470238877873375,-0.0202650255818063,8.36567319537901e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL16,C-C motif chemokine 16,39283,-0.0233908538824585,0.00474809202479847,-0.0326971142510635,-0.0140845935138535,8.46399456213871e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3C,Protein FAM3C,39086,-0.0130019319140547,0.00263943981100883,-0.018175233943632,-0.00782862988447743,8.48025127273565e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSA,Arylsulfatase A,39093,-0.0201747585040098,0.00409802076657063,-0.0282068792064882,-0.0121426378015313,8.60978107299209e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39023,-0.024146728973854,0.00490649232058267,-0.033763453922196,-0.0145300040255119,8.68371486993826e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,38642,-0.00869098246243905,0.00176644446591633,-0.0121532136156351,-0.00522875130924304,8.74564843256842e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPY30,Protein dpy-30 homolog,39206,-0.0266384537385506,0.00542871761128547,-0.0372787402566701,-0.0159981672204311,9.34518985104238e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39204,-0.0462196609900396,0.00942882848511676,-0.0647001648208685,-0.0277391571592108,9.58589671249284e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP10,Stromelysin-2,39091,0.0261970193901303,0.00534825029693866,0.0157144488081305,0.03667958997213,9.7691036924915e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,38630,0.0162962762204219,0.0033294199448169,0.00977061312858075,0.022821939312263,9.95310525360984e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSNAX,Translin-associated protein X,36391,-0.0175651636582012,0.0035953839310557,-0.0246121161630704,-0.010518211153332,1.04454651516989e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GET3,ATPase GET3,36792,-0.0248847538319783,0.00509920247290356,-0.0348791906788693,-0.0148903169850873,1.07282259622921e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPR,Nucleoprotein TPR,36391,-0.0210658580122517,0.00432588334390971,-0.0295445893663147,-0.0125871266581887,1.13118713263932e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,39165,-0.0122896374403702,0.00252743504634923,-0.0172434101312147,-0.00733586474952577,1.17067101910438e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAP,Prolyl endopeptidase FAP,39283,-0.0120998105010434,0.00249089834654078,-0.0169819712602633,-0.00721764974182344,1.19977960386154e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,39241,-0.0287399319458975,0.00592225075712934,-0.040347543429871,-0.017132320461924,1.22878773192152e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,38727,-0.0299989920545101,0.0061856972456965,-0.0421229586560752,-0.017875025452945,1.24877817818207e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHPS,Deoxyhypusine synthase,36731,-0.0180156502305219,0.0037237508226553,-0.0253142018429263,-0.0107170986181175,1.32646351406544e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,39283,-0.0129681605371445,0.00268119784034483,-0.0182233083042203,-0.00771301277006859,1.33284162008815e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL1,Follistatin-related protein 1,36420,-0.0100393299595067,0.00208353324253369,-0.0141230551148728,-0.00595560480414069,1.46394338402178e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UMOD,Uromodulin,39244,0.0231168686003341,0.00481646993178496,0.0136765875340356,0.0325571496666326,1.60519763579539e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RETN,Resistin,39031,0.017719197117138,0.00369435361210926,0.0104782640374038,0.0249601301968721,1.63165789470934e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,36420,-0.0370795590957166,0.0077324958479321,-0.0522352509576635,-0.0219238672337697,1.64304095571106e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,38994,-0.011368768137748,0.00237241481476489,-0.0160187011746871,-0.00671883510080878,1.66639707064525e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,38973,-0.0145854376391799,0.00305194005298432,-0.0205672401430291,-0.0086036351353306,1.77763840503754e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTYMK,Thymidylate kinase,36792,-0.0298959013917985,0.00625531530912168,-0.042156319397677,-0.01763548338592,1.7785992767482e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,39229,-0.0143321422018075,0.00300239311475729,-0.0202168327067318,-0.00844745169688319,1.82652746619325e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA1,Ephrin-A1,39062,0.0114648218191657,0.0024018991365358,0.00675709951155554,0.0161725441267759,1.82980203132443e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BACH1,Transcription regulator protein BACH1,39099,-0.0323167167456506,0.00677362687130096,-0.0455930254134005,-0.0190404080779008,1.85047393892192e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG3,Desmoglein-3,39191,-0.0145107498129306,0.00304557387698898,-0.020480074611829,-0.00854142501403224,1.9102241165001e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR2,Folate receptor beta,39241,0.0125129511452595,0.00262645251393885,0.00736510421793938,0.0176607980725797,1.91333692044563e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,39165,-0.0198124233093652,0.00416442494188054,-0.0279746961954511,-0.0116501504232793,1.9775409128676e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,36767,-0.0261668606336525,0.00550384568552377,-0.0369543981772791,-0.015379323090026,2.01299601057837e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,36726,-0.0354399695199682,0.0074699640035565,-0.050081098966939,-0.0207988400729975,2.11447156312722e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,36747,-0.0300584562968786,0.00633986457076863,-0.0424845908555851,-0.0176323217381721,2.14748769692144e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEPR,Leptin receptor,39106,0.0132361269341513,0.00279276938415673,0.00776229894120411,0.0187099549270985,2.16258644662427e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39023,-0.0190823319866335,0.00403429321994,-0.0269895466977159,-0.0111751172755511,2.2650825219616e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,38926,-0.0156867055433843,0.00331980805453686,-0.0221935293302765,-0.00917988175649204,2.31983229287786e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN1,Pantetheinase,36796,-0.0311606232389861,0.006613872489293,-0.0441238133180004,-0.0181974331599719,2.48576971360792e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB7,Integrin beta-7,39255,-0.0194915300468241,0.00414623588034014,-0.0276181523722908,-0.0113649077213574,2.61110907525959e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,39099,-0.010451959169066,0.00222362728081114,-0.0148102686394558,-0.00609364969867612,2.61912144830003e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,38727,-0.0218387690939953,0.00465189715664025,-0.0309564875210101,-0.0127210506669804,2.69521525966221e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN5,CCN family member 5,39093,0.0164649137128938,0.00350733021936135,0.00959054648294556,0.023339280942842,2.6968107775826e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUS,RNA-binding protein FUS,38706,-0.0168174341990269,0.00358993603772119,-0.0238537088329605,-0.00978115956509339,2.8298693415852e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBB,Inhibin beta B chain,36500,0.0209850135592279,0.00449624178612764,0.0121723796584177,0.0297976474600381,3.08417441284458e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG6,Large proline-rich protein BAG6,38832,-0.0157986172454948,0.0033872376403273,-0.0224376030205363,-0.00915963147045328,3.12559809675995e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,39241,-0.0222041949771912,0.004768805067323,-0.0315510529091443,-0.0128573370452381,3.24895830399971e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,36507,-0.0277352283315529,0.00596266829240859,-0.0394220581846738,-0.0160483984784321,3.32902260764331e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,39059,0.0138517427267245,0.00298314728612584,0.00800477404591788,0.0196987114075312,3.45704817081096e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,36743,-0.0124345445563449,0.00268009130374585,-0.0176875235116867,-0.00718156560100302,3.52527374871524e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,39106,-0.00741964323322174,0.00160081320424211,-0.0105572371135363,-0.00428204935290721,3.60032251686277e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCG,Gamma-synuclein,38987,-0.0274575464509423,0.0059287335453785,-0.0390778641998842,-0.0158372287020004,3.6646155481069e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,39147,0.0114085588716693,0.00246522944765413,0.00657670915426717,0.0162404085890714,3.72628759406487e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,38700,-0.0119233450715995,0.00257943999549487,-0.0169790474627694,-0.00686764268042956,3.82420759067642e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,39106,-0.0264098147169936,0.00571423976124791,-0.0376097246490396,-0.0152099047849477,3.83626542172545e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,36430,-0.0217436630804853,0.00470640156275715,-0.0309682101434894,-0.0125191160174813,3.87517161267761e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALY,RNA-binding protein Raly,36731,-0.0205152079108034,0.00444566912893028,-0.0292287194035068,-0.0118016964181001,3.97560566660336e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POSTN,Periostin,36791,0.0155706150037682,0.003381984137219,0.00894192609481899,0.0221993039127175,4.18424745071596e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL15,C-C motif chemokine 15,39283,-0.0180790600102633,0.00394693258639254,-0.0258150478795927,-0.010343072140934,4.67420026272443e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,38727,-0.0271370284581889,0.00592507719897918,-0.0387501797681881,-0.0155238771481898,4.68684451484291e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,36747,-0.0259271150236729,0.00566351921711466,-0.0370276126892176,-0.0148266173581282,4.74023806591601e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD6,T-cell differentiation antigen CD6,39274,-0.0218777590103005,0.0047830044072137,-0.0312524476484394,-0.0125030703721616,4.82084398712895e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,39106,-0.0125791809360647,0.00275124967685545,-0.0179716303027014,-0.00718673156942803,4.86495009785903e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJAP1,Tight junction-associated protein 1,39147,-0.0346673594748909,0.0075881785490103,-0.0495401894309511,-0.0197945295188307,4.94829624090212e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,36731,-0.0289300039381423,0.00635037823778876,-0.0413767452842083,-0.0164832625920764,5.27076257507985e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,39099,0.0166503136407231,0.00365723832921978,0.0094821265154523,0.0238185007659938,5.33713250228201e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,36743,-0.0123071979645236,0.00270467506451879,-0.0176083610909805,-0.00700603483806682,5.40482490384262e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,36538,-0.0233073782897583,0.00512928749986278,-0.0333607817894893,-0.0132539747900272,5.57120263220013e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39136,-0.0210279487996278,0.00463021837337472,-0.0301031768114422,-0.0119527207878133,5.62933730019979e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL25,C-C motif chemokine 25,39291,-0.0205547937582825,0.0045352322893251,-0.0294438490453597,-0.0116657384712053,5.87978727406477e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,39241,-0.00963363538953707,0.00212902564404303,-0.0138065256518614,-0.00546074512721274,6.08756196647908e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAB2,Stabilin-2,36791,-0.0115370194289792,0.00255381869421248,-0.0165425040696356,-0.00653153478832271,6.31115404869279e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,36420,0.0247730371598155,0.00548769138890227,0.0140171620375671,0.035528912282064,6.41066497630087e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,36767,-0.0152880890241666,0.00338676798558602,-0.0219261542759152,-0.00865002377241802,6.41595626339562e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEP,Leptin,39106,-0.0278612036028414,0.00617292298373966,-0.0399601326509711,-0.0157622745547117,6.42575479656813e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,39283,0.0139687444040565,0.00309871325924038,0.00789526641594538,0.0200422223921677,6.5948904234342e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,36420,-0.0169065954048151,0.00375969214751912,-0.0242755920139526,-0.00953759879567764,6.96009105221089e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A12,Protein S100-A12,38856,-0.0304532279375138,0.00678343380371016,-0.0437487581927857,-0.0171576976822419,7.19723148878774e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,36261,-0.021927215025004,0.00488731539696436,-0.0315063532030542,-0.0123480768469539,7.30348334796692e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CX3CL1,Fractalkine,38987,0.0135313682126462,0.0030180489115718,0.0076159923459655,0.019446744079327,7.39746105426431e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,36430,-0.0226408897626508,0.00505377129177736,-0.0325462814945344,-0.0127354980307672,7.53021813615007e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA9,Carbonic anhydrase 9,39255,-0.0177026780534682,0.00395205678163739,-0.0254487093454775,-0.00995664676145897,7.54066571491716e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,38727,-0.0182715508331552,0.00407912343440327,-0.0262666327645856,-0.0102764689017248,7.54521739460581e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLUL1,Clusterin-like protein 1,39079,0.0184592323587201,0.00412324133914666,0.0103776793339926,0.0265407853834475,7.62942017141189e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLFM4,Olfactomedin-4,36052,-0.0500423681048135,0.0112146514130882,-0.0720230848744664,-0.0280616513351606,8.18375452190088e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,38841,-0.0242755220092796,0.00545498739852055,-0.0349672973103799,-0.0135837467081794,8.64286175721784e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,36391,0.0112746924992778,0.00254110472007143,0.00629412724793776,0.0162552577506178,9.20312838099247e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN2,Dynactin subunit 2,39023,-0.0383479301374679,0.0086713970127358,-0.0553438682824301,-0.0213519919925057,9.83136112289305e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,39291,-0.0309017648296174,0.00699791147178103,-0.0446176713143082,-0.0171858583449265,1.01295325226606e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,36731,-0.0460885981084599,0.0104402169377148,-0.0665514233063808,-0.025625772910539,1.02056587248543e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL32,Interleukin-32,39099,0.0172475678597897,0.00391342990174117,0.00957724525237706,0.0249178904672024,1.0539376481627e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFLAM,Pikachurin,36743,-0.012321197033281,0.0027991133723949,-0.017807459243175,-0.00683493482338702,1.08209856601533e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYAL1,Hyaluronidase-1,38990,0.00918265145348444,0.00208683981027425,0.00509244542534691,0.013272857481622,1.08857560826212e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM1,Dynamin-1,36743,0.0459273446186449,0.010456130027593,0.0254333297645627,0.0664213594727272,1.13009054963951e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,36767,0.0147394919402344,0.00335714705527024,0.00815948371190472,0.0213195001685641,1.1399956188323e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,36391,0.0103841323049357,0.00236582607094492,0.00574711320588364,0.0150211514039877,1.14688726925259e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF15,Growth/differentiation factor 15,39283,-0.0169814023277223,0.00386959993434608,-0.0245658181990406,-0.00939698645640394,1.14939145334042e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLNS1A,Methylosome subunit pICln,36421,-0.0134672944363481,0.00307167966530869,-0.0194877865803531,-0.00744680229234302,1.1728267558099e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",36767,0.0364950974153701,0.0083263129414922,0.0201755240500454,0.0528146707806948,1.17924759811732e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCA2A,Guanylin,39034,-0.01284467317661,0.00293722452275812,-0.0186016332412159,-0.00708771311200406,1.23330359414587e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,36731,-0.027477014779503,0.00628781081267584,-0.0398011239723477,-0.0151529055866584,1.2528543252158e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39140,0.0357390748516181,0.00817948629289061,0.0197072817175525,0.0517708679856837,1.25435925609153e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,36679,0.0106685533972994,0.00244723856391258,0.00587196581203075,0.0154651409825681,1.31420919216159e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFAP,Glial fibrillary acidic protein,38704,0.0174238890211813,0.00399751061167089,0.00958876822230636,0.0252590098200563,1.31726147543516e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,36747,-0.0249654138780584,0.00572889178463592,-0.0361940417759448,-0.013736785980172,1.32388247733997e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTP1,Glutathione S-transferase P,38652,0.0275494341135545,0.00632260614813719,0.0151571260632056,0.0399417421639034,1.32569648666848e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,36430,-0.0317686399726467,0.0073008957476789,-0.0460783956380973,-0.0174588843071961,1.36379363574104e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F9,Coagulation factor IX,39145,-0.00721819687009294,0.00166139031323499,-0.0104745218840335,-0.00396187185615235,1.40383159378933e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39099,-0.0389519734178705,0.00896689202660123,-0.0565270817900089,-0.0213768650457321,1.4083073686967e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",39283,-0.01920149480713,0.00442041156421236,-0.0278655014729862,-0.0105374881412737,1.40917289871069e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,39023,-0.0493339833007938,0.0113664510941262,-0.0716122274452811,-0.0270557391563066,1.43199784752049e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTN,Pleiotrophin,38832,0.0198924727138526,0.00458682060269233,0.0109023043325757,0.0288826410951296,1.45467123699287e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,36747,-0.0163783263605931,0.00378463592813806,-0.0237962127797436,-0.00896043994144246,1.51890942081066e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML1,Trem-like transcript 1 protein,36796,0.0209701451586397,0.00484916960668967,0.0114657727295279,0.0304745175877514,1.54035932575862e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY96,Lymphocyte antigen 96,38987,0.0139414081468245,0.00322774039792669,0.00761503696688822,0.0202677793267609,1.57560113648643e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASN,Vasorin,38888,0.0108050296178023,0.00250403698741371,0.00589711712247144,0.0157129421131332,1.60590909813447e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,39099,-0.0339870670878636,0.00787946010789825,-0.0494308088993442,-0.0185433252763831,1.61792703914217e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,36421,-0.0240027796540454,0.0055660408440176,-0.0349122197083199,-0.0130933395997709,1.62752708506002e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,39241,0.0175088463444091,0.00406881630941912,0.00953396637794759,0.0254837263108705,1.69404632147709e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,39241,-0.0114347789257575,0.00266210259467852,-0.0166525000113274,-0.00621705784018756,1.7545346505039e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPACT,Protein IMPACT,36747,-0.0216389851928793,0.00503916085916867,-0.0315157404768499,-0.0117622299089087,1.76635770333663e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,36747,-0.00864734284714623,0.00201476403794688,-0.0125962803615221,-0.00469840533277035,1.78374016388524e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBS,Cystathionine beta-synthase,36420,-0.0199901298186005,0.00466395416504671,-0.029131479982092,-0.0108487796551089,1.83200637494263e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,39162,-0.0109620790202922,0.00256050172145145,-0.015980662394337,-0.00594349564624737,1.87000869125037e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39023,0.0167238908689622,0.00390941021538495,0.00906144684680773,0.0243863348911167,1.89858963545308e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100G,Protein S100-G,36767,0.017533590332933,0.00410494126897403,0.00948790544574392,0.0255792752201221,1.95695053194993e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,39099,-0.0213768740241264,0.00500801696747415,-0.0311925872803757,-0.0115611607678771,1.97954470437427e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LG,CMRF35-like molecule 9,39093,0.0141727927349723,0.00333012003752251,0.00764575746142813,0.0206998280085164,2.09417111616561e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,36785,0.00745021698192301,0.00175279724642753,0.00401473437892505,0.010885699584921,2.14816643769623e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFA,Protransforming growth factor alpha,39099,0.017815313666053,0.00419442234324728,0.00959424587328828,0.0260363814588176,2.17566228249399e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF2,Trefoil factor 2,39140,-0.0220071155133889,0.00518186379878768,-0.0321635685590128,-0.0118506624677651,2.17982141665365e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPACAM2,HEPACAM family member 2,36747,-0.0161746873173618,0.00381870102800607,-0.0236593413322537,-0.00869003330246994,2.29472441562308e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200,OX-2 membrane glycoprotein,39099,0.009946203312816,0.00234910304620749,0.00534196134224933,0.0145504452833827,2.30872501546363e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,36430,-0.0185188858551732,0.00437464329384755,-0.0270931867111144,-0.00994458499923196,2.31991879734164e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,36791,0.00835401472177437,0.00197625016242691,0.00448056440341764,0.0122274650401311,2.38237142870734e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMSB10,Thymosin beta-10,39093,0.0298483692316377,0.00706407060963467,0.0160027908367537,0.0436939476265216,2.39927899901912e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D5,TBC1 domain family member 5,39099,-0.02995230075843,0.00710479559416826,-0.0438777001229998,-0.0160269013938603,2.5034449941032e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARF6,ADP-ribosylation factor 6,36743,-0.0409280823373078,0.00971736264618685,-0.0599741131238341,-0.0218820515507816,2.55008840403256e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,38727,-0.0327602282301394,0.00779102370879526,-0.0480306346993781,-0.0174898217609007,2.62763175694647e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39093,0.0183103831277902,0.00435607567314111,0.0097724748084336,0.0268482914471467,2.64420495820838e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39023,-0.0172242172273731,0.00409903595037892,-0.0252583276901158,-0.00919010676463043,2.66061769842398e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB44,Ras-related protein Rab-44,36731,-0.0161725548971639,0.00385209346166499,-0.0237226580820272,-0.0086224517123005,2.70637669429814e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",36767,-0.0241044522017168,0.00574697354721585,-0.0353685203542598,-0.0128403840491737,2.75560380923706e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TALDO1,Transaldolase,36770,-0.0171046537943891,0.00408192736599589,-0.025105231431741,-0.00910407615703712,2.80392964248274e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXN,"Frataxin, mitochondrial",39255,0.0280463763951013,0.00669931610937639,0.0149157168207235,0.041177035969479,2.84921509152194e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,39093,0.0102030177608854,0.00243861776103349,0.00542332694925976,0.014982708572511,2.88111882970059e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,36792,-0.0128082390082623,0.00306782606442832,-0.0188211780945418,-0.00679529992198279,2.9990990108106e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,36731,-0.0227529254086333,0.00545732380712794,-0.0334492800706041,-0.0120565707466626,3.07609704167761e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG2,Bone marrow proteoglycan,36791,0.0192494160001036,0.00461998881176841,0.0101942379290375,0.0283045940711697,3.11253736117702e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,39099,0.0206272236212743,0.00495616686832047,0.0109131365593662,0.0303413106831824,3.17300570808905e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39023,-0.0145761465787159,0.00350262962554541,-0.0214413006447849,-0.00771099251264687,3.17926412435354e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBP,Protein AMBP,39229,-0.00733042759280041,0.00176318165231095,-0.0107862636313299,-0.00387459155427095,3.23493857560109e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,39255,0.0120898157943333,0.00290978415327425,0.00638663885391581,0.0177929927347509,3.27209883928592e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO3,R-spondin-3,39255,0.010202435746004,0.00245670215489175,0.00538729952241613,0.0150175719695918,3.30059214926875e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLTP,Phospholipid transfer protein,39210,0.0136166219594139,0.00328128615810718,0.00718530108952383,0.020047942829304,3.34586044824126e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA2,Annexin A2,36261,-0.0264500337021538,0.00637984500105157,-0.0389545299042149,-0.0139455375000928,3.40771523722894e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSG,Basigin,39274,-0.0073474964247147,0.00177358719572755,-0.0108237273283407,-0.00387126552108872,3.45023249800874e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLO1,Lactoylglutathione lyase,38832,-0.0218303049460942,0.00527226546096485,-0.0321639452495853,-0.0114966646426031,3.48307679257423e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNC,Tenascin,39165,0.0177996299086585,0.00430358858036012,0.00936459629115262,0.0262346635261643,3.55303240013839e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",36743,0.0329974297804932,0.00800648901288515,0.0173047113152383,0.048690148245748,3.79039505271874e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,39283,-0.0150772699808544,0.00365940771844922,-0.0222497091090149,-0.00790483085269392,3.8061987502033e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,38832,-0.0212548674830026,0.00516069322813833,-0.0313698262101537,-0.0111399087558514,3.83216504950864e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,36747,-0.0100532150231281,0.00244537439667968,-0.0148461488406203,-0.00526028120563592,3.96193757506883e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,38987,-0.0176426661296711,0.00429317678387186,-0.02605729262606,-0.00922803963328227,3.98664385246588e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,36747,-0.0410790834588835,0.00999581107365449,-0.0606708731632463,-0.0214872937545207,3.98746727775776e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,38727,-0.0191361750034261,0.00466400901397075,-0.0282776326708088,-0.00999471733604346,4.10097733062317e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASS1,Argininosuccinate synthase,36391,-0.0299221087405876,0.00731070974242207,-0.0442510998357349,-0.0155931176454404,4.28655136014455e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,39162,-0.0142007587028581,0.00347075190411012,-0.0210034324349139,-0.00739808497080225,4.30693259972269e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG3,Proteoglycan 3,36791,0.0185451466888061,0.00453235993729692,0.00966172121170412,0.0274285721659081,4.30783642020287e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,36743,-0.0189535970286104,0.00463418025551779,-0.0280365903294252,-0.00987060372779548,4.34076569712662e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,36792,-0.00993938741449866,0.00244018907358565,-0.0147221579987265,-0.00515661683027079,4.66473054884298e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,36792,-0.00892114213565514,0.00219427251911853,-0.0132219162731275,-0.00462036799818283,4.81825513444764e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,36767,-0.0140873580836701,0.00346615843597156,-0.0208810286181744,-0.00729368754916584,4.847122166838e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTL1,Cytokine-like protein 1,36791,0.00848840065205811,0.00208886621742194,0.0043942228659111,0.0125825784382051,4.85988229676024e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSB,Cathepsin B,39085,0.0188304830205403,0.004643571344107,0.00972908318609055,0.02793188285499,5.0346711685601e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,39099,-0.0160314292796867,0.00395695194200384,-0.0237870550860142,-0.00827580347335916,5.11514889244389e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",39023,-0.0389755700803637,0.00962439565899423,-0.0578393855719924,-0.020111754588735,5.15462617199354e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,38727,-0.0363583273402261,0.00898790413732094,-0.0539746194493751,-0.018742035231077,5.25311295199502e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",36420,0.0337440763463031,0.00834273657591802,0.0173923126575037,0.0500958400351024,5.26977063781651e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,36767,-0.0176952473816993,0.0043838177371627,-0.0262875301465382,-0.00910296461686037,5.45694392959201e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXLNA,Alpha-taxilin,38987,-0.0328195169991809,0.00813434480220256,-0.0487628328114979,-0.0168762011868639,5.49443972851735e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5L,CD5 antigen-like,36737,0.0171843784427811,0.00426344177157024,0.00882803257050338,0.0255407243150587,5.5946389278589e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILP,Rab-interacting lysosomal protein,39211,-0.0218252680920066,0.00541874713614385,-0.0324460124788485,-0.0112045237051647,5.65881694657164e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",36747,-0.0141185091208438,0.00350775404897257,-0.0209937070568301,-0.00724331118485759,5.73150851039649e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6AP2,Renin receptor,38727,-0.0149001556749846,0.003702788176993,-0.0221576205018909,-0.00764269084807836,5.74922523336798e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX1,Neuronal pentraxin-1,39093,-0.0150258673883087,0.00373833814560448,-0.0223530101536935,-0.00769872462292392,5.86278501641431e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,38741,-0.0246709754318795,0.00615102334306658,-0.03672698118429,-0.012614969679469,6.07901189664623e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,39099,0.0191717900631289,0.00478464152681198,0.00979389267057743,0.0285496874556804,6.18018249163842e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,36731,-0.0266453735456221,0.00665009751967999,-0.0396795646841949,-0.0136111824070493,6.19026796403322e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,39283,-0.00902481705313844,0.00225621796780862,-0.0134470042700433,-0.00460262983623354,6.36445279268769e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,36430,-0.0182425989691228,0.00457432312280532,-0.0272082722898212,-0.00927692564842436,6.69976786313108e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC5D,Netrin receptor UNC5D,36430,0.0095391064332001,0.00239565624649661,0.00484362019006675,0.0142345926763334,6.87703256147002e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,39093,-0.0109249720427432,0.00274920363604966,-0.0163134111694005,-0.00553653291608582,7.10406330091754e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,36391,-0.0132685117615143,0.00334006534681087,-0.0198150398412636,-0.00672198368176495,7.15110576604294e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCHE,Cholinesterase,36571,-0.00994856990417325,0.00250623137178968,-0.014860783392881,-0.00503635641546548,7.24095626067595e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,36500,-0.0281984224361125,0.00711378172600556,-0.0421414346190834,-0.0142554102531416,7.4136360810597e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST13,Hsc70-interacting protein,36500,-0.0199550008076541,0.00503578548067432,-0.0298251403497758,-0.0100848612655325,7.45331346110728e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11R,Junctional adhesion molecule A,39093,-0.0204709981251022,0.00516923055671178,-0.0306026900162573,-0.0103393062339471,7.52390938208442e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40LG,CD40 ligand,39291,0.0279983994061836,0.00709806788293384,0.0140861863556333,0.0419106124567339,8.03169743719284e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,38987,-0.0100962618804815,0.00256308642763097,-0.0151199112786382,-0.00507261248232482,8.21538310414215e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,39117,0.00853348264325173,0.00216955165656827,0.00428116139637792,0.0127858038901255,8.416072896995e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,36743,-0.0092677239545517,0.00235809140703568,-0.0138895831123416,-0.00464586479676177,8.53258757197745e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POF1B,Protein POF1B,36430,-0.01617872515248,0.00412539197995969,-0.024264493433201,-0.00809295687175903,8.83780013847065e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,39291,0.0263914863181587,0.00674582037865346,0.0131696783759979,0.0396132942603194,9.18237218762344e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,36420,-0.0111464197928247,0.00285183766302313,-0.01673602161235,-0.00555681797329935,9.33568480333558e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22,Interleukin-22,36731,-0.0232416150077209,0.00594654855790968,-0.0348968501812239,-0.011586379834218,9.3377211976424e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,36430,0.0113319353068179,0.00290276623048686,0.00564251349506363,0.0170213571185721,9.51727519357657e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,39023,-0.024373459719502,0.00625706244194585,-0.0366373021057158,-0.0121096173332881,9.84771666265497e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,36500,-0.0245814008708082,0.0063282697508859,-0.0369848095825446,-0.0121779921590719,0.000103114379700589
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPK2,SRSF protein kinase 2,39099,-0.0299148558769154,0.00770323115218712,-0.0450131889352022,-0.0148165228186287,0.000103433677127356
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPS,Colipase,39071,0.0244826290218477,0.00630847361324781,0.012118020739882,0.0368472373038134,0.000104504679127557
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SATB1,DNA-binding protein SATB1,36767,-0.0105404468285555,0.00271650744217704,-0.0158648014152225,-0.00521609224188855,0.00010491237920874
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD207,C-type lectin domain family 4 member K,38743,-0.0133270858444946,0.00343661076840196,-0.0200628429505624,-0.00659132873842676,0.000105783042920123
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOD,Apolipoprotein D,36157,0.015308058526633,0.00394786292818429,0.0075702471873918,0.0230458698658742,0.000106060196156808
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,36747,-0.0244685438334355,0.00635476094875832,-0.0369238752930018,-0.0120132123738692,0.00011848211402205
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFC,Platelet-derived growth factor C,38727,-0.010246136184329,0.00266157874605184,-0.0154628305265906,-0.00502944184206734,0.000118783878567527
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,36767,-0.0168337058603711,0.00437680507779018,-0.0254122438128399,-0.00825516790790235,0.000120581179700363
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99,CD99 antigen,39093,0.00669988526856079,0.0017451904556975,0.00327931197539369,0.0101204585617279,0.000124007310404547
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39093,-0.0163599751496424,0.00426251926012448,-0.0247145128994864,-0.00800543739979842,0.000124490917508829
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB1A1,Uteroglobin,39136,0.0191363796972398,0.00498953304143805,0.00935689493602122,0.0289158644584584,0.00012591254775616
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",36750,-0.0141307799406659,0.00368438984587025,-0.0213521840385716,-0.00690937584276023,0.000126002889084564
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENAH,Protein enabled homolog,38841,-0.0168559095175966,0.00439841076705547,-0.0254767946210253,-0.00823502441416787,0.000127483488248412
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",38741,-0.0176781505002959,0.00461746172707611,-0.0267283754853651,-0.0086279255152267,0.000129432263603038
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOL1,Apolipoprotein L1,36796,0.0212502688132353,0.00555130193326425,0.0103697170240374,0.0321308206024332,0.000129808336301047
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,38741,0.0113856352865526,0.00297496939441739,0.00555469527349453,0.0172165752996107,0.000130169254098365
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",39076,-0.022823854637389,0.00596389591976748,-0.0345130906401333,-0.0111346186346447,0.00013023123883668
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4C,Semaphorin-4C,39023,0.00988986417853664,0.00258524315911306,0.00482278758667504,0.0149569407703982,0.000131026706002908
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD5,Programmed cell death protein 5,39241,-0.0202470648087419,0.00529560331804415,-0.0306264473121085,-0.00986768230537541,0.000132157718419629
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNLY,Granulysin,39093,0.0177162664987262,0.00463367354970291,0.00863426634130844,0.0267982666561439,0.000132162092277993
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS2,Protein MTSS 2,36731,-0.034807667661935,0.00911560829427151,-0.0526742599187072,-0.0169410754051629,0.000134912371130521
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,39093,-0.0081703033554424,0.00214334482879141,-0.0123712592198736,-0.00396934749101124,0.000138422816848252
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN3,Calsyntenin-3,36747,-0.0104903199422731,0.00275500151471574,-0.015890122911116,-0.0050905169734303,0.000140894692025088
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,36420,-0.0258389904745666,0.00678813728506327,-0.0391437395532906,-0.0125342413958426,0.000141621447527954
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,36391,-0.0121352577458786,0.00320107409069252,-0.018409362963636,-0.00586115252812127,0.000150748176398389
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,39099,-0.036735596642959,0.00970457424822056,-0.0557565621694713,-0.0177146311164467,0.000154056086397765
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",39070,0.0187492669371823,0.00496364833953443,0.00902051619169484,0.0284780176826698,0.000159131664695626
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,36767,-0.0118906699786781,0.00314983052625394,-0.0180643378101358,-0.00571700214722039,0.000160712311092339
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRN,Agrin,39162,-0.0112450210088075,0.00297942341833061,-0.0170846909087355,-0.00540535110887953,0.000161110340755554
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,39291,-0.0111860365200506,0.00296670569674982,-0.0170007796856803,-0.00537129335442099,0.000163512397446316
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,39283,0.0105690326859287,0.00280917558265011,0.00506304854393445,0.0160750168279229,0.000168963878528773
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,38727,0.0159313452150391,0.00423578228014338,0.00762921194595805,0.0242334784841201,0.000169793413264444
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTD,Biotinidase,36806,-0.00702360634714267,0.00186748715973333,-0.01068388118022,-0.00336333151406534,0.000169985513033148
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA10,Annexin A10,38741,-0.0267496352060874,0.00711705652523935,-0.0406990659955565,-0.0128002044166182,0.000171571111796116
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OBP2B,Odorant-binding protein 2b,38942,0.0215566833657376,0.00574240706140711,0.0103015655253797,0.0328118012060956,0.000174726053418801
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39078,-0.00831272623011215,0.00221535817145127,-0.0126548282461566,-0.00397062421406766,0.000175858353621332
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,39023,-0.039028047319802,0.0104037995291384,-0.0594194943969133,-0.0186366002426906,0.000176556524257374
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,38948,-0.00946668911212035,0.00252526119219339,-0.0144162010488194,-0.00451717717542132,0.000178348735314415
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39023,-0.0112067683326279,0.00298986642519178,-0.0170669065260038,-0.00534663013925203,0.000178733356401194
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,39241,0.0266003197578667,0.00710303536090716,0.0126783704504887,0.0405222690652447,0.000181107298867297
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSH,Pro-cathepsin H,38795,-0.0246482169617709,0.00658803062918491,-0.0375607569949733,-0.0117356769285685,0.000183709626025077
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39115,0.0167831959894203,0.00448704977628371,0.00798857842790421,0.0255778135509363,0.000184427134547127
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,36791,-0.0168954701752354,0.00451892413365207,-0.0257525614771934,-0.00803837887327733,0.000185679087371969
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,36538,-0.0183668663694371,0.00492062017893021,-0.0280112819201403,-0.00872245081873393,0.000190317356998027
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,36702,-0.0163850429339792,0.00439704639717997,-0.025003253872452,-0.00776683199550651,0.000195086503921834
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,36538,-0.0114316095895541,0.00306968343461243,-0.0174481891213944,-0.00541503005771373,0.000196913126747175
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,38935,0.00881246705500693,0.00238096565718979,0.00414577436691494,0.0134791597430989,0.000215333086414931
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,36792,-0.0132380801073099,0.00357672034257584,-0.0202484519787585,-0.00622770823586125,0.00021549135004888
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXJ3,Forkhead box protein J3,36430,-0.0151866527469607,0.00410629228984321,-0.0232349856350534,-0.00713831985886801,0.000217899042473784
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,36743,0.0385206888622968,0.0104217478833391,0.0180940630109521,0.0589473147136414,0.000219772491425849
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,36629,-0.0100645934971389,0.00272317762493072,-0.0154020216420032,-0.00472716535227472,0.000220025039068396
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,36792,-0.00890048112332189,0.00241096760154875,-0.0136259776223574,-0.00417498462428635,0.000223708024523634
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39211,-0.0237431652045843,0.00644843097978115,-0.0363820899249554,-0.0111042404842133,0.000232198859966694
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R9B,Neurabin-2,39291,-0.0317412243072325,0.00863297625786431,-0.0486618577726466,-0.0148205908418185,0.000237033405612882
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,38727,-0.0134232489988287,0.00365450926460152,-0.0205860871574477,-0.00626041084020976,0.000240499541332382
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A4,Protein S100-A4,39147,-0.0190116703324019,0.00518323703774489,-0.0291708149263819,-0.00885252573842194,0.000245366822777139
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,36420,-0.0145641729098534,0.00397162260564743,-0.0223485532169224,-0.00677979260278446,0.000246369404689306
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39136,-0.0215228814190672,0.00587041340404386,-0.0330288916909932,-0.0100168711471412,0.000246889254651116
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHBP1,EH domain-binding protein 1,36792,-0.0251714373451464,0.0068661095121653,-0.0386290119889904,-0.0117138627013025,0.000247321237605528
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,36743,-0.013487140552129,0.00368326694161422,-0.0207063437576929,-0.00626793734656514,0.000251517441971921
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,36500,-0.00938480879438953,0.00256454223315657,-0.0144113115713764,-0.00435830601740264,0.000253787912080771
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT1,Deaminated glutathione amidase,36420,-0.0156410602525263,0.00427596936104057,-0.0240219602001658,-0.00726016030488677,0.000255332003076511
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNMBP,Dynamin-binding protein,38987,-0.0206772644538281,0.00565712597989715,-0.0317652313744265,-0.00958929753322966,0.000257969138483822
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],38739,-0.0161157540671703,0.0044165861073819,-0.0247722628376388,-0.00745924529670178,0.000264249202175133
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,39092,0.0315785212951555,0.00866064763674871,0.014603651927128,0.0485533906631829,0.00026702526127105
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,39099,-0.0345157254516376,0.00947528591383816,-0.0530872858427604,-0.0159441650605148,0.000270676988065507
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",38832,-0.0294624469788571,0.00809685915535673,-0.0453322909233563,-0.0135926030343579,0.0002748858377676
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP6,Platelet glycoprotein VI,39071,0.0294525199071083,0.00810697795781739,0.0135628431097862,0.0453421967044303,0.000281084435349093
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,38841,-0.023386831091127,0.006441232987038,-0.0360116477457214,-0.0107620144365325,0.000283485533882553
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,36421,-0.0266476767899643,0.00734653945509951,-0.0410468941219593,-0.0122484594579693,0.000287599700486857
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDK,Midkine,39079,0.0167876699456224,0.00462891589640327,0.00771499478867202,0.0258603451025728,0.000288009116025259
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEXIM1,Protein HEXIM1,39099,-0.02700880537074,0.00745339561014682,-0.0416174607666277,-0.0124001499748522,0.000291372900796609
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",36420,0.0256900853198855,0.00709114586761562,0.0117914394193589,0.0395887312204121,0.000292535638456169
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,39023,-0.0197608155433063,0.00545670935195093,-0.0304559658731302,-0.00906566521348251,0.000293992000489132
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNMT,Histamine N-methyltransferase,38909,-0.0153320844280402,0.00423424242266817,-0.0236311995764698,-0.00703296927961057,0.000294459383572485
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,36391,0.00667808215311133,0.00184421217210827,0.00306342629577913,0.0102927380104435,0.000294507389566849
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP6,Gastrotropin,38811,0.0178378167199045,0.00493546321858108,0.0081643088114856,0.0275113246283234,0.000302250138412771
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,36500,-0.0139029045188831,0.00384816424325397,-0.0214453064356608,-0.00636050260210528,0.000304005057983624
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD70,CD70 antigen,39099,0.0139290982820983,0.00386126260409689,0.00636102357806843,0.0214971729861282,0.000310276242272896
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,36765,0.0159237003033779,0.00441639589919576,0.00726756434095415,0.0245798362658016,0.00031262229815079
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG4,Regenerating islet-derived protein 4,39117,-0.0154545694741873,0.00428808964677227,-0.0238592251818609,-0.00704991376651362,0.000314271625423421
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB8,Serpin B8,39291,-0.0180941441531844,0.0050227588649327,-0.0279387515284525,-0.0082495367779163,0.000316245297814201
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,36743,-0.0276563231662662,0.00767871743710466,-0.0427066093429914,-0.0126060369895411,0.000317350361762715
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRIB,Protein scribble homolog,36420,-0.0294617126323453,0.00818462220644448,-0.0455035721569765,-0.0134198531077141,0.000319882130004288
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXIN1,Axin-1,39099,-0.0313549170327306,0.00871372409260926,-0.0484338162542448,-0.0142760178112165,0.000321273044127693
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F13B,Coagulation factor XIII B chain,36737,-0.00835562823300854,0.00232264030187386,-0.0129080032246813,-0.00380325324133577,0.00032253187983828
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,39283,-0.0105096058803742,0.00292358305641429,-0.0162398286709463,-0.00477938308980224,0.000325692165947472
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,39241,-0.0155115164713635,0.00431525022873237,-0.0239694069196789,-0.00705362602304802,0.000325930056593362
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST5,Cystatin-D,38807,-0.0177292431981985,0.00494684259041662,-0.027425054675415,-0.00803343172098187,0.000339512175354627
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39093,0.0388708416335987,0.010851167912995,0.0176025525241286,0.0601391307430688,0.000341800292174754
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP1,Guanylate-binding protein 1,36735,-0.0208456296206111,0.00582481414068393,-0.0322622653363516,-0.00942899390487058,0.000346493036796539
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP2B1,AP-2 complex subunit beta,36421,-0.0161778375988917,0.00452118353840726,-0.0250393573341699,-0.00731631786361344,0.000347230523668096
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGCR6,Protein DGCR6,36363,-0.0142876993039804,0.00399396098233295,-0.022115862829353,-0.00645953577860785,0.000348439302807787
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,38727,-0.0196824831463029,0.00550731702689846,-0.0304768245190239,-0.00888814177358197,0.000352845469627472
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,36430,-0.014743081287814,0.00413182498926593,-0.0228414582667752,-0.00664470430885275,0.000360812469135641
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN1,Tetraspanin-1,38832,-0.0131513054185828,0.00368671945546784,-0.0203772755512997,-0.00592533528586582,0.000361927616099362
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,36733,-0.0193227435474725,0.00541955034718225,-0.0299450622279497,-0.00870042486699525,0.000364649572224082
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR1,Cadherin-related family member 1,38741,-0.0138145621541826,0.00387996355251489,-0.0214192907171118,-0.00620983359125345,0.000371321286023601
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGL1,Fibrinogen-like protein 1,36796,0.0200382416448207,0.00562808344999802,0.00900719808282458,0.0310692852068168,0.000371615574802915
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,36391,0.0105498336594245,0.0029718298085981,0.00472504723457223,0.0163746200842768,0.000386722636376464
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",38741,-0.0175037047233358,0.00493241916849884,-0.0271712462935935,-0.00783616315307803,0.000388321818960552
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,36767,-0.0248086221901798,0.00699620323839424,-0.0385211805374325,-0.0110960638429271,0.000392493389038836
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASHC3,WASH complex subunit 3,36747,-0.0245538653218695,0.00692993769573229,-0.0381365432055048,-0.0109711874382342,0.000396763865616242
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,36743,-0.0136535752655258,0.00385382249443696,-0.0212070673546223,-0.00610008317642937,0.000397204233138576
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,36767,-0.0213135238573606,0.00601928392208558,-0.0331113203446484,-0.00951572737007287,0.000400209443648038
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,39147,0.00876446273366343,0.00248007120593669,0.00390352317002752,0.0136254022972993,0.000410597701306326
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPTC,Opticin,39023,0.0141696364068055,0.00402273726278134,0.00628507137175405,0.0220542014418569,0.000428937176938915
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,38741,-0.0131136456756959,0.00372317328022704,-0.0204110653049409,-0.00581622604645093,0.000429313160747546
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,39255,-0.0192265052012452,0.00546123409613945,-0.0299305240296785,-0.00852248637281188,0.000431910108755354
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,36806,0.00558571301109835,0.00158733628365359,0.00247453389513732,0.00869689212705938,0.000434790534358187
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FYB1,FYN-binding protein 1,39071,-0.0294580047139655,0.00838091716067079,-0.0458846023488802,-0.0130314070790507,0.000441214789004649
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,36403,-0.0184283019328503,0.00524853888482756,-0.0287154381471124,-0.00814116571858833,0.000447773660083258
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZN,Kazrin,36743,-0.0334697563541004,0.00953254316893396,-0.0521535409652109,-0.0147859717429898,0.000447774830290235
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST1,Cystatin-SN,35080,-0.0324061003913598,0.00923320065980137,-0.0505031736845704,-0.0143090270981491,0.000450310187823416
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM3,Myomesin-3,36500,-0.0299652175726662,0.00853845374358691,-0.0467005869100966,-0.0132298482352359,0.000450608576317406
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QDPR,Dihydropteridine reductase,39032,-0.013918126177606,0.00396811426530026,-0.0216956301375945,-0.00614062221761751,0.000453661501697621
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,36420,-0.0104576933478925,0.0029824072094516,-0.0163032114784176,-0.00461217521736734,0.000455693771563534
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,36373,-0.0163086126365604,0.00466167308299708,-0.0254454918792347,-0.0071717333938861,0.000469603133133104
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPN,Asporin,36792,0.00861983860108288,0.00246427796259687,0.00378985379439301,0.0134498234077728,0.000470483081247928
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,38741,-0.0196777705650075,0.00562928637058364,-0.0307111718513515,-0.00864436927866359,0.000474362695986851
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,39255,0.0203071800357137,0.00581391196696809,0.00891191258045626,0.0317024474909712,0.000479218147136662
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGN,Secretagogin,38841,-0.0137174254633365,0.00392734124300179,-0.02141501429962,-0.00601983662705302,0.000479359042424871
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO1,Alpha-enolase,39069,0.025176458788009,0.00720866210075005,0.0110474810705389,0.0393054365054791,0.000479828927623688
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,39071,0.0112746985621562,0.00322991793277771,0.0049440594139119,0.0176053377104005,0.00048310854907904
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2R,Proteinase-activated receptor 1,39140,0.0186177263048216,0.00534059884724365,0.0081501525642241,0.0290853000454192,0.000491540018421938
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK4,Kallikrein-4,39255,0.0191171319282696,0.00548580965144024,0.00836494501144672,0.0298693188450925,0.000493813882163313
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,36743,-0.0344649660827813,0.00989552906861379,-0.0538602030572644,-0.0150697291082983,0.000497691868864925
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,39241,0.0408682973658299,0.0117411918868253,0.0178555612676523,0.0638810334640076,0.000501375385313634
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,36421,0.0101297993278762,0.00291852935393198,0.00440948179416956,0.0158501168615829,0.000520542429946883
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,38960,-0.0282926746610854,0.00815241752211042,-0.0442714130044219,-0.012313936317749,0.000521010482000492
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,36420,-0.0189769855748802,0.00547470749857245,-0.0297074122720822,-0.00824655887767817,0.000529436015923924
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,38987,-0.018275013779459,0.00527463321844186,-0.0286132948876051,-0.00793673267131297,0.000532297154873489
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,36391,-0.0238049259143672,0.00687315350193311,-0.0372763067781561,-0.0103335450505783,0.00053504791757012
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,39093,0.00760322116606483,0.00219743624285969,0.00329624613005984,0.0119101962020698,0.000541570355386043
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,36743,-0.0151429284402319,0.00437851470470989,-0.0237248172614633,-0.00656103961900049,0.000545024152486659
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39076,-0.0200631089024504,0.00580651131368541,-0.0314438710772738,-0.00868234672762704,0.000551225434588614
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL1,Delta-like protein 1,39147,0.00896635883327841,0.00259561506424429,0.00387895330735961,0.0140537643591972,0.000552962038774485
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39117,0.0100141301729262,0.00290014001782402,0.00432985573799114,0.0156984046078613,0.000555930880001473
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,36391,-0.0112602435325061,0.00326186586506259,-0.0176535006280288,-0.00486698643698347,0.000558105055756506
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,36430,-0.0271314843401616,0.00787139363223783,-0.0425594158593478,-0.0117035528209755,0.0005690266520012
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFD,Complement factor D,36806,0.00574866230952537,0.00166851806196012,0.00247836690808354,0.0090189577109672,0.000572086523092052
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,36724,-0.01275276866124,0.00370514418846523,-0.0200148512706319,-0.00549068605184816,0.00057946151323655
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,39099,0.0155588394334467,0.00453674664287092,0.00666681601341973,0.0244508628534737,0.000606262741176102
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,39291,-0.0112636886825001,0.00328725498049614,-0.0177067084442725,-0.00482066892072765,0.000613069483852901
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,36466,-0.0121189440007617,0.00353730664637747,-0.0190520650276616,-0.00518582297386186,0.000614410044456549
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,39147,-0.00931724232965731,0.002720623171574,-0.0146496637459423,-0.00398482091337228,0.000617158086737717
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFI,Complement factor I,36806,-0.00620993941103387,0.00181383974961926,-0.00976506532028762,-0.00265481350178012,0.000619791718876892
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5E,5'-nucleotidase,39147,-0.0172435743968773,0.00504347250939313,-0.0271287805152879,-0.00735836827846681,0.000630184139245044
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX4,Syntaxin-4,39023,-0.0184643752009738,0.00540068424523849,-0.0290497163216412,-0.00787903408030633,0.000630412709657617
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",36420,0.0218256482583672,0.00639506803450294,0.00929131491074147,0.034359981605993,0.000644812976483217
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS22,Brain-specific serine protease 4,36430,-0.0104806418888757,0.00307108600081988,-0.0164999704504827,-0.00446131332726875,0.00064529596095876
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39140,-0.0269930854566939,0.00793695092325289,-0.0425495092662695,-0.0114366616471182,0.000673267360389365
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,39147,0.0112399555623422,0.0033073327621643,0.00475758334850021,0.0177223277761843,0.000679304841835341
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,38832,0.00664860908761596,0.00195873585220897,0.00280948681728639,0.0104877313579455,0.000689734822828567
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRB1,Chymotrypsinogen B,39093,-0.0164488559961384,0.00485190148352819,-0.0259585829038537,-0.0069391290884232,0.000700220714114539
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL4,C-C motif chemokine 4,39114,-0.0193253842283173,0.00570866752111537,-0.0305143725697034,-0.0081363958869312,0.000712873584384444
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID1,Nidogen-1,39131,0.011596137912852,0.00343289019017851,0.00486767314010216,0.0183246026856019,0.000732102527984033
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,38727,-0.0162409153079294,0.00481059427275722,-0.0256696800825336,-0.00681215053332528,0.000737167783168841
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,39099,-0.0172148630365812,0.00510051134865237,-0.0272118652799398,-0.00721786079322256,0.00073966282422464
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,38987,-0.0120712522229562,0.00357814903428337,-0.0190844243301516,-0.00505808011576084,0.000743776173742636
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39162,0.037011934658263,0.010994804638003,0.0154621175677771,0.0585617517487489,0.000763681614700955
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,36421,-0.0206240196968918,0.00612724889940434,-0.0326334275397243,-0.00861461185405924,0.000765088710454158
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,36421,-0.0239561057309005,0.0071229264961165,-0.0379170416632889,-0.00999516979851218,0.000772637674276071
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS1,Galectin-1,39106,0.0103488111650243,0.00307817808570076,0.00431558211705081,0.0163820402129978,0.000775724829834533
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH17,Protocadherin-17,39106,-0.0107399839935149,0.0031956879033053,-0.0170035322839933,-0.00447643570303652,0.000779152662934021
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,39182,-0.0144755947529273,0.00431167686550222,-0.0229264814093116,-0.00602470809654289,0.00078899045790079
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD209,CD209 antigen,39124,0.0118681272564238,0.00353627023991913,0.00493703758618233,0.0187992169266653,0.000792386994310493
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFR,Epidermal growth factor receptor,39283,0.00490933324888995,0.00146365550205589,0.00204056846486041,0.0077780980329195,0.000797983771781785
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",39023,-0.0187675864554402,0.00559971052410343,-0.0297430190826829,-0.00779215382819749,0.000805632673258706
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,38741,-0.0261222844014864,0.00779744408502404,-0.0414052748081335,-0.0108392939948393,0.000809806692345893
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBI3_IL27,Interleukin-27,39237,0.00941128256647751,0.00281083392129871,0.00390204808073204,0.014920517052223,0.000815284562814306
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMD,Dystrophin,36420,-0.0158190388344719,0.00472595020225852,-0.0250819012308986,-0.00655617643804517,0.000818508261410655
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX15,Sorting nexin-15,36500,-0.0164285288246849,0.00491263190357896,-0.0260572873556996,-0.00679977029367011,0.000827780409202813
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,36421,-0.0147941418976724,0.00442474425210744,-0.0234666406318029,-0.00612164316354178,0.000829699145212305
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LARP1,La-related protein 1,36731,-0.0194679373629638,0.00582979221789445,-0.0308943301100369,-0.00804154461589065,0.00084201704677296
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,36792,-0.0232696021927253,0.00697015085974651,-0.0369310978778284,-0.00960810650762213,0.000844806329274016
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRN,"Attractin, Isoform 2",36806,-0.00496298349173963,0.00148749453686815,-0.0078784727840012,-0.00204749419947807,0.000850878581740782
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,39229,-0.00915938335758069,0.00275190114999545,-0.0145531096115718,-0.00376565710358961,0.000875566244825873
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,39064,-0.0196964102664146,0.00591989256051225,-0.0312993996850187,-0.00809342084781062,0.000879450821964373
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTPN,Myotrophin,38832,0.00979229859366247,0.00294950456946332,0.00401126963751437,0.0155733275498106,0.00090238702884003
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39023,-0.00847964294043064,0.00255476221898773,-0.0134869768896466,-0.00347230899121469,0.000905042104924484
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APCS,Serum amyloid P-component,36693,0.0104962792007401,0.00316256335201317,0.00429765503079429,0.0166949033706859,0.000906195136349629
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39023,-0.00908290417196048,0.0027418433653949,-0.0144569171681345,-0.00370889117578647,0.000926162740784089
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAMBP,STAM-binding protein,38951,-0.0194384576308364,0.00587004903810662,-0.0309437537455254,-0.0079331615161474,0.000930269823911768
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,38931,0.0127687075297284,0.00385945847282315,0.00520416892299508,0.0203332461364618,0.000940439812102205
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,36743,-0.0147229288842533,0.00446350748279439,-0.0234714035505303,-0.00597445421797632,0.000974625291979062
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,36767,-0.020158700428265,0.00611211186697804,-0.032138439687542,-0.00817896116898807,0.000975851570882906
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,36767,0.0135319390840476,0.00410835330045701,0.00547956661515184,0.0215843115529433,0.000991221240469035
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,38741,-0.0239298315371314,0.00727398383008721,-0.0381868398441023,-0.00967282323016042,0.00100497497483869
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,36391,0.0109650930188345,0.00333415912045707,0.00443014114273867,0.0175000448949304,0.00100923961875917
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,36420,-0.0117247120031583,0.00356552277680603,-0.0187131366456981,-0.00473628736061844,0.00101050967273266
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMB,Granzyme B,39099,0.0191767811315551,0.00584873769065494,0.00771325525787146,0.0306403070052388,0.00104486921447327
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,36731,-0.023912594633195,0.00730253069875849,-0.0382255548027617,-0.0095996344636284,0.00106105146673618
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",36391,0.0254682420372965,0.00777904902770796,0.0102213059429889,0.0407151781316041,0.00106341700554185
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",36420,-0.020845852967358,0.00637210085925574,-0.0333351706514993,-0.00835653528321675,0.00107295386063654
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,36608,0.00241829661597143,0.000740194090455365,0.000967516198678919,0.00386907703326395,0.00108938178792466
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJP3,Tight junction protein ZO-3,36363,0.0130974348334287,0.00401427975160354,0.00522944652028579,0.0209654231465717,0.00110648013990186
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,39023,0.0101304929713715,0.00310549550685026,0.00404372177794502,0.016217264164798,0.00110827495512938
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,39241,-0.0194391373279517,0.00597715938926132,-0.0311543697309039,-0.00772390492499953,0.0011474731570061
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,36743,-0.0255882518878469,0.00786854557502963,-0.041010601214905,-0.0101659025607888,0.0011490402296541
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,38945,-0.00820443780995597,0.00252459420276711,-0.0131526424473795,-0.00325623317253244,0.00115737343638649
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFC1,Cryptic protein,38727,-0.0137654768781467,0.00423744298548423,-0.0220708651296958,-0.00546008862659761,0.00116258912375684
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOBR,Apolipoprotein B receptor,36420,0.0125960559332625,0.00387837249928221,0.00499444583466931,0.0201976660318556,0.00116619259571581
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,39197,0.0123283919867778,0.00380501255604697,0.00487056737692573,0.0197862165966299,0.00119767712987414
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",36792,-0.00889388075636399,0.00274559794039133,-0.014275252719531,-0.00351250879319698,0.00120116061492041
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,36500,-0.0110490095688516,0.00341997924132869,-0.0177521688818559,-0.0043458502558474,0.00123792975852338
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,39274,-0.0113089026349286,0.00350112371884175,-0.0181711051238584,-0.00444670014599875,0.0012401589655288
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTR,Transthyretin,36670,-0.00739333661067168,0.00228948737823264,-0.0118807318720077,-0.0029059413493357,0.0012442636598688
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39118,0.014356065105037,0.00445212658595611,0.00562989699656308,0.023082233213511,0.00126440275854401
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",36792,-0.0144409758157483,0.00447913622814403,-0.0232200828229106,-0.00566186880858599,0.00126703366390477
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,36430,-0.016567227856527,0.00514979300866489,-0.0266608221535102,-0.00647363355954385,0.00129836508403506
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,39283,0.00885022556780098,0.0027534948251382,0.0034533757105301,0.0142470754250719,0.00131087175089813
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,38997,-0.0176640953262137,0.00549644699708575,-0.0284371314405018,-0.00689105921192567,0.00131297432518505
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,38727,-0.0167738562071679,0.00522523144129046,-0.0270153098320972,-0.00653240258223859,0.00132940532946898
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39093,0.0102516477266116,0.00319509863778669,0.00398925439654971,0.0165140410566735,0.00133680169784362
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,36767,-0.0228069466018073,0.00711246832353483,-0.0367473845159356,-0.00886650868767904,0.00134634031755473
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39099,0.0243017617279939,0.00758187115879592,0.00944129425675392,0.0391622291992339,0.00135225235398911
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF1,Trefoil factor 1,39029,-0.0219372736999463,0.00684746802687117,-0.0353583110326138,-0.00851623636727884,0.00135951389729275
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,36430,-0.0104644998056865,0.00326625226519585,-0.0168663542454703,-0.00406264536590259,0.00135953328178524
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",39283,0.00845876423724815,0.00264178871436579,0.0032808583570912,0.0136366701174051,0.00136797556018052
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN1,Ficolin-1,36782,-0.0163808203051413,0.00511993957009156,-0.0264159018625207,-0.00634573874776184,0.00138038444290784
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,36731,-0.0128032543507922,0.00400345497844339,-0.0206500261085413,-0.00495648259304319,0.00138694528190888
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,36421,-0.0127923152737285,0.00400215708472211,-0.0206365431597838,-0.00494808738767315,0.00139520180504992
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPL14,60S ribosomal protein L14,36420,-0.0116686168663233,0.0036508829988965,-0.0188243475441604,-0.00451288618848615,0.00139639595818261
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,36767,-0.0311153250784599,0.00973653069590253,-0.0501989252424289,-0.012031724914491,0.00139813195936167
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD160,CD160 antigen,39291,0.0130351339065748,0.00407925924010185,0.00503978579597516,0.0210304820171744,0.0013988621405443
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM25,Transmembrane protein 25,36767,-0.0130486862223014,0.00408882359996802,-0.0210627804782388,-0.00503459196636411,0.00141970486152214
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,39145,0.00778922485813533,0.00244163833440607,0.00300361372269943,0.0125748359935712,0.00142479578233892
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,36420,-0.0152030135080456,0.00476961702606355,-0.0245514628791302,-0.00585456413696105,0.00143874742267807
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",36767,0.012602009232326,0.00395990355744018,0.0048405982597432,0.0203634202049087,0.00146404583344359
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,38987,-0.0128585702089898,0.00404144694630604,-0.0207798062237496,-0.00493733419422992,0.00146721939440301
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,36430,-0.0105809425509643,0.00333421640305369,-0.0171160067009495,-0.00404587840097906,0.00151005811784471
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,36792,-0.0185020490153481,0.00584044866535016,-0.0299493283994344,-0.00705476963126179,0.00153893186361354
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN2,Transcobalamin-2,39246,0.00846207804578669,0.00267129872150664,0.00322633255163368,0.0136978235399397,0.0015390966808279
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,38841,-0.0124547111099633,0.00393303357367781,-0.0201634569143718,-0.00474596530555476,0.00154491965185288
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,36420,-0.0132610162436936,0.00418771900515674,-0.0214689454938008,-0.00505308699358642,0.00154577654089893
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASET2,Ribonuclease T2,39209,-0.00735686472822034,0.00232746786693707,-0.011918701747417,-0.00279502770902369,0.00157594811477845
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,38987,0.0165334502128686,0.00524114267267782,0.00626081057442011,0.0268060898513172,0.00161060151684288
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,36420,-0.0156909769939685,0.00497777620061412,-0.0254474183471722,-0.00593453564076485,0.00162422871677696
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,36430,-0.0281953405859535,0.00894619718291671,-0.0457298870644703,-0.0106607941074368,0.00162728371910061
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR3,Toll-like receptor 3,39291,-0.017464460586555,0.00554917414590652,-0.0283408419125318,-0.00658807926057827,0.00165145676146982
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNF,Tumor necrosis factor,38805,0.0109302344506935,0.00347589596394045,0.00411747836137025,0.0177429905400168,0.00166650952703953
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,36391,-0.0217201281834062,0.00691844828175727,-0.0352802868156504,-0.00815996955116193,0.00169657891703858
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,36747,0.0187509796899747,0.00597283493916116,0.00704422320921886,0.0304577361707306,0.00169689836136033
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMS1,PMS1 protein homolog 1,36421,-0.0142906332474259,0.00456235936475211,-0.02323285760234,-0.00534840889251176,0.00173846842226975
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA,Adenosine deaminase,39291,-0.00994804689219024,0.00317938143610915,-0.0161796345069642,-0.00371645927741631,0.0017577368682982
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUMB,Protein numb homolog,36430,-0.0241200794337672,0.00772670013521287,-0.0392644116987844,-0.00897574716874995,0.00180246272665293
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP9,Matrix metalloproteinase-9,39079,0.0172622254823988,0.00553585737299813,0.00641194503132249,0.0281125059334752,0.00182263410057764
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,36421,-0.0195662646969318,0.00627854633791133,-0.031872215519238,-0.00726031387462558,0.00183506071599838
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39099,0.0341926680726929,0.0109735539580228,0.0126845023149682,0.0557008338304175,0.00183715317611808
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,39089,-0.0161193704819837,0.0051775711467608,-0.0262674099296349,-0.00597133103433257,0.00185345995407646
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNLZ,DNL-type zinc finger protein,36363,0.0255830234859886,0.00823472559205929,0.00944296132555236,0.0417230856464248,0.00189596282374542
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX6,Peroxiredoxin-6,39255,-0.0166956143972066,0.0053843346050812,-0.0272489102231658,-0.00614231857124748,0.00193362932569718
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,38841,0.0135235225257029,0.00437506426564364,0.00494839656504141,0.0220986484863645,0.00199818993313469
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD36,Platelet glycoprotein 4,36430,-0.0129158856119919,0.00417877132543118,-0.021106277409837,-0.00472549381414678,0.00200031970267934
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,36743,-0.0289226027475109,0.00937534729162601,-0.0472982834390978,-0.0105469220559239,0.00204008430324822
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES2,Cocaine esterase,39023,-0.0152611030455175,0.00495234303957514,-0.0249676954030847,-0.00555451068795019,0.0020626552281523
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1B,Interleukin-1 beta,38739,0.0156369443369764,0.00508124444926457,0.00567770521641788,0.025596183457535,0.00209205053711157
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR1,Complement receptor type 1,36772,-0.00998040062987796,0.00324760605302428,-0.0163457084938055,-0.00361509276595038,0.00212248964339566
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRD2,Protein ZNRD2,36743,-0.0191051226595118,0.00622076641973714,-0.0312978248421966,-0.00691242047682705,0.00213655458815324
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,39283,0.00439794343230927,0.00143270045955192,0.00158985053158752,0.00720603633303103,0.00214654727822246
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,38727,-0.0165559773424127,0.00540559530272164,-0.0271509441357471,-0.00596101054907827,0.00219706486633937
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH12,Protocadherin-12,36767,-0.00708022899231092,0.00231207428109739,-0.0116118945832618,-0.00254856340136002,0.00220106635375046
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SWAP70,Switch-associated protein 70,36743,-0.00996763782533992,0.00326431811270981,-0.0163657013262512,-0.00356957432442868,0.00226640318543561
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,36407,-0.00776388153051916,0.00254808934279937,-0.0127581366424059,-0.0027696264186324,0.00231662425753735
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF8,SLAM family member 8,38727,0.014494456467426,0.00476023905728809,0.00516438791514137,0.0238245250197107,0.00233164140656521
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,36538,0.00995642834069342,0.00327486751388454,0.00353768801347972,0.0163751686679071,0.00236861146847593
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MELTF,Melanotransferrin,36792,-0.00804322424424539,0.00265481447485725,-0.0132466606149656,-0.00283978787352519,0.00245300734730195
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMM2,Phosphomannomutase 2,36391,0.0166962035503671,0.00551489960877005,0.00588700031717777,0.0275054067835564,0.00247109907579425
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,39165,0.00831610480218232,0.00274819816261678,0.00292963640345342,0.0137025732009112,0.00248206875174924
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA11,Serpin A11,39283,0.0112961275799735,0.00373434559938322,0.00397681020518237,0.0186154449547646,0.00249101504973729
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39147,-0.0125375829848824,0.00414789665772754,-0.0206674604340284,-0.00440770553573645,0.00250998251286521
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,39147,-0.00786860805421718,0.00261177316187768,-0.0129876834514974,-0.00274953265693693,0.00259319566363152
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L,Seizure 6-like protein,39147,0.00741885438832858,0.00246262726145936,0.00259210495586823,0.0122456038207889,0.00259463511201267
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",36391,0.0119059430218319,0.00395916190297372,0.00414598569200344,0.0196659003516604,0.00264199832141508
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRAP,BRCA1-associated protein,36619,-0.0302617088454251,0.0100704534892745,-0.0499997976844032,-0.010523620006447,0.00266097115835025
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLKB1,Plasma kallikrein,36549,-0.00684600077094797,0.00228231199705532,-0.0113193322851764,-0.00237266925671954,0.0027086765098654
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF3,Trefoil factor 3,39077,0.013064300904116,0.00435866308410105,0.00452132125927793,0.021607280548954,0.00272805590060416
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNR,Tenascin-R,38987,0.0114352655074701,0.00382343051767543,0.00394134169282622,0.0189291893221139,0.00278660068590782
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLI2,Zinc finger protein GLI2,36430,0.00929698448884551,0.0031085588337489,0.00320420917469767,0.0153897598029933,0.00278814297998358
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOM,Apolipoprotein M,39145,0.00725116397767043,0.00242502687300255,0.00249811130658543,0.0120042166487554,0.0027929585820615
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BEX3,Protein BEX3,36339,0.0128431046647719,0.00429840552034354,0.00441822984489861,0.0212679794846453,0.00281469546848171
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLC,Galectin-10,39079,0.0180852541549515,0.00605644055384469,0.00621463066941595,0.0299558776404871,0.00282992027745351
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGF,Hepatocyte growth factor,39291,-0.00922904646656761,0.0030929618298189,-0.0152912516530127,-0.00316684128012257,0.00285058005805184
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRN,Progranulin,39024,0.00673133859615944,0.00225631965216383,0.00230895207791832,0.0111537251144006,0.00285587357041513
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,38832,0.0132088495282577,0.0044284983399597,0.00452899278193669,0.0218887062745787,0.00286185038121358
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR2,GMP reductase 2,36500,-0.0182379988435535,0.00611577416792313,-0.0302249162126828,-0.00625108147442416,0.00286801625283734
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,36500,-0.0224891311309626,0.00754633903292862,-0.0372799556355027,-0.00769830662642249,0.00288666732066522
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,36743,-0.0105294001884288,0.00353335525336732,-0.0174547764850287,-0.0036040238918288,0.00288785888682502
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",36403,-0.0216737527307828,0.00727348422191705,-0.0359297818057402,-0.00741772365582537,0.00288960277839989
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,36420,0.0158642817202067,0.00532443610423113,0.00542838695591368,0.0263001764844997,0.00289249512949043
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENSA,Alpha-endosulfine,36731,0.0142192167169394,0.00478773975386887,0.00483524679935642,0.0236031866345224,0.00298424310965958
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,39106,-0.0069108641706184,0.00233019297083566,-0.0114780423934563,-0.0023436859477805,0.00302373890187497
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",36500,0.0242271848974721,0.00817363370425702,0.00820686283712832,0.0402475069578158,0.00304170037117732
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK3,Dickkopf-related protein 3,39283,0.00778006197243427,0.00262739672575218,0.00263036438995999,0.0129297595549085,0.00306979843316934
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIT2,Slit homolog 2 protein,38741,-0.0139155976140877,0.00470018899103274,-0.0231279680365119,-0.00470322719166354,0.00307478479721597
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPL,Periplakin,36430,-0.00868516824743648,0.00293622592044814,-0.0144401710515148,-0.00293016544335813,0.00310282977925011
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON2,Spondin-2,39017,0.00902048893074289,0.00305679891219923,0.00302916306283241,0.0150118147986534,0.00317273567082114
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,38727,-0.0139626137341443,0.00473424096923401,-0.0232417260338429,-0.00468350143444561,0.0031900869694619
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD276,CD276 antigen,39095,-0.00944257618808704,0.00320722876189345,-0.0157287445613982,-0.00315640781477587,0.0032432750635063
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,39068,0.0102211516091256,0.00347177037955052,0.00341648166520655,0.0170258215530446,0.0032441162118592
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVALB,Parvalbumin alpha,39198,0.0306053266254866,0.0104089863963482,0.0102037132886442,0.0510069399623291,0.00328406005846719
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,36731,-0.00910396946265811,0.00309640935454581,-0.0151729317975679,-0.00303500712774832,0.0032861577181776
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUK1,Guanylate kinase,36391,0.0111835635987827,0.00380692689900155,0.0037219868767397,0.0186451403208258,0.00331271789333898
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,36664,-0.00812320403731612,0.00277267436881607,-0.0135576458001956,-0.00268876227443662,0.00339848765977272
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVPL,Envoplakin,36538,0.00880252531176906,0.00300906049847513,0.00290476673475781,0.0147002838887803,0.00344689906948427
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGLAP,Osteocalcin,36791,-0.0229462268147511,0.00785790089936569,-0.0383477125775078,-0.00754474105199433,0.00350470302858738
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REN,Renin,39106,-0.0175903426014215,0.00603292359029401,-0.0294148728383977,-0.00576581236444523,0.00355380637262677
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,36391,0.0192044116998714,0.00658644370958322,0.00629498202908823,0.0321138413706545,0.00355465534391366
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39023,-0.0117897184165407,0.00404765809209489,-0.0197231282770467,-0.00385630855603471,0.00358811712524386
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39093,0.0096162698087677,0.00330221853724973,0.00314392147575823,0.0160886181417772,0.00359570725429972
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,36792,-0.0188726787903775,0.0064841921985347,-0.0315816954995055,-0.00616366208124945,0.00361388616007462
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,38969,-0.0251850544667101,0.00866215965948585,-0.0421628873993024,-0.00820722153411784,0.00364883837236948
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39086,0.00837973097090422,0.00288364309148293,0.00272779051159767,0.0140316714302108,0.00366664055904799
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,39069,-0.00460583417714303,0.00158551911133535,-0.00771345163536031,-0.00149821671892575,0.0036785537235455
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,38915,-0.0155692437173802,0.00536967670635886,-0.0260938100618436,-0.00504467737291684,0.00374328305213809
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,36430,-0.0155399909170239,0.00536193596676986,-0.0260493854118928,-0.00503059642215494,0.00375953572604381
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGA4,Pepsin A-4,36796,-0.0165083800200452,0.00569871112268575,-0.0276778538205093,-0.00533890621958111,0.00377547395831971
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP43,Centrosomal protein 43,38728,-0.0185138018194471,0.00639803770581233,-0.0310539557228392,-0.0059736479160549,0.00381322819555984
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN4,CCN family member 4,39255,-0.0105493554754583,0.00364821788812017,-0.0176998625361739,-0.00339884841474281,0.00383765562219829
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39147,-0.00674270647985331,0.00233234545477355,-0.0113141035712095,-0.00217130938849716,0.00384613589876728
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,36391,-0.0113366039885551,0.00392495946588939,-0.0190295245416983,-0.00364368343541185,0.00387948415338992
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAYN,Layilin,38951,-0.00844088606124339,0.00293111793315247,-0.0141858772102222,-0.00269589491226456,0.00398550765336739
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,36393,-0.010483522711063,0.00364651671724225,-0.0176306954768578,-0.00333634994526821,0.0040478251336974
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,39075,0.02516686521286,0.0087595682452127,0.00799811145224308,0.0423356189734769,0.00407064555528874
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,39004,-0.0121835350388675,0.00424206624343234,-0.0204979848759949,-0.00386908520174011,0.00408351435656083
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,38506,-0.0161476730090119,0.00562691443141487,-0.027176425294585,-0.00511892072343875,0.0041142241172597
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNU13,NHP2-like protein 1,36391,-0.0162809377884784,0.00568130168932539,-0.0274162890995562,-0.00514558647740065,0.0041677352303313
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,36391,0.0109210232726901,0.00381324226866524,0.0034470684261062,0.0183949781192739,0.00419058285399626
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYMP,Thymidine phosphorylase,39006,0.0176766130630061,0.00618700854434012,0.00555007631609952,0.0298031498099128,0.00428176362664148
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRK1,Protein BRICK1,38741,0.0116348850977678,0.00407839070630451,0.003641239313411,0.0196285308821247,0.00433938871883434
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROS1,Vitamin K-dependent protein S,36806,-0.00635480354654207,0.00223097623885683,-0.0107275169747014,-0.00198209011838269,0.00440032791298438
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM132A,Transmembrane protein 132A,36420,-0.0162380563766717,0.00570984089533036,-0.0274293445315192,-0.00504676822182415,0.00446409366177343
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGA,Fibrinogen alpha chain,36517,0.00797792834159301,0.00280533987891393,0.0024794621789217,0.0134763945042643,0.00446453287397589
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",36721,-0.0284025022415215,0.00999368174424464,-0.047990118460241,-0.00881488602280201,0.00448955731545926
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPS10,40S ribosomal protein S10,36391,0.0111855256629507,0.00393855466091465,0.00346595852755802,0.0189050927983434,0.00451851107149748
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN7,Septin-7,36538,0.0131956100943317,0.00464951534882564,0.00408256001063348,0.02230866017803,0.0045460535845949
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,36363,-0.019980296039869,0.00704471631469939,-0.0337879400166798,-0.00617265206305816,0.00457257412325851
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,36538,0.0114152967596883,0.00403312402061885,0.00351037367927534,0.0193202198401012,0.00465650318842259
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMA,Repulsive guidance molecule A,39241,-0.0079895604992991,0.00282739618357471,-0.0135312570191055,-0.00244786397949267,0.00472284629934024
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNXB,Tenascin-X,39093,-0.00663348287571084,0.00234755284392704,-0.0112346864498078,-0.00203227930161384,0.00472386297420031
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL28,C-C motif chemokine 28,39049,0.0153363436374358,0.00542971045629777,0.00469411114309217,0.0259785761317794,0.00474126982580415
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,39023,-0.00522890959081946,0.00185488983150753,-0.00886449366057422,-0.0015933255210647,0.00482379571796907
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,36743,-0.0137383392865041,0.00487618347192651,-0.02329565889148,-0.0041810196815281,0.00484823147985447
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYT1,Synaptotagmin-1,36747,0.00959235493313997,0.00340524566288109,0.00291807343389302,0.0162666364323869,0.00485581057970883
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,36421,-0.0177414928142051,0.00629845708884825,-0.0300864687083477,-0.00539651692006254,0.00485804148951474
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MBL2,Mannose-binding protein C,36618,0.0275995800914432,0.0098001974130595,0.00839119316184661,0.0468079670210399,0.00486659052085886
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTOA,Otoancorin,36363,0.0136301072045577,0.00484496220304167,0.004133981286596,0.0231262331225193,0.00491194749996569
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,38841,-0.0108133269877235,0.0038459857538497,-0.0183514590652689,-0.00327519491017808,0.00493616679856705
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THPO,Thrombopoietin,38832,0.00976388633579897,0.00347867617661435,0.00294568102963484,0.0165820916419631,0.00501037133023046
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGN,Biglycan,38699,-0.0305011616236,0.0108820811553911,-0.0518300406881665,-0.00917228255903346,0.00507142905954755
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ING1,Inhibitor of growth protein 1,38705,-0.0115477911686741,0.00412291718353099,-0.0196287088483949,-0.00346687348895338,0.00510295671499343
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,38832,-0.0241220128774807,0.00861388413258964,-0.0410052257773564,-0.00723879997760501,0.00511103842923017
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,39023,-0.02159994192645,0.00771970218306038,-0.0367305582052484,-0.00646932564765169,0.00514805305574478
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD10,Frizzled-10,36421,-0.0152610672743429,0.00546209100863846,-0.0259667656512743,-0.00455536889741152,0.00521397878898712
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7,Interleukin-7,39099,0.0165938109628566,0.005951160919813,0.00492953556002316,0.0282580863656901,0.00530459272114694
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM2,Junctional adhesion molecule B,39241,-0.00637353161421003,0.0022860821043897,-0.0108542525388139,-0.00189281068960621,0.00531043238376961
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROK1,Prokineticin-1,39099,0.0163314751710364,0.00586162990695714,0.00484268055340036,0.0278202697886724,0.00534014405239913
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,36792,0.00864822354122015,0.00311388917659665,0.00254500075509071,0.0147514463273496,0.00548904522798827
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,36538,-0.0192646810253032,0.00694266480510392,-0.0328723040433069,-0.00565705800729955,0.00553122547998016
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,39136,-0.0181231191386689,0.00653376484613127,-0.0309292982370862,-0.00531694004025161,0.00554791616573267
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA1,Laminin subunit alpha-1,36391,0.0137293751480246,0.00495129127287453,0.00402484425319049,0.0234339060428586,0.00556433696838143
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,36420,-0.0183566711791956,0.00662343855329459,-0.031338610743653,-0.00537473161473824,0.00558856686635557
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC3B,Tetranectin,36506,-0.00531776291533408,0.00192330020846963,-0.00908743132393455,-0.0015480945067336,0.0057020013658088
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCR,Breakpoint cluster region protein,39099,-0.0231312114814798,0.00839429362098035,-0.0395840269786013,-0.00667839598435835,0.00586564045084801
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,36747,-0.0142963965106751,0.00519928968235029,-0.0244870042880817,-0.00410578873326855,0.00597361617291106
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39044,-0.0164298392958376,0.0059777596998208,-0.0281462483074863,-0.00471343028418879,0.00599403650802543
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,36731,-0.0138287788402302,0.00503459421387867,-0.0236965834994324,-0.00396097418102806,0.00602724127956848
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,36767,-0.0156327108278134,0.00569455662463274,-0.0267940418120936,-0.00447137984353327,0.00605572495634676
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,39162,-0.00653081071345891,0.00238088869884286,-0.0111973525631909,-0.00186426886372691,0.00609489556026092
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPO,Lactoperoxidase,38602,-0.0149145413057869,0.00543758776783653,-0.0255722133307465,-0.00425686928082728,0.00609802220409572
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,36430,-0.0108525859103901,0.00395757291408057,-0.018609428821988,-0.0030957429987922,0.00611094509151827
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,38741,-0.0161468059752159,0.00588940280656045,-0.0276900354760744,-0.00460357647435739,0.00612005145613508
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB2,Plexin-B2,39217,-0.00589710435477889,0.00215268999574204,-0.0101163767464333,-0.00167783196312449,0.00616202574737053
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,39106,-0.00790937780441199,0.00289104046930969,-0.013575817124259,-0.002242938484565,0.00622962935718672
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC79,Protein unc-79 homolog,36339,-0.0141985478774288,0.00519612131046453,-0.0243829456459393,-0.00401415010891834,0.00629387552440358
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,36391,0.00949836207574196,0.0034785397651671,0.00268042413601445,0.0163163000154695,0.00633151841439669
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39023,-0.0191592548796232,0.00701908741861777,-0.0329166662201141,-0.00540184353913242,0.00634856433071492
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,38727,-0.0143086699557401,0.0052435568600757,-0.0245860414014885,-0.00403129850999174,0.00636380540796139
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,38721,-0.0147228032346569,0.00539543859619445,-0.025297862883198,-0.00414774358611573,0.00636496352757483
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QL2,Complement C1q-like protein 2,36430,0.0104524012402377,0.00383434051967218,0.00293709382168019,0.0179677086587951,0.00641963650568092
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA13,Carbonic anhydrase 13,38907,0.0262370274972063,0.00962972493693309,0.00736276662081743,0.0451112883735951,0.00644562467757886
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,38962,0.0146199285133715,0.00537020548421518,0.00409432576430972,0.0251455312624332,0.00648810516139733
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,36792,-0.0179496369199099,0.00660894388064499,-0.0309031669259741,-0.00499610691384573,0.00661714207764272
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP10,Caspase-10,38741,-0.0176698557393089,0.0065070607058005,-0.0304236947226779,-0.0049160167559399,0.00662542220513922
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,38841,-0.0139184840555661,0.00512808864203333,-0.0239695377939514,-0.00386743031718077,0.00665188841827232
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,36767,-0.00787188232507116,0.00290123154847076,-0.0135582961600739,-0.00218546849006847,0.00667071750280881
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,39106,-0.00687153340581091,0.00253444387111702,-0.0118390433932003,-0.00190402341842155,0.00671033518675317
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,38987,-0.0149080099804006,0.00550269824470308,-0.0256932985400186,-0.00412272142078253,0.00675179081555311
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGA,Protein O-GlcNAcase,36743,-0.0176384300878434,0.00652014600348415,-0.0304179162546723,-0.00485894392101444,0.00683489059454304
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPE,Carboxypeptidase E,39139,0.00950164875828568,0.00351447602281668,0.002613275753565,0.0163900217630064,0.00686739021369196
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,39255,-0.00951664120935286,0.00352382455596561,-0.0164233373390455,-0.00260994507966025,0.0069278371572048
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDHD2,Phospholipase DDHD2,36767,-0.0164396805921015,0.00609868776960102,-0.0283931086205195,-0.0044862525636835,0.0070351036076293
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,36345,-0.0241977721796567,0.00898034848862954,-0.0417992552173707,-0.00659628914194284,0.00705833712470464
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA1,Annexin A1,36450,-0.0107095231144067,0.00398365251725335,-0.0185174820482232,-0.00290156418059011,0.00718967419605219
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,36743,-0.0205485565497384,0.00764881831274406,-0.0355402404427167,-0.00555687265676002,0.00722973908404801
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,38727,-0.0270616182991839,0.0100802172464606,-0.0468188441022467,-0.00730439249612118,0.00726914041982731
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN2,Nectin-2,39086,-0.00690334479017751,0.0025715726638093,-0.0119436272112437,-0.00186306236911128,0.00727205583072307
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,36430,-0.0109041463820851,0.00406606167537291,-0.018873627265816,-0.00293466549835421,0.00733346242510461
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,36743,-0.0124032026786743,0.0046359218274599,-0.0214896094604957,-0.00331679589685293,0.00747220960880891
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39147,0.00841700925765258,0.0031490013589573,0.00224496659409627,0.0145890519212089,0.00752753838726877
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN3,CCN family member 3,39273,-0.00790582233615431,0.00295778618660177,-0.0137030832618938,-0.00210856141041484,0.00752811952752874
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIM,Vimentin,38832,-0.028322116898675,0.0106449044380171,-0.0491861295971885,-0.00745810420016155,0.00780785291479218
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,39283,0.0141742167725366,0.00533216999311614,0.003723163586029,0.0246252699590443,0.00786296883007003
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,36743,-0.0158370354952158,0.00596182422636547,-0.0275222109788921,-0.00415186001153948,0.00790753806030376
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",36391,0.0121565120255312,0.00458352423979541,0.0031728045155322,0.0211402195355302,0.00800652720954998
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP6,Bone morphogenetic protein 6,38816,-0.0100741711519305,0.00380029293915045,-0.0175227453126654,-0.00262559699119566,0.00803637569645136
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,36727,0.0213786826463091,0.00808472491820601,0.00553262180662535,0.0372247434859929,0.00819520896420225
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA6,Integrin alpha-6,39099,0.0128056792848111,0.00485886283208211,0.00328230813393018,0.0223290504356921,0.00840910329997984
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",36755,-0.00543798696136457,0.00206588334254474,-0.00948711831275226,-0.00138885560997688,0.00849145491442239
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,36420,-0.00787889198450222,0.00299501036245584,-0.0137491122949157,-0.00200867167408877,0.00853200694204187
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,38979,0.00941037425661798,0.00358388556090737,0.00238595855723954,0.0164347899559964,0.00865463076889468
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,38841,-0.00734057883933857,0.00279660972725859,-0.0128219339047654,-0.00185922377391173,0.0086784459454645
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,36420,-0.0184113572222676,0.00702023203704117,-0.0321710120148683,-0.00465170242966687,0.00873634692868264
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,36776,0.00588711223305548,0.0022450686818439,0.00148677761664143,0.0102874468494695,0.00874560078008589
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TADA3,Transcriptional adapter 3,36731,-0.00948071855857876,0.00361784463059697,-0.0165716940345488,-0.00238974308260871,0.00878929073684869
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGR,Progesterone receptor,36430,0.0249432336817761,0.00955359964693944,0.00621817837377477,0.0436682889897774,0.00904186835330973
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,39234,-0.011127645675435,0.0042628700290018,-0.0194828709322786,-0.00277242041859152,0.00905334507880536
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPIND1,Heparin cofactor 2,36779,-0.00668893329464774,0.00257169482357123,-0.0117294551488474,-0.00164841144044813,0.00930631179935576
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,39291,-0.0101732252822456,0.00392080558665649,-0.0178580042320923,-0.00248844633239889,0.0094769312372798
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL8,Interleukin-8,38990,-0.0156254960934965,0.00602280969919852,-0.0274302031039256,-0.0038207890830674,0.00948512693490138
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300E,CMRF35-like molecule 2,39221,0.00909673143138802,0.00350826192583253,0.00222053805675627,0.0159729248060198,0.00952480870142768
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON1,Spondin-1,39117,-0.00753488148546842,0.00290641195305513,-0.0132314489134565,-0.00183831405748037,0.00953712437498989
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL34,Interleukin-34,38713,-0.00842927683348973,0.00325954622288577,-0.0148179874303458,-0.00204056623663362,0.00971834007848806
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,36500,-0.0137663032844351,0.00532568494918987,-0.0242046457848473,-0.00332796078402299,0.00975213892975443
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,36767,-0.0220686361540672,0.0085635021068157,-0.038853100283426,-0.00528417202470842,0.00997553934534326
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICALL2,MICAL-like protein 2,36421,-0.0160415073820937,0.00623782019753784,-0.0282676349692679,-0.00381537979491956,0.0101328295606351
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,36377,-0.00939852933264878,0.00365980543652588,-0.0165717479882395,-0.00222531067705806,0.0102390106257574
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APLP1,Amyloid-like protein 1,39106,0.0120470097373611,0.00469319768443888,0.00284834227586092,0.0212456771988613,0.01027041794787
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,39165,0.00764443097013635,0.00298567143882597,0.00179251495003745,0.0134963469902352,0.0104655130749385
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,36430,0.0140307562894405,0.00549095136453215,0.00326849161495747,0.0247930209639235,0.01062280820846
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE3,Eosinophil cationic protein,39030,-0.0250954583679224,0.00982181794956839,-0.0443462215490764,-0.00584469518676835,0.0106262344946432
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOSB,Protein fosB,38741,-0.00901195898326278,0.00352898783457585,-0.0159287751390315,-0.00209514282749411,0.0106685329299915
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,36391,-0.0202277385647554,0.00792409222998174,-0.0357589593355196,-0.0046965177939912,0.0107012562765391
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RP2,Protein XRP2,39023,-0.00976757423978398,0.00382754137319278,-0.0172695553312418,-0.00226559314832613,0.0107228732155416
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX16,Syntaxin-16,38727,-0.0135735606151313,0.00532435636060907,-0.0240092990819251,-0.00313782214833753,0.0108028520337877
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,36430,-0.0128047509267228,0.00502641168510258,-0.0226565178295239,-0.00295298402392177,0.0108617914828436
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,39046,0.00783405891610848,0.00307614893044557,0.00180480701243517,0.0138633108197818,0.010884160044644
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,38844,-0.00528343847005884,0.00207479149337278,-0.00935002979706949,-0.00121684714304819,0.0108911084012098
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,39023,0.0200960962802728,0.00789375094854655,0.00462434442112158,0.0355678481394241,0.0109118394176375
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAM,Integrin alpha-M,39093,0.00730005945055089,0.00286855571083658,0.00167769025731118,0.0129224286437906,0.0109420774838737
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,39062,0.00522652728370441,0.00205436263614883,0.00119997651685271,0.00925307805055611,0.0109654234697058
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOC1,Apolipoprotein C-I,36779,-0.00862727366157542,0.00339650044068659,-0.0152844145253211,-0.00197013279782971,0.0110953405728878
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,39099,0.00768102572085164,0.00302754356385132,0.00174704033570305,0.0136150111060002,0.0111890231958631
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPT,Dermatopontin,39283,0.00617246407190802,0.00243428473620174,0.00140126598895262,0.0109436621548634,0.0112340680253012
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,39093,-0.00641051685051306,0.00252907641671445,-0.0113675066272734,-0.00145352707375273,0.0112634402464611
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39079,-0.0141966148046359,0.00561011438665161,-0.025192439002473,-0.00320079060679871,0.0113987263185321
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA7,Carbonic anhydrase 7,36538,0.0077786470748739,0.00307417284964207,0.00175326828957544,0.0138040258601724,0.01140779037289
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,36339,-0.0114423027202843,0.00452364361097523,-0.0203086441977958,-0.00257596124277287,0.0114365507106933
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YJU2,Splicing factor YJU2,36731,-0.00751997135333348,0.00297336042504307,-0.0133477577864179,-0.00169218492024907,0.0114468861736101
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD248,Endosialin,36791,0.00911012022339435,0.00360378276912848,0.00204670599590252,0.0161735344508862,0.0114854411142826
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2,Brorin,38924,0.00884421760953068,0.00350892018797431,0.00196673404110104,0.0157217011779603,0.0117292164387332
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39099,0.0281037865327401,0.0111589158163979,0.00623231153260013,0.04997526153288,0.0117955719923317
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MESD,LRP chaperone MESD,39093,0.0280586810946827,0.011168613930036,0.00616819779181222,0.0499491643975533,0.0120056499035376
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1,DNA topoisomerase 1,36743,-0.0261370701862042,0.0104038251530161,-0.0465285674861158,-0.00574557288629269,0.0120083295529898
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,36538,0.0166188102891317,0.00662708763959522,0.00362971851552508,0.0296079020627383,0.0121640501233847
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,39241,0.0162278722076136,0.00647450684739173,0.00353783878672582,0.0289179056285014,0.0122060946923933
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK7,Kallikrein-7,36203,-0.00894038027587758,0.00357176704961116,-0.0159410436931154,-0.0019397168586397,0.0123249615830486
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,38828,-0.00683333167722741,0.0027318046469308,-0.0121876687852118,-0.00147899456924304,0.0123809877978982
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,39147,-0.0111902584095417,0.00447565088659472,-0.0199625341472674,-0.00241798267181608,0.0124208622636938
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,36445,0.00771082635651356,0.00308568670140599,0.00166288042175783,0.0137587722912693,0.0124705462174426
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR1,Folate receptor alpha,39046,-0.00625666815691647,0.00250537603127099,-0.0111672051782076,-0.00134613113562532,0.0125249097458307
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,39283,0.00487678293034314,0.00195786724364468,0.00103936313279957,0.00871420272788672,0.0127536882017989
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F10,Coagulation factor X,36796,-0.00603994237733076,0.002424832968706,-0.0107926149959945,-0.001287269758667,0.0127555335667573
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,38841,0.0149211374208175,0.00599097013844119,0.00317883594947277,0.0266634388921622,0.0127633433216936
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,38841,0.00943818924754166,0.00379066472565541,0.00200848638525706,0.0168678921098263,0.0127904337246294
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,36363,0.0111783815059287,0.00449432333005277,0.00236950777902528,0.0199872552328321,0.0128874269171658
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,39255,0.00810071121354828,0.0032576819155796,0.00171565465901226,0.0144857677680843,0.0129057734308014
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAN,Versican core protein,39241,0.00669072691970262,0.00269375452044517,0.00141096805963009,0.0119704857797752,0.0130097239155658
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,36792,-0.0243915990847264,0.00982689653586269,-0.0436523162950173,-0.00513088187443554,0.0130726914032482
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,36538,-0.025788631219134,0.0103945987135143,-0.0461620446976219,-0.00541521774064603,0.0131156090051881
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,36548,-0.00944122128438207,0.00380613957250676,-0.0169012548464953,-0.00198118772226882,0.0131318035647868
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,36500,0.00818787343146026,0.00330902414087612,0.00170218611534306,0.0146735607475775,0.0133587713926998
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,39165,0.00746997582382643,0.00301921202819299,0.00155232024856818,0.0133876313990847,0.0133662163741095
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1B,Lithostathine-1-beta,39283,-0.0122595346773858,0.00495676285969016,-0.0219747898823785,-0.00254427947239309,0.0133980658057357
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN2,Contactin-2,39255,-0.0100031367527409,0.00405093249119795,-0.0179429644354889,-0.00206330906999292,0.0135469561939867
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD46,Membrane cofactor protein,39022,0.00639636531935512,0.00259102378089919,0.00131795870879271,0.0114747719299175,0.0135728202984094
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,36538,0.0166773399419381,0.00676463212793928,0.00341866097117713,0.0299360189126991,0.0137002251512698
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,36791,0.00666219642111985,0.00270756470123513,0.00135536960669899,0.0119690232355407,0.0138839986000234
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,36391,-0.0104635401913861,0.00425284383239213,-0.0187991141028746,-0.00212796627989749,0.0138930433386407
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,36767,0.013488786131537,0.00548288562435822,0.00274233030779493,0.0242352419552791,0.0139004433024478
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,36792,-0.00725383070150117,0.00294858683926828,-0.013033060906467,-0.00147460049653534,0.0139026530340784
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,36743,0.0104417807904898,0.00424663219247643,0.00211838169323595,0.0187651798877436,0.0139518025996644
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",36767,-0.0173919081032394,0.00708125614023932,-0.0312711701381085,-0.00351264606837034,0.0140605013762302
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36G,Interleukin-36 gamma,36397,-0.0149718590129836,0.00610300987895766,-0.0269337583757406,-0.00300995965022658,0.0141729654370084
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH5,Cadherin-5,39283,0.00681710321689317,0.00278363054408985,0.00136118735047707,0.0122730190833093,0.0143365085753409
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPAG1,Sperm-associated antigen 1,36767,-0.0130272220611626,0.00532511838485571,-0.0234644540954798,-0.00258999002684537,0.0144434414132914
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,36743,-0.01071467860176,0.00438370183097036,-0.0193067341904619,-0.00212262301305808,0.0145303722563846
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB2,Lysosome membrane protein 2,38733,-0.00638639500940566,0.00261295126273602,-0.0115077794843683,-0.00126501053444307,0.0145316889259926
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,36391,0.00822528128938325,0.00336783390425629,0.00162432683704092,0.0148262357417256,0.0146074891485965
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF7,SLAM family member 7,39099,0.0128865055838485,0.00528160301345334,0.00253456367747993,0.023238447490217,0.0147032455243469
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,38946,0.00632611579196108,0.00259652527933394,0.00123692624446656,0.0114153053394556,0.0148466809541805
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1,Programmed cell death protein 1,39223,0.00912598439754363,0.00374760862214012,0.00178067149814899,0.0164712972969383,0.0148969687269003
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,36430,-0.0069791625607685,0.00286623603976622,-0.0125969851987103,-0.0013613399228267,0.0149073580613723
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COCH,Cochlin,36792,-0.0101219464564046,0.0041606980631706,-0.018276914660219,-0.00196697825259026,0.0149980271584922
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,38727,-0.0115714926959594,0.00475778155416648,-0.0208967445421257,-0.00224624084979313,0.0150224821062974
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,39093,0.00745228710084689,0.00307369923199043,0.00142783660614565,0.0134767375955481,0.0153396200102732
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAL,Galanin peptides,39162,0.0142924484359981,0.00589540620940445,0.00273745226556536,0.0258474446064308,0.0153478941247486
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIF,Leukemia inhibitory factor,38741,-0.0111872711328167,0.00461469533427746,-0.0202320739880005,-0.00214246827763288,0.0153509958215875
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A16,Protein S100-A16,38713,-0.0136530630506799,0.00563529098027047,-0.02469823337201,-0.00260789272934974,0.0154141840543878
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF16,Fibroblast growth factor 16,36430,-0.0105442746226459,0.00435924495471559,-0.0190883947338884,-0.00200015451140331,0.0155846026495686
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,36391,0.00683566898402309,0.0028291361143658,0.00129056219986612,0.0123807757681801,0.0156990113958697
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,39283,0.00942242698441139,0.00390775942132425,0.00176321851861587,0.0170816354502069,0.0159113209795912
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELB,Transcription factor RelB,36430,0.0107623827269164,0.00447209049903539,0.00199708534880708,0.0195276801050258,0.0161176100949574
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39041,-0.0409619546896815,0.0170293286992865,-0.0743394389402832,-0.00758447043907991,0.0161676779953801
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,39147,-0.0200019097647048,0.00834021333395064,-0.036348727899248,-0.00365509163016151,0.0164855660727256
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,36339,0.00656658383221284,0.00274151344201006,0.00119321748587311,0.0119399501785526,0.01662411805002
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY6D,Lymphocyte antigen 6D,38998,0.00789656027964195,0.00329692127753511,0.00143459457567314,0.0143585259836108,0.0166264781256373
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,39265,-0.0121444924576936,0.00507229080315557,-0.0220861824318785,-0.0022028024835087,0.0166648384528052
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,36767,-0.0129773050530493,0.00542444091957733,-0.0236092092554209,-0.00234540085067777,0.0167538737341658
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,38960,-0.00860473956712004,0.00360322107268247,-0.0156670528695777,-0.0015424262646624,0.0169493892352174
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN2,Alpha-actinin-2,36391,-0.0129337726696343,0.00541650081184143,-0.0235501142608435,-0.00231743107842511,0.0169621411301248
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLGN,Calmegin,36421,-0.00951742930732184,0.00399546089212372,-0.0173485326558843,-0.00168632595875934,0.0172308674094558
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C5,Complement C5,36806,0.00331402798011495,0.0013928180448532,0.00058410461220269,0.00604395134802722,0.017356713016736
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK11,Kallikrein-11,39017,-0.00633292718118816,0.00266165109801564,-0.0115497633332988,-0.0011160910290775,0.0173567823019668
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,38987,-0.00751293747914598,0.00315778387786092,-0.0137021938797534,-0.00132368107853858,0.0173635121742455
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,39207,0.00497370913547479,0.00209171986548809,0.000873938199118133,0.00907348007183144,0.017428044750322
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,36500,0.0139608241302917,0.00587903851386701,0.00243790864311236,0.025483739617471,0.0175790980318927
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILPL2,RILP-like protein 2,36792,0.021315738372359,0.00901302238097705,0.003650214505644,0.0389812622390741,0.0180450701344472
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,38832,-0.0113610458166102,0.00482329174656258,-0.0208146976398728,-0.00190739399334751,0.0185128718422898
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT2,Omega-amidase NIT2,36737,-0.0162178753203026,0.00688884298911722,-0.0297200075789724,-0.00271574306163288,0.0185763869926052
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,36363,0.0102336483410205,0.00434757296436639,0.00171240533086234,0.0187548913511786,0.0185941876128068
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB2,Integrin beta-2,38976,0.00614754156354525,0.00261509922776579,0.00102194707712429,0.0112731360499662,0.0187465237396239
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,36748,-0.00423541567330546,0.00180922324122509,-0.00778149322610664,-0.000689338120504279,0.0192466422955141
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMTN,Smoothelin,36702,-0.0205671633724613,0.00878951881791322,-0.0377946202555713,-0.00333970648935143,0.0193007986012437
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,36420,-0.00625562289498691,0.00267417462640617,-0.011497005162743,-0.00101424062723082,0.0193369287795646
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX2,Heme oxygenase 2,38741,-0.0101565291718902,0.00434343730390546,-0.0186696662875449,-0.00164339205623548,0.0193816432967446
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",36731,-0.0107911659844665,0.00461696008340788,-0.0198404077479459,-0.00174192422098703,0.0194394552493188
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,38998,-0.00514113738876094,0.00220184935577221,-0.00945676212607448,-0.000825512651447399,0.0195607125968238
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,36420,-0.0219124501765098,0.00938537090691503,-0.0403077771540633,-0.00351712319895637,0.0195724051630895
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS2,Growth arrest-specific protein 2,36538,-0.0113760906068884,0.00487791673973831,-0.0209368074167755,-0.00181537379700135,0.0197077600742249
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSPN,Persephin,39099,-0.0200195782794884,0.00859661511691492,-0.0368689439086416,-0.00317021265033514,0.0198840218496312
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,36792,-0.00546185504524241,0.00234596149052993,-0.0100599395666811,-0.000863770523803752,0.0199171083861264
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,36747,-0.00596246385308267,0.00256178103322109,-0.010983554678196,-0.000941373027969339,0.0199557665103606
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RYR1,Ryanodine receptor 1,36391,0.00712566086700409,0.00306610722427954,0.00111609070741618,0.013135231026592,0.0201409183526827
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,38727,-0.0165926648395003,0.00714669970949192,-0.0306001962701044,-0.0025851334088961,0.0202612412807896
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,39023,0.00508165264289489,0.00219553302276358,0.000778407918278282,0.0093848973675115,0.0206513206684854
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WIF1,Wnt inhibitory factor 1,39255,0.0070630132571817,0.00305775951563893,0.00106980460652941,0.013056221907834,0.0209087628790908
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,39283,-0.00821284543159932,0.00356245262281221,-0.0151952525723112,-0.00123043829088739,0.0211579030112579
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,36391,0.00790764957340218,0.00343384037868547,0.00117732243117866,0.0146379767156257,0.0213030888747041
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,36743,-0.0105463670182425,0.00459673087323565,-0.0195559595297843,-0.00153677450670059,0.0217881906737958
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBI,Acyl-CoA-binding protein,39035,0.0167301339425592,0.00730186694244624,0.00241847473536456,0.0310417931497538,0.0219647241790053
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,39291,-0.00718380963854739,0.00313968837358148,-0.0133375988507671,-0.00103002042632769,0.0221472223117656
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLN,Promotilin,39099,-0.0185108386895258,0.00811074186404868,-0.0344078927430612,-0.00261378463599038,0.0224875885907717
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,36767,-0.0102325813294581,0.00448699797586538,-0.0190270973621543,-0.00143806529676195,0.0225945103277802
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,39291,-0.0206686161835768,0.00906402178414808,-0.0384340988805071,-0.00290313348664659,0.0226039534017596
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEXN,Nexilin,36796,-0.0143236217710288,0.00629628088460029,-0.0266643323048454,-0.00198291123721225,0.0229261963920678
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACYP1,Acylphosphatase-1,36452,-0.013609357742785,0.0059953820267635,-0.0253603065152415,-0.00185840897032856,0.0232260240061722
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTF2,Transcription termination factor 2,36421,-0.0102426570246878,0.00451367094679539,-0.0190894520804067,-0.00139586196896879,0.0232698849642488
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD93,Complement component C1q receptor,38500,0.00639978562066201,0.00282149620058964,0.000869653067506313,0.0119299181738177,0.023330053191372
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOC,Brother of CDO,38832,-0.00485096606040828,0.00213899561331091,-0.00904339746249767,-0.000658534658318892,0.0233512565781019
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18,Interleukin-18,39030,-0.00941175543244755,0.00415184557133615,-0.0175493727522664,-0.00127413811262869,0.0234112811011331
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",36391,0.0116750018489904,0.00515366865522624,0.00157381128474693,0.0217761924132338,0.0235065553893536
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPP1,Osteopontin,39246,0.0092676184252329,0.00409377695512113,0.00124381559319549,0.0172914212572703,0.0235983858646661
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,36767,0.0161467972004474,0.00713304732101804,0.00216602445125207,0.0301275699496428,0.0236115354684833
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,36363,0.00594715716651173,0.00263324485841288,0.000785997244022493,0.011108317089001,0.0239322867315103
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,36747,-0.0067389847538035,0.00298425405113396,-0.0125881226940261,-0.00088984681358094,0.0239510523739784
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,38741,-0.0119090927656802,0.00528529659172454,-0.0222682740854603,-0.00154991144590011,0.0242579096003821
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,39266,-0.00477738611173538,0.00212085739727142,-0.00893426661038735,-0.000620505613083406,0.0243000990517677
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,39153,-0.00680355113614227,0.00302274907544482,-0.0127281393240141,-0.000878962948270412,0.0244134522586841
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39099,0.012620653069719,0.00561079142043554,0.00162350188566535,0.0236178042537726,0.0245042335794636
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",36391,0.00980888200305283,0.00436830227328302,0.00124700954741811,0.0183707544586875,0.0247554784855934
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,36421,-0.0150134470818966,0.00668789016831343,-0.0281217118117909,-0.00190518235200225,0.0247937792484252
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,36420,0.0197660855421108,0.00880842045729256,0.00250158144581734,0.0370305896384042,0.0248498209202379
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX101,Testis-expressed protein 101,36421,0.0100652806472634,0.00448558328425868,0.0012735374101164,0.0188570238844104,0.0248550307732202
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,36421,-0.024865868713694,0.0111025564527909,-0.0466268793611641,-0.00310485806622384,0.0251309140675944
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,36731,-0.00595917318524302,0.00266144958825919,-0.011175614378231,-0.000742731992255019,0.0251683467080707
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,36430,-0.0176321366699184,0.0078748812056002,-0.0330669038328948,-0.00219736950694206,0.0251710458105422
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWF,von Willebrand factor,39283,0.0149097327127457,0.00666272258805727,0.0018507964401535,0.027968668985338,0.025249375864236
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,36743,0.019694323520208,0.00881359800542813,0.00241967142956887,0.0369689756108471,0.0254647466475997
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,36731,-0.00907977694932768,0.00407343445542641,-0.0170637084819634,-0.00109584541669192,0.0258296037746405
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMVK,Phosphomevalonate kinase,38733,0.0224723267306058,0.0100832899025216,0.00270907852166349,0.042235574939548,0.0258507480732712
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPHN1,Oligophrenin-1,36747,-0.0219890897629906,0.00986976152399507,-0.0413338223500209,-0.00264435717596023,0.0259027002650216
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,36743,-0.0154177021650909,0.00693078842806719,-0.0290020474841026,-0.0018333568460792,0.0261304970849394
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,36339,0.0134781607740557,0.00605967635128409,0.00160119512553888,0.0253551264225725,0.0261502758493369
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,36500,-0.00645505680862569,0.00290529921059333,-0.0121494432613886,-0.00076067035586275,0.0263129968086142
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID2,Nidogen-2,39093,0.0147856202309335,0.00665833681397017,0.00173528007555201,0.0278359603863151,0.0263915234707924
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSL,Cathepsin L1,39106,-0.00483561164947595,0.0021799832019976,-0.00910837872539125,-0.000562844573560645,0.0265567234451141
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,36767,-0.0137237364627559,0.00619460007447856,-0.0258651526087339,-0.00158232031677791,0.0267475783808341
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIN2,Bridging integrator 2,39093,-0.0181594743525113,0.00819782630502868,-0.0342272139103675,-0.0020917347946551,0.0267640087964201
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF4,Neurotrophin-4,38727,0.00805169934810485,0.00363775825174816,0.000921693174678456,0.0151817055215312,0.0268873796282495
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,39243,-0.0165800230866489,0.00749313322048332,-0.0312665641987962,-0.00189348197450156,0.0269332655870625
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO1,Roundabout homolog 1,39117,-0.00478914154672821,0.00216451300000283,-0.00903158702673377,-0.000546696066722654,0.0269418961743226
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,39093,-0.0104072166488981,0.0047064293320981,-0.0196318181398104,-0.00118261515798587,0.0270314881719448
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK8,Kallikrein-8,38575,-0.0069904547420867,0.00316135329920394,-0.0131867072085264,-0.00079420227564698,0.0270357657680215
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,39241,-0.00564140245196315,0.00255414951017348,-0.0106475354919032,-0.000635269412023122,0.0272087746398882
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAN,Aggrecan core protein,38974,0.00567101889622115,0.0025682306688633,0.000637286785249079,0.0107047510071932,0.0272493089096227
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,38727,0.0255676403091112,0.0115960163847074,0.00283944819508474,0.0482958324231377,0.0274788874360281
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTC,Probetacellulin,38727,0.0148840525978186,0.00675456811838327,0.00164509908578742,0.0281230061098498,0.0275710321188779
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STEAP4,Metalloreductase STEAP4,36363,0.0151879099289623,0.00689742755499811,0.001668951921166,0.0287068679367586,0.0276858111101221
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSHB,Follitropin subunit beta,36420,-0.0130364853797525,0.00592448088130229,-0.024648467907105,-0.0014245028524,0.0277935827687617
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH7,Protocadherin-7,36743,-0.00672436039710889,0.0030579783648691,-0.0127179979922523,-0.000730722801965442,0.027898747787378
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",36538,-0.00926842602782079,0.00421691903024888,-0.0175335873271086,-0.00100326472853298,0.0279732377941226
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,39099,0.00922481526379773,0.00420148921130307,0.000989896409643703,0.0174597341179518,0.0281351710458381
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,39106,-0.0132084017277184,0.00601886717478718,-0.0250053813903013,-0.00141142206513551,0.0282145411733024
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA4,Ephrin-A4,38960,-0.00552734051963781,0.00252074970715132,-0.0104680099456544,-0.000586671093621228,0.0283415529336425
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,38987,-0.015694152390077,0.00717065050395403,-0.0297486273778269,-0.00163967740232708,0.0286364265368268
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,36731,0.0113980407685625,0.00521383669348533,0.00117892084933124,0.0216171606877937,0.0288252248182235
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,36747,-0.00712138765015312,0.00326224558770472,-0.0135153890020544,-0.000727386298251863,0.0290559251597145
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,39291,0.0113520538886243,0.00520957490924524,0.00114128706650368,0.021562820710745,0.0293411792904752
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN2,Neuroligin-2,36363,0.00944547339679265,0.00433478052442078,0.000949303568927924,0.0179416432246574,0.0293505033433575
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN2,Ficolin-2,39049,-0.00802964451073217,0.00368704410120453,-0.015256250949093,-0.000803038072371297,0.0294362658010281
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,38727,-0.00878002479787734,0.00403558006592867,-0.0166897617270975,-0.000870287868657149,0.0295968605073965
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,36792,-0.00930151809258624,0.00427895619734058,-0.0176882722393738,-0.000914763945798697,0.0297395875256172
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD1,COMM domain-containing protein 1,36420,-0.0122728799513754,0.00564620109538355,-0.0233394340983272,-0.00120632580442369,0.029749848141913
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,39211,0.0143705674557289,0.0066234656847825,0.00138857471355522,0.0273525601979026,0.0300490595099382
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XG,Glycoprotein Xg,39219,0.0059635456231107,0.00275088857203137,0.000571804021929215,0.0113552872242922,0.0301845282036295
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,39162,-0.0249643273337027,0.0115429466905107,-0.0475885028471037,-0.00234015182030178,0.030577056509406
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,36767,0.00942007760915644,0.00435749301295869,0.000879391303757412,0.0179607639145555,0.0306510446700823
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,38832,-0.0104512478499343,0.00483874024542138,-0.0199351787309602,-0.000967316968908425,0.0307953882168289
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,36538,0.012310148877648,0.0057030769926117,0.00113211797212907,0.0234881797831669,0.0309069082633932
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,36391,0.0102302468045825,0.00474675351058847,0.000926609923829095,0.0195338836853359,0.03116445414368
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,36391,0.012448146962318,0.00578476947163151,0.00110999879792022,0.0237862951267157,0.0314256169919349
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2B,Alpha-amylase 2B,38106,0.00941562779641571,0.00438211164252541,0.000826688977065915,0.0180045666157655,0.0316788913975233
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRBP,Acrosin-binding protein,36731,0.00754843640052983,0.00351738659550549,0.000654358673339071,0.0144425141277206,0.0318887903336159
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,35989,-0.0212684699190749,0.00992387990461151,-0.0407192745321135,-0.00181766530603636,0.0321200265522839
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,39106,-0.00547837882676396,0.0025568592481002,-0.0104898229530404,-0.000466934700487576,0.0321593769003986
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSMB,Beta-microseminoprotein,39024,0.0130745718149082,0.00610308261557804,0.00111252988837519,0.0250366137414411,0.0321860433902379
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSG1,Tryptase gamma,36430,0.00524548547490131,0.00244952788750987,0.000444410815381976,0.0100465601344206,0.032258777262192
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALLD,Palladin,36430,0.00801190614944574,0.00374188193068262,0.000677817565307809,0.0153459947335837,0.0322816413557674
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,36767,-0.0133067289148769,0.00621613426111984,-0.0254903520666718,-0.00112310576308202,0.0323188623050777
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39023,0.0184967948830515,0.00864473084241471,0.00155312243191869,0.0354404673341843,0.0323980750642606
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36A,Interleukin-36 alpha,36430,0.0114377705901225,0.00535275994837125,0.000946361091314867,0.0219291800889302,0.0326336151551947
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,39093,-0.00780173551667293,0.00365148679980117,-0.0149586496442832,-0.000644821389062643,0.0326471211304893
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH4,Myosin-4,36391,0.00935663303215226,0.0043816080689025,0.000768681217103353,0.0179445848472012,0.0327449419428486
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ULBP2,UL16-binding protein 2,38987,-0.00711121730013107,0.00333042065509388,-0.0136388417841151,-0.000583592816147057,0.0327581662830294
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,36747,-0.00495202643229545,0.00232453153224109,-0.00950810823548799,-0.000395944629102906,0.0331630080499847
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,36731,-0.0165682840712095,0.00778299074315418,-0.0318229459277916,-0.00131362221462728,0.0332913040717886
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NENF,Neudesin,36731,0.0212920666447843,0.0100126186530646,0.00166733408477779,0.0409167992047909,0.033478684862306
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,39106,-0.00855672826543097,0.00402551831745753,-0.0164467441676477,-0.000666712363214198,0.0335508173516895
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,39229,-0.011006235822928,0.00518027929726886,-0.0211595832455749,-0.00085288840028099,0.033632461673131
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,36391,0.00947091062105946,0.00446282811930264,0.000723767507226291,0.0182180537348926,0.0338424493902827
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,36731,-0.0069383633910405,0.00326973399376294,-0.0133470420188159,-0.000529684763265146,0.0338570976595406
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPD52L2,Tumor protein D54,36500,0.0210857927334659,0.00994724203206324,0.00158919835062198,0.0405823871163099,0.0340454953817353
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOC,Myocilin,39093,-0.00889629830344211,0.00419691538887674,-0.0171222524656405,-0.000670344141243697,0.0340455338760604
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,39241,-0.00653889047043203,0.00308601970211631,-0.01258748908658,-0.00049029185428406,0.0341170021488675
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,36363,-0.00844117260984313,0.00398589562493049,-0.0162535280347069,-0.000628817184979361,0.0342150311409125
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,38987,-0.0135370034973033,0.00639748605389206,-0.0260760761629317,-0.000997930831674839,0.0343621234208235
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,36430,-0.0110604224961506,0.00523062832190863,-0.0213124540070915,-0.00080839098520972,0.0344879929660293
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39165,-0.00820398270395076,0.00388030011750412,-0.0158093709342588,-0.00059859447364268,0.0345087673954875
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSHB,Thyrotropin subunit beta,39106,0.0144282262259914,0.00682466475010727,0.00105188331578111,0.0278045691362016,0.0345203850529745
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOB,Apolipoprotein B-100,36796,0.00436788942226384,0.0020689104605665,0.000312824919553497,0.00842295392497418,0.0347740210000625
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM19,Probable RNA-binding protein 19,36391,0.00921265079827198,0.00436426195811008,0.000658697360376237,0.0177666042361677,0.034798096885146
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,36430,-0.0175427548928052,0.00833167752361892,-0.0338728428390982,-0.0012126669465121,0.0352633348227094
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,36500,-0.00712996794656469,0.00338659636771078,-0.0137676968272778,-0.000492239065851562,0.035280600380785
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,38987,0.0196660611431968,0.00934899017356303,0.00134204040301322,0.0379900818833803,0.0354342538513615
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSN,Gelsolin,36737,0.00358578257442082,0.00170472812238318,0.000244515454549781,0.00692704969429185,0.0354472228604097
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,39099,-0.00703983758438268,0.00335222768903671,-0.0136102038548946,-0.000469471313870723,0.0357410529623606
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPG,Macrophage-capping protein,38972,-0.0111243723559064,0.00530993426582438,-0.0215318435169222,-0.00071690119489063,0.0361865905477148
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRP15,RRP15-like protein,36363,0.0173684833787077,0.00829330497258313,0.00111360563244475,0.0336233611249706,0.0362553336419983
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGB,Secretogranin-1,39185,0.00754089173797231,0.00360419185701525,0.000476675698222412,0.0146051077777222,0.0364320396254697
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP3,Stromelysin-1,39093,0.00911075352153479,0.00435464780239145,0.000575643828847554,0.017645863214222,0.0364379731698862
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR1,Toll-like receptor 1,36430,0.00499029870989245,0.00238592920627464,0.000313877465594146,0.00966671995419075,0.0364984905512521
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA4,Carboxypeptidase A4,36251,-0.00829971505722741,0.00398084757919028,-0.0161021763124404,-0.000497253802014471,0.0370977519340365
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP2,Methionine aminopeptidase 2,39237,-0.0109446712291081,0.00526222486124018,-0.0212586319571389,-0.000630710501077365,0.0375552443596721
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,39140,0.0146490794737528,0.00704504925339055,0.00084078293710731,0.0284573760103983,0.037602397866006
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP15,Matrix metalloproteinase-15,36792,0.00939652928437395,0.004521450814617,0.000534485687724627,0.0182585728810233,0.0377095943868583
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",36767,-0.00894818341477524,0.0043089622621304,-0.0173937494485508,-0.000502617380999654,0.0378541067035168
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,38502,-0.00556412775849782,0.00267962970234983,-0.0108162019751035,-0.000312053541892164,0.0378693847738514
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGA,Chromogranin-A,36791,-0.0148506113959013,0.00715454190407768,-0.0288735135278935,-0.000827709263909009,0.0379423437816354
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,38832,-0.00927195277843236,0.00446941150960456,-0.0180319993372573,-0.000511906219607429,0.0380466510801646
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JCHAIN,Immunoglobulin J chain,38841,0.0114247285354483,0.00550900760527134,0.000627073629116487,0.0222223834417801,0.0381124276770206
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO2,Roundabout homolog 2,39241,-0.0043018151503544,0.00207581698060124,-0.00837041643233283,-0.000233213868375974,0.0382496204100996
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,36391,0.00768959363393215,0.00371218250163868,0.000413715930720338,0.014965471337144,0.0383373493801034
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,36806,0.00353130055703269,0.00170549367075141,0.000188532962359914,0.00687406815170546,0.0384211579672988
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,39023,0.00596640346449675,0.00288257498458975,0.000316556494700843,0.0116162504342926,0.0384863540803285
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,39033,-0.00648943996922002,0.00313732969395731,-0.0126386061693763,-0.000340273769063701,0.0386137196266711
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,36363,0.0106206416687885,0.00513849920186682,0.000549183233129575,0.0206921001044475,0.0387663581314617
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOST,Sclerostin,39086,-0.00718853531104304,0.00348472759409993,-0.0140186013954789,-0.000358469226607173,0.0391420268664317
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,36421,0.00593953968456106,0.00288130186225975,0.00029218803453196,0.0115868913345902,0.0392846307871144
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,39110,-0.00738683825898888,0.0035908028363768,-0.0144248118182874,-0.000348864699690346,0.0396882791072973
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESYT2,Extended synaptotagmin-2,36747,-0.0154780118171341,0.00752676652560036,-0.0302304742073108,-0.000725549426957352,0.0397644617425706
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39023,0.0130941016893886,0.00638317792378361,0.000583072958772756,0.0256051304200045,0.0402504792460825
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36363,0.0114872683547655,0.00560653037957253,0.000498468810803334,0.0224760678987277,0.0404918809661968
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,36363,0.0144856033839703,0.00707244520926069,0.000623610773819323,0.0283475959941212,0.0405637242703051
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,38987,0.00669987456145388,0.00327582834496876,0.000279251005315118,0.0131204981175926,0.0408478832033413
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI2B,Protein EVI2B,36339,0.00773247395626831,0.00378139270082006,0.000320944262660989,0.0151440036498756,0.0408881542455576
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB5,Serpin B5,38832,-0.00905071396762782,0.00443528629170566,-0.0177438750993709,-0.00035755283588473,0.0413065644365497
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,38727,-0.0118989163653827,0.00583858816834427,-0.0233425491753374,-0.000455283555427894,0.0415697599998222
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA1,BolA-like protein 1,36363,-0.010283336256583,0.00505173124749037,-0.0201847295016642,-0.000381943011501929,0.0418109394632163
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,36747,-0.0109657708689238,0.00538891211943559,-0.0215280386230175,-0.000403503114829994,0.0418837217391661
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA11,Integrin alpha-11,39099,0.00630802025772165,0.00310198654729685,0.000228126625019819,0.0123879138904235,0.0420150738652307
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARFIP1,Arfaptin-1,36767,0.0129031054805568,0.00634721164327635,0.000462570659735144,0.0253436403013784,0.0420852969754075
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP8,Neutrophil collagenase,39218,0.0133110065988916,0.00655432897515824,0.00046452180758143,0.0261574913902017,0.042285118230962
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,36420,0.00983981043732809,0.00484992429055736,0.00033395882783566,0.0193456620468205,0.0424937493946921
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,39147,-0.00470796705329181,0.00232108649362685,-0.00925729658080042,-0.000158637525783189,0.0425422255922472
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,38741,-0.00603569047237335,0.00297997584499422,-0.011876443128562,-0.000194937816184683,0.0428424887459303
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",36767,-0.0148798450681571,0.0073514309582701,-0.0292886497463665,-0.000471040389947707,0.0429830289802987
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,38789,0.00927754800432098,0.00458496993917795,0.000291006923532204,0.0182640890851098,0.0430425199538098
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,38841,-0.0105208925188565,0.00520264679586049,-0.0207180802387431,-0.000323704798969954,0.0431714419206938
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA5,Integrin alpha-5,39093,-0.00458071634897716,0.00226545239203281,-0.00902100303736147,-0.000140429660592855,0.0431950917797569
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIFBP,KIF-binding protein,39023,0.0152954627267395,0.00756585217022649,0.000466392473095593,0.0301245329803834,0.0432306312110557
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36339,-0.0104197092392377,0.00516492169742031,-0.0205429557661815,-0.00029646271229393,0.04367523078054
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,36421,-0.00544755367318053,0.00270136993596132,-0.0107422387476647,-0.000152868598696337,0.0437596318193302
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,36391,0.00677286725338569,0.00336208880828634,0.000183173189144463,0.0133625613176269,0.0439802801972183
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,36363,0.0131518224800939,0.0065317176981515,0.000349655791716981,0.0259539891684709,0.0440800795476076
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,36421,0.00671485356895906,0.00333844659450776,0.000171498243723847,0.0132582088941943,0.0443076387175692
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,39234,-0.00585971645751591,0.00291407840178699,-0.0115713101250184,-0.000148122790013406,0.04436083509702
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5A,Cytochrome b5,36339,0.0132205907589759,0.00657734823045496,0.00032898822728415,0.0261121932906676,0.0444507256121945
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,36796,0.0134087504385,0.00668135664022285,0.000313291423663176,0.0265042094533368,0.0447821033874416
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLNL,Mesothelin-like protein,36421,0.00659790703778761,0.00329629316629622,0.000137172431847022,0.0130586416437282,0.0453477142014691
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,36391,0.0105295127537778,0.00526259172233081,0.000214832978009399,0.0208441925295462,0.0454330361933619
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C8B,Complement component C8 beta chain,36806,0.00551708162036373,0.00276238536669124,0.000102806301648906,0.0109313569390786,0.0458225636053121
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSV,Cathepsin L2,39195,-0.00744794103365765,0.00372951539468139,-0.0147577912072332,-0.000138090860082135,0.0458399464906335
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,36363,0.00618900966199318,0.00310057936916273,0.000111874098434225,0.0122661452255521,0.0459466843490151
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO9B,Unconventional myosin-IXb,38841,-0.0120481525042379,0.00604224456367295,-0.0238909518490368,-0.000205353159438893,0.0461716544405848
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST7,Cystatin-F,39114,0.0168437337842478,0.00845067685806703,0.000280407142436382,0.0334070604260591,0.0462593449728268
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAND5,DAN domain family member 5,36430,0.00981704056456686,0.00492607739218045,0.000161928875893167,0.0194721522532405,0.0462970739475723
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNST,Consortin,39106,-0.0196245550817524,0.00986024297710392,-0.0389506313168761,-0.000298478846628744,0.0465789240026034
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOH,Beta-2-glycoprotein 1,39093,0.00640686356338809,0.00323560519252037,6.50773860481676e-05,0.012748649740728,0.0477088099035528
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL24,C-C motif chemokine 24,39140,-0.0148866121517059,0.00751809134315052,-0.029622071184281,-0.000151153119130921,0.0477096133416554
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,36391,-0.0122059686995232,0.00616482473503003,-0.0242890251801821,-0.000122912218864318,0.0477323751347352
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,36391,0.00573961361421463,0.00290126848525519,5.31273831144508e-05,0.0114260998453148,0.0479154108616815
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBPL,FK506-binding protein-like,36743,-0.0107855187210347,0.00545717663541586,-0.0214815849264498,-8.9452515619589e-05,0.0481317238699769
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB2A2,Mammaglobin-A,36391,0.00561720787349818,0.00284345968716945,4.40268866460604e-05,0.0111903888603503,0.0482352049012303
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",38999,-0.0187867754847629,0.00954020491763636,-0.0374855771233301,-8.79738461955978e-05,0.0489458825864623
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,36747,0.00540969100462373,0.00275302871859622,1.37547161751404e-05,0.0108056272930723,0.0494361244076909
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,38913,0.0210921150188544,0.0107355702216948,5.03973843324935e-05,0.0421338326533762,0.0494679807330585
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA,Lymphotoxin-alpha,39099,-0.00709322826113306,0.00361258705552159,-0.0141738988899554,-1.25576323107435e-05,0.0496090373777453
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,36339,0.00469676425335653,0.00239282446419961,6.8283035252947e-06,0.00938670020318777,0.0496853612389395
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,36391,-0.00498751531668385,0.00254214750158822,-0.00997012441979676,-4.90621357093681e-06,0.0497927420448618
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCA,Alpha-synuclein,36500,-0.0208148351695165,0.0106111147231797,-0.0416126200269488,-1.70503120842241e-05,0.0498301913580064
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",39291,0.0122923034698108,0.00629652634590585,-4.88881681646874e-05,0.0246334951077863,0.0509282871625245
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRL,Appetite-regulating hormone,39106,0.0136437845902595,0.00700233129791052,-8.0784753645138e-05,0.0273683539341641,0.0513778894484325
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,36363,0.0107197536101061,0.0055036608082502,-6.74215740642872e-05,0.0215069287942765,0.0514672722708671
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH9,Protocadherin-9,36743,-0.00591212239008095,0.00303690797467073,-0.0118644620204356,4.02172402736893e-05,0.05158555796421
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,36421,0.00865703635247072,0.00445011263216813,-6.51844065788082e-05,0.0173792571115202,0.0517548851835669
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",36767,0.0124558382950247,0.0064066466079032,-0.000101189056465596,0.025012865646515,0.051892359628115
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO3,Forkhead box protein O3,38727,-0.0173063827537676,0.0089041256504068,-0.0347584690285649,0.000145703521029727,0.0519581570398313
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,36421,-0.0099001353377193,0.00509400813001647,-0.0198843912725516,8.41205971129754e-05,0.0519797274055448
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,36430,-0.0075854066643751,0.00390555023848219,-0.0152402851318002,6.94718030499917e-05,0.0521337446012157
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,36731,0.00991948453394401,0.00510806207341499,-9.23171299493687e-05,0.0199312861978374,0.0521677071028542
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,39162,-0.0184603760803783,0.00951089812646831,-0.0371017364082562,0.000180984247499561,0.0522801510346898
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,36767,0.0135407149107171,0.00697934500100258,-0.000138801291248004,0.0272202311126821,0.0523877646262774
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39099,0.0163788432866032,0.00844360504748419,-0.000170622606465779,0.0329283091796722,0.0524233179376633
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",38705,0.00832223994661572,0.00429299258958898,-9.20255289786846e-05,0.0167365054222101,0.0525734082793872
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC3,Membrane primary amine oxidase,39165,-0.00530471158896747,0.00274177480735047,-0.0106785902113744,6.9167033439451e-05,0.0530365743528717
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMIP,C-Maf-inducing protein,36731,-0.0146755611583227,0.00758799668063676,-0.0295480346523708,0.000196912335725318,0.0531289365300348
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEO1,Neogenin,36767,-0.0038260935554526,0.00197942019419941,-0.00770575713608344,5.35700251782394e-05,0.0532658674868385
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TUBB3,Tubulin beta-3 chain,36363,0.00499405419535417,0.00258546718586194,-7.34614889352399e-05,0.0100615698796436,0.0534331025167301
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,38727,0.0101219256804452,0.00524548440222183,-0.000159223747909557,0.0204030751088,0.0536697742326423
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,39162,0.0228487033328515,0.011865071637388,-0.000406837076428846,0.0461042437421319,0.054158930860071
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,39099,-0.00608763750004979,0.00316206917815253,-0.0122852930892287,0.000110018089129168,0.0542220645010486
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,36499,-0.00923581788437525,0.00480029999669143,-0.0186444058778905,0.000172770109139945,0.0543759500825654
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,36363,0.00670396171165313,0.00348909239300058,-0.000134659378627997,0.0135425828019343,0.0547032989139585
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,39162,0.0113803402538777,0.00592914080389843,-0.000240775721763219,0.0230014562295186,0.0549534285229022
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,38705,-0.0116215599972624,0.00605648678779753,-0.0234922741013455,0.000249154106820776,0.0550210033583555
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,36538,0.00486098302606701,0.00253696604361862,-0.000111470419425485,0.0098334364715595,0.0553797282711965
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,38987,0.00672270857792856,0.00350980673206965,-0.000156512616927947,0.0136019297727851,0.0554594457007569
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PITHD1,PITH domain-containing protein 1,36311,0.0138385247789822,0.00722638094024178,-0.000325181863891714,0.0280022314218561,0.0555152972800039
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,38812,0.0071454497273463,0.00373429669403081,-0.000173771792954083,0.0144646712476467,0.0557074983940935
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,36791,0.00445304140790825,0.00232798486173091,-0.000109808921084338,0.00901589173690084,0.055791766884081
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEK,Angiopoietin-1 receptor,39147,-0.00378005895600868,0.00197701310352931,-0.00765500463892613,9.48867269087686e-05,0.0558942243230521
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",36731,0.00764962210126863,0.00401168646658449,-0.000213283373236957,0.0155125275757742,0.0565642665719494
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,38741,-0.0117358291196292,0.00616730350450839,-0.0238237439884656,0.000352085749207269,0.0570714514262649
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKKL1,Dickkopf-like protein 1,39023,-0.0145991475888058,0.00767307571408936,-0.029638375988421,0.00044008081080934,0.0571056637605303
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39099,0.0142577947480469,0.00749414660089922,-0.000430732589715547,0.0289463220858094,0.0571214984953284
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,36363,0.00743353521899516,0.00391803587144493,-0.000245815089036889,0.0151128855270272,0.05781656648949
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,38727,0.00527935761939185,0.00278500735597948,-0.000179256798327931,0.0107379720371116,0.0580276917723069
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RUVBL1,RuvB-like 1,38727,-0.0175277158048651,0.00925199043294326,-0.0356616170534339,0.000606185443703729,0.0581806429434169
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,36686,-0.0105832861158641,0.00558920625650949,-0.0215381303786227,0.000371558146894447,0.0583109435007348
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,35842,-0.00894323590183061,0.004737913091978,-0.0182295455621075,0.000343073758446281,0.0591052000656357
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",38832,-0.0144246922068165,0.00765515740211851,-0.0294288007149688,0.000579416301335811,0.0595423665900047
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,36791,-0.00607487391825922,0.0032308105443016,-0.0124072625850904,0.000257514748571912,0.0600904691463854
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",38951,0.0165280793153433,0.0088067705312886,-0.000733190925982341,0.033789349556669,0.0605720702383071
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN4,Nectin-4,39147,0.00504199752738813,0.00268862868952029,-0.000227714704071649,0.0103117097588479,0.0607698883844038
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,36363,0.013077700249821,0.00697651210348486,-0.000596263473009361,0.0267516639726513,0.0608803321491532
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,39099,-0.00790527419786658,0.00421864261407088,-0.0161738137214455,0.000363265325712351,0.0609646429647114
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXN,Thioredoxin,36652,-0.0073938479545876,0.00394603753453468,-0.0151280815222756,0.000340385613100369,0.0609890635606975
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,39255,-0.00565089025240235,0.00301630863416008,-0.0115628551753561,0.000261074670551403,0.0610258034276161
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,36538,-0.0181861619170421,0.00971214172293506,-0.0372219596939949,0.000849635859910578,0.0611579478318869
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,36743,-0.0131472035039377,0.0070292278386385,-0.0269244900676692,0.000630083059793776,0.0614561656380859
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,38841,0.00626495165250477,0.00335862297750085,-0.000317949383396895,0.0128478526884064,0.0621542179173807
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AAMDC,Mth938 domain-containing protein,36420,-0.00909946194403292,0.00488280711943637,-0.0186697638981282,0.000470840010062361,0.0624051710507929
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",38841,0.0123447133015507,0.00662492915510993,-0.000640147842464753,0.0253295744455662,0.0624293753117126
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,36391,0.0106270936722615,0.0057047552216084,-0.000554226562090976,0.0218084139066139,0.0625069906172466
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,38832,-0.0165111499573543,0.00887819179651232,-0.0339124058785184,0.00089010596380985,0.0629415750164446
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,36743,-0.00853635207036254,0.00459042257458169,-0.0175335803165426,0.000460876175817573,0.0629648481597668
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN15,Tetraspanin-15,36391,0.00837243618933765,0.00451111222032492,-0.0004693437624992,0.0172142161411745,0.0634829608362895
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,39093,-0.00975382070824392,0.00526171070972274,-0.0200667736993005,0.000559132282812638,0.063796307985422
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPE4,NXPE family member 4,36391,0.00596156500523564,0.00321649839589439,-0.000342771850717373,0.0122659018611887,0.0638437763029785
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39023,-0.00643149044897414,0.00347680472970108,-0.0132460277191883,0.000383046821239989,0.0643578000212094
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,36420,-0.00850836230149488,0.00460650824962561,-0.0175371184707611,0.000520393867771309,0.0647661912504072
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,38727,-0.00762202708870585,0.00413005199886004,-0.0157169290064715,0.000472874829059833,0.0649841426007922
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRH,Corticoliberin,38706,0.0146208976383919,0.00793432208679917,-0.000930373651734491,0.0301721689285183,0.0653868147235643
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,39066,-0.00601579057059215,0.00326631884078906,-0.0124177754985387,0.000386194357354415,0.0655290453687587
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLMP,CXADR-like membrane protein,39255,-0.0034419744272114,0.00187001494039195,-0.00710720371037962,0.000223254855956825,0.0656974762586296
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP7,Matrilysin,38810,-0.00834345624611681,0.00454064589806068,-0.0172431222063157,0.000556209714082127,0.0661553200356593
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,38951,0.00504010833182741,0.00275223220675611,-0.000354266793414559,0.0104344834570694,0.0670784358037015
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,36500,-0.0046071709180207,0.00251837021844237,-0.00954317654616775,0.000328834710126354,0.0673594209103864
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,38502,0.00782576685854247,0.00427975115563029,-0.000562545406492903,0.0162140791235778,0.067486404334091
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,36421,0.00612095940464031,0.00334947545518233,-0.000444012487517059,0.0126859312967977,0.0676576222648582
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF20,Fibroblast growth factor 20,36430,0.00711027710074919,0.00389489081990148,-0.000523708906257705,0.0147442631077561,0.0679433688287885
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,36391,0.0084915254555204,0.00465529104047826,-0.000632844983816987,0.0176158958948578,0.0681669593387382
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,39057,0.00473094017598562,0.00259426866180783,-0.000353826401157732,0.00981570675312898,0.0682303415231246
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,36796,0.00411782351545863,0.00225824695645559,-0.000308340519194324,0.00854398755011159,0.068256780065825
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNW1,Interferon omega-1,36391,0.0059350058672318,0.00326325530141148,-0.000460974523534692,0.0123309862579983,0.0689752957437189
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,39283,0.00680672693505027,0.00374313552050072,-0.000529818685131144,0.0141432725552317,0.0690138656413225
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK12,Kallikrein-12,38727,0.0228135536958942,0.0125595722029408,-0.00180320782186979,0.0474303152136581,0.0693249326891522
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",36767,0.00599571591646615,0.00330186409185955,-0.000475937703578569,0.0124673695365109,0.0694153681603452
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,39162,-0.00679658545959947,0.00374437257100244,-0.0141355556987642,0.000542384779565302,0.0695209380339478
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGF,Pro-epidermal growth factor,39044,0.0171872397031815,0.00947291040994114,-0.00137966470030311,0.0357541441066662,0.0696425336614475
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,36363,-0.0141737705984334,0.00781405595149024,-0.0294893202633542,0.00114177906648751,0.0697199507156747
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,36420,-0.00517554739766063,0.00285916583818509,-0.0107795124405034,0.000428417645182132,0.0702948803192018
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,39098,0.00436227858882144,0.00241162766140967,-0.000364511627541511,0.00908906880518439,0.0704936313242098
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGT,Angiotensinogen,36796,-0.00366613367795902,0.00202912792002107,-0.00764322440120031,0.000310957045282278,0.0708239712817938
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARCL1,SPARC-like protein 1,39108,0.00449293801209383,0.00248986788160112,-0.000387203035844368,0.00937307906003204,0.0711744800553177
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17A,Interleukin-17A,38813,-0.0069754567639438,0.00387062106981697,-0.0145618740607851,0.000610960532897453,0.0715412488695106
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,39084,0.00365845832685972,0.00203014612663287,-0.000320628081340693,0.00763754473506014,0.0715547167146758
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNA4,Plexin-A4,39099,-0.0133289365852505,0.00740569561456842,-0.0278440999898046,0.00118622681930361,0.0719084629778352
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,39062,0.0144493850934762,0.0080497974754063,-0.00132821795832012,0.0302269881452726,0.0726735841287691
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,39241,-0.00917672204053722,0.00511746370215416,-0.0192069508967594,0.000853506815684945,0.072957899326116
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,38832,0.00540910298582084,0.00301993722847931,-0.00050997398199861,0.0113281799536403,0.0732924783298116
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REST,RE1-silencing transcription factor,36339,0.00584527828913851,0.00326785886202126,-0.000559725080423167,0.0122502816587002,0.0736844748931565
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPA1,Inositol monophosphatase 1,38987,0.0100115893768975,0.00560229923568798,-0.000968917125050968,0.0209920958788459,0.0739494084643108
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANK2,Ankyrin-2,36391,0.0115826426440441,0.00648401526012309,-0.00112602726579714,0.0242913125538854,0.074068721994598
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG3,Secretogranin-3,39117,0.00530578535684446,0.00297031083874456,-0.000516023887094881,0.0111275946007838,0.0740749555240186
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE6,Ribonuclease K6,36740,-0.00444311081841298,0.0024928659031585,-0.00932912798860364,0.000442906351777677,0.0747189083594269
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,38832,-0.0119341282391349,0.00669989494467047,-0.0250659223306891,0.00119766585241918,0.0748933388912367
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,36791,-0.00960640056406978,0.00539488273400018,-0.0201803707227101,0.000967569594570561,0.0749930373698805
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",36420,0.0141981268383313,0.00797381927426866,-0.00143055893923523,0.0298268126158979,0.0750031275825336
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROC,Vitamin K-dependent protein C,39145,0.00418343425735277,0.00235498462562139,-0.000432335608865148,0.00879920412357069,0.0756841302724284
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLG,Plasminogen,36527,0.00366218373791383,0.00206365696223093,-0.000382583908058797,0.00770695138388645,0.0759865207495689
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,36767,0.0161420277732459,0.00910025831509497,-0.00169447852434021,0.0339785340708321,0.0761200001394758
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2B3,SH2B adapter protein 3,38727,-0.0159479921004125,0.00900086186478614,-0.0335896813553933,0.00169369715456835,0.0764433518057367
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A13,Protein S100-A13,36430,-0.00562595058200542,0.00317555889907806,-0.0118500460241984,0.000598144860187574,0.0764783795901147
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK2,Protein AHNAK2,36420,-0.00470536326438056,0.00266669151013308,-0.0099320786242414,0.000521352095480277,0.0776730145075774
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA12,Serpin A12,38664,-0.0189520251226354,0.0107424297458762,-0.0400071874245526,0.00210313717928192,0.0777153207417222
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171B,Protein FAM171B,36731,-0.00443792345657834,0.00251860554570794,-0.0093743903261659,0.000498543413009229,0.0780836080872115
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,36747,-0.0174596889887044,0.00990880583046525,-0.0368809484164163,0.00196157043900743,0.0780866406752296
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGF,Hepatoma-derived growth factor,39239,-0.0150933770891139,0.00856970809295777,-0.0318900049513111,0.00170325077308336,0.078216388126339
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,39147,-0.00382280558705087,0.00217825281112056,-0.00809218109684716,0.000446569922745424,0.0792815441067162
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,36500,0.00451390951561804,0.00257738849410298,-0.000537771932823797,0.00956559096405988,0.0799098811966323
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPLAH,5-oxoprolinase,36420,-0.0110598018321697,0.00631634880992728,-0.0234398454996272,0.00132024183528774,0.0799737274918495
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSS,Cathepsin S,35946,0.00390137306573571,0.0022290340397082,-0.000467533652092356,0.00827027978356378,0.0801000754026756
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53,Cellular tumor antigen p53,38727,-0.00706147952789343,0.00404065832108271,-0.0149811698372155,0.000858210781428686,0.0805528857142536
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1B,Meprin A subunit beta,39106,-0.018365029977083,0.0105157864150851,-0.0389759713506498,0.00224591139648384,0.0807573058031859
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,36538,-0.0113656591850504,0.00651710880221453,-0.0241391924373909,0.00140787406729005,0.0811881039359448
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX1,Peroxiredoxin-1,38681,0.0144305048312747,0.00828900025969975,-0.00181593567773684,0.0306769453402862,0.0817179623552785
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,38987,-0.00461997563701029,0.00265935720742801,-0.0098323157635692,0.000592364489548605,0.082362920438951
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,39241,-0.00734270140745341,0.00422666160586373,-0.0156269581549463,0.000941555340039495,0.0823658452133875
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,38644,0.00928295096716764,0.00534668616295227,-0.00119655391221882,0.0197624558465541,0.0825481708153158
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20,Interleukin-20,38841,0.00771395623408579,0.00445212023699505,-0.0010121994304245,0.0164401118985961,0.0831788716665491
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN3,Perilipin-3,39106,-0.00680189642785687,0.00393069731068485,-0.0145060631567992,0.000902270301085444,0.0835691762152463
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMH,Granzyme H,38832,0.0119231413356672,0.00689308628218105,-0.0015873077774077,0.025433590448742,0.0837000899432982
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST2,Bone marrow stromal antigen 2,39241,-0.00844354132343198,0.00488210549566933,-0.0180124680949439,0.0011253854480799,0.0837419118695204
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA5,Annexin A5,38674,0.00476001768073687,0.0027522938729761,-0.000634478310296296,0.01015451367177,0.0837453225491441
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,36767,-0.0154580035107435,0.008943889699639,-0.0329880273220359,0.00207202030054891,0.083952780952808
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNN,Tenascin-N,36791,-0.00675434732520674,0.00390946871117584,-0.0144169059991114,0.000908211348697894,0.0840678162632792
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39099,0.0131562754485796,0.00762008949907602,-0.00177909996960944,0.0280916508667686,0.0842732624017763
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAEP,Glycodelin,38987,0.0226438014862856,0.0131276473276792,-0.00308638727596561,0.0483739902485367,0.0845669842698358
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,36430,0.0033538891682427,0.00194627491843117,-0.000460809671882391,0.0071685880083678,0.0848706191126891
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR2,Complement receptor type 2,39165,-0.00711325647735517,0.00413918318392348,-0.0152260555178452,0.000999542563134847,0.0857225883594315
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,36421,0.0163077877965206,0.00949990725026397,-0.00231203041399681,0.034927606007038,0.0860721824561611
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,38841,0.00557742114414566,0.00325192770233425,-0.000796357152429472,0.0119511994407208,0.0863453224580865
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,39106,-0.0135886481053333,0.00792740866251448,-0.0291263690838617,0.00194907287319506,0.0865242730516596
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39106,0.0145016475630133,0.00846925637990846,-0.00209809494160724,0.0311013900676339,0.0868673895218433
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PENK,Proenkephalin-A,36500,-0.00454581129879665,0.00265699267476599,-0.00975351694133799,0.000661894343744692,0.0871267146993458
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,36339,0.01001627802474,0.00585920607587805,-0.00146776588398093,0.021500321933461,0.0873843314632976
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,38841,0.00555951599968681,0.00325465982161778,-0.000819617250684044,0.0119386492500577,0.087625307023286
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA4,Annexin A4,39025,0.011254327975161,0.00662274190778421,-0.00172624616409605,0.0242349021144181,0.0892745759493379
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSC2,Desmocollin-2,38923,0.00514128181256073,0.00302999385468396,-0.000797506142619837,0.0110800697677413,0.0897558731388061
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,39283,-0.010462132415552,0.006169909910822,-0.0225551558407631,0.00163089100965913,0.0899685371183769
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,36391,0.00761815904052809,0.00449360276774015,-0.00118930238424262,0.0164256204652988,0.0900368590859458
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39117,0.00513035723730038,0.00302809712380719,-0.000804713125361707,0.0110654275999625,0.0902379657610312
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCLRE1C,Protein artemis,36339,0.00479966070478926,0.00283777443953487,-0.000762377196699084,0.0103616986062776,0.0907955568882817
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITM2A,Integral membrane protein 2A,39099,0.00912030002833064,0.00540514219766232,-0.00147377867908751,0.0197143787357488,0.0915589072412257
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL4,Delta-like protein 4,36420,-0.0133988783683523,0.00794585407166546,-0.0289727523488166,0.00217499561211195,0.0917680848506851
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,36806,-0.00463867349184708,0.00275128415916171,-0.010031190443804,0.000753843460109877,0.0918193083270437
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR5,Cadherin-related family member 5,39106,-0.00596946342077025,0.00354113804501124,-0.0129100939889923,0.000971167147451784,0.0918649710649056
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH4,Cadherin-4,36363,0.00720813277166687,0.00429092909187773,-0.00120208824841348,0.0156183537917472,0.093010782502357
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUCL3,Mucin-like protein 3,36339,0.00685321222801978,0.00408320515505649,-0.00114986987589095,0.0148562943319305,0.0932959541260371
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,36391,-0.00559775409904313,0.00333540356430912,-0.012135145085089,0.000939636887002738,0.0933166249577199
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36339,-0.00780868414416219,0.00465965462728277,-0.0169416072136364,0.00132423892531204,0.0938009573716802
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO1,Forkhead box protein O1,39099,-0.0131387794769992,0.00785020935707272,-0.0285251898168617,0.00224763086286331,0.0942130004902077
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,39255,-0.00822536186165904,0.00492437628928495,-0.0178771393886575,0.00142641566533947,0.0948732779649316
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36108,0.0165748519240295,0.0099364190460164,-0.00290052940616267,0.0360502332542216,0.0953232107838422
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,36363,0.00956770225628623,0.00574320262797863,-0.00168897489455189,0.0208243794071243,0.0957548812508894
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB10,Ras-related protein Rab-10,36792,-0.00815413078074456,0.00489825018079862,-0.0177547011351099,0.00144643957362074,0.0959962896501111
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,39057,-0.00615929346022925,0.00371148217295385,-0.0134337985192188,0.0011152115987603,0.0970308973244915
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF7,Fibroblast growth factor 7,36339,0.0120786819751819,0.00727940223845401,-0.00218894641218799,0.0263463103625517,0.0970813182496622
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,39106,-0.0103186350127846,0.0062224655651963,-0.0225146675205694,0.00187739749500014,0.0972800824212496
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGF,Placenta growth factor,39291,-0.00389276611953404,0.00234903777000545,-0.00849688014874472,0.000711347909676639,0.0975044751916826
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST3,Cystatin-C,39132,-0.00401185296005266,0.0024216154009058,-0.00875821914582803,0.000734513225722711,0.0976037986737784
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39147,-0.0143310857798746,0.00866082016521948,-0.0313062933037048,0.00264412174395557,0.0980052712353503
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN3,Matrilin-3,38960,0.00470174810598485,0.00284412372571006,-0.000872734396406865,0.0102762306083766,0.0983222030622862
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,36391,0.00978015066725291,0.00591674653524438,-0.00181667254182607,0.0213769738763319,0.098363872559349
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,36500,0.0179937978781684,0.0108912213660157,-0.00335299599922234,0.0393405917555592,0.0985313125606816
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,36538,-0.0100981210396116,0.00614903763834682,-0.0221502348107714,0.00195399273154813,0.100567588169186
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GM2A,Ganglioside GM2 activator,36548,0.00544557365402848,0.00331627339079528,-0.00105432219193028,0.0119454694999872,0.100598992549725
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,36420,-0.0120435192784145,0.0073459136296853,-0.0264415099925977,0.0023544714357687,0.101137220697182
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,36747,-0.0135597547054238,0.00827869711951135,-0.0297860010596661,0.00266649164881841,0.101465036979884
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,38727,-0.00526995725443657,0.00321934492710403,-0.0115798733115605,0.00103995880268732,0.101658799657834
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCP1,Plastin-2,36791,0.0069929304928986,0.00427533513476574,-0.00138672637124225,0.0153725873570394,0.101938246920504
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBXN1,UBX domain-containing protein 1,36500,-0.0103616145643291,0.00634129771454179,-0.022790558084831,0.00206732895617284,0.102285936765119
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGT1,Protein SGT1 homolog,38727,0.0120859620263362,0.00740184381886277,-0.00242165185863484,0.0265935759113072,0.102525665694406
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A11,Protein S100-A11,38949,-0.00677427167841515,0.00415123425242233,-0.0149106908131629,0.00136214745633262,0.102727893137721
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",38741,0.00451241783041234,0.00276639981070858,-0.000909725798576469,0.00993456145940115,0.102879469523954
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,39241,-0.00868094418285525,0.00532353503665157,-0.0191150728546923,0.00175318448898183,0.102979837787326
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUOX2,Dual oxidase 2,38832,0.0106069282902256,0.00650462516542173,-0.00214213703400104,0.0233559936144521,0.102979992315672
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK15,Kallikrein-15,36714,-0.00745128942145911,0.00458515445245707,-0.016438192148275,0.00153561330535674,0.104167863949543
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,36430,0.00815523293946156,0.00501954366091848,-0.00168307263593867,0.0179935385148618,0.104252403312955
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM17,Splicing factor 45,36767,0.0113715916364106,0.00700473964384513,-0.00235769806552589,0.025100881338347,0.104525377892996
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NINJ1,Ninjurin-1,38727,0.00834800312020799,0.0051438802796416,-0.00173400222788955,0.0184300084683055,0.104631993609845
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,38727,-0.00971786916931502,0.00600063989591151,-0.0214791233653016,0.00204338502667153,0.105366925222902
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,36538,0.00611393155474441,0.00377796025055533,-0.00129087053634403,0.0135187336458328,0.105619501988442
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,36731,0.00614862683915174,0.00380257133484368,-0.00130441297714187,0.0136016666554453,0.105910224098774
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,36743,0.0103899117902109,0.00642858386463754,-0.00221011258447864,0.0229899361649005,0.106074402419793
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36363,0.00835244849203884,0.00516910888285103,-0.00177900491834919,0.0184839019024269,0.106154325357442
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6,Interleukin-6,39023,-0.0104287439788888,0.00645713351119679,-0.0230847256608345,0.00222723770305689,0.106315626384532
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,36391,-0.0103957902043097,0.00643763073520328,-0.0230135464453081,0.00222196603668875,0.10636895724144
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBIN,Erbin,39023,-0.0151150101051445,0.0093731185230706,-0.0334863224103629,0.00325630220007382,0.106854124085916
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RWDD1,RWD domain-containing protein 1,39241,-0.00938094520259495,0.00582420235424689,-0.0207963818169189,0.00203449141172895,0.107269297071958
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,36779,0.00276243082455942,0.00171526399613139,-0.000599486607858098,0.00612434825697693,0.107313410190132
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,38727,0.0113228663970998,0.00703205029064477,-0.00245995217256392,0.0251056849667636,0.107379806959359
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFH,Complement factor H,36141,-0.00345114416709517,0.00214488295022356,-0.00765511474953335,0.000752826415343004,0.107639241389051
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,36391,0.00475365135032415,0.00295696120706356,-0.00104199261552042,0.0105492953161687,0.107945003222057
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL5,C-C motif chemokine 5,39165,0.0148628319519779,0.00925168436676648,-0.00327046940688437,0.0329961333108402,0.108184700201258
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17F,Interleukin-17F,38841,0.0112798263340005,0.00702478759976544,-0.00248875736153973,0.0250484100295408,0.1083570103364
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,39283,-0.00393273294846791,0.00245063441306559,-0.00873597639807648,0.000870510501140653,0.10856235713753
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD59,CD59 glycoprotein,38444,0.0030886384471343,0.0019310290996068,-0.000696178588095033,0.00687345548236363,0.109736107901476
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMI,N-myc-interactor,36677,0.0105043426596276,0.00658109912592226,-0.00239461162718002,0.0234032969464352,0.110482631186067
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39052,0.0085403060053166,0.00536360132392781,-0.00197235258958191,0.0190529646002151,0.111344666212333
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,36767,-0.00511364907116436,0.00321345890300345,-0.0114120285210511,0.0011847303787224,0.111561532266263
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FN1,Fibronectin,36806,-0.00386564612734482,0.0024294128549806,-0.00862729532310679,0.000896003068417148,0.11159228652076
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,36339,0.00607870382831157,0.00382333434939375,-0.00141503149650018,0.0135724391531233,0.111883590719419
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN1,Calsyntenin-1,38741,-0.00725289721328945,0.00458054675537728,-0.0162307688538289,0.00172497442725002,0.113348615567918
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL3,C-C motif chemokine 3,39099,-0.00886520911936991,0.00559992695743688,-0.0198410659559462,0.00211064771720639,0.113420859523191
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTD,Deoxycytidylate deaminase,36500,0.0137884182349672,0.00872695688383204,-0.00331641725734362,0.030893253727278,0.114136445072975
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36363,0.00815159303098862,0.00516030966947221,-0.00196261392117691,0.0182657999831541,0.114207460229118
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,36747,-0.00552480173875621,0.00351043298796539,-0.0124052503951684,0.00135564691765595,0.115552820353112
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC16,Mucin-16,39023,-0.0266642337252725,0.0169473899149825,-0.0598811179586381,0.00655265050809314,0.115657872125601
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,38727,-0.0132980728782905,0.00845269713009393,-0.0298653592532746,0.00326921349669358,0.115685859805211
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,39291,0.00598782514220987,0.00381845440987825,-0.00149634550115149,0.0134719957855712,0.116871775776629
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,36363,0.0105458530308071,0.0067321489163118,-0.00264915884516405,0.0237408649067782,0.117258939534437
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,39283,0.00323462393657962,0.00206694198791383,-0.000816582359731477,0.00728583023289072,0.117619339387026
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",39162,-0.00384460769483609,0.00245774221283849,-0.00866178243199952,0.000972567042327345,0.117771483164925
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,36731,0.0139198545292579,0.00890152520218153,-0.00352713486701791,0.0313668439255337,0.117898381359655
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D1,DCN1-like protein 1,36363,0.0107366681299664,0.00687242325775837,-0.00273328145524004,0.0242066177151728,0.118246708819066
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,36391,-0.0165539940242242,0.0105987418923319,-0.0373275281331948,0.00421954008474633,0.118340823336397
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARCO,Macrophage receptor MARCO,39106,0.00373616025146719,0.00239237082287167,-0.000952886561361289,0.00842520706429566,0.118379952884422
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY4,Protein canopy homolog 4,39023,0.0107816976970714,0.00690428872985673,-0.00275070821344781,0.0243141036075906,0.118404470205436
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,39162,-0.00399491353782218,0.00256491058659132,-0.00902213828754117,0.00103231121189681,0.119366461447063
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,36743,-0.00616327745847524,0.00395790911547821,-0.0139207793248125,0.00159422440786204,0.119446289648043
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB118,Beta-defensin 118,36363,0.00828920353189513,0.00532334088422385,-0.00214454460118362,0.0187229516649739,0.119461824025086
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39099,-0.0104169466959513,0.00669266749488625,-0.0235345749859283,0.0027006815940258,0.119616763627117
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",36466,-0.0122668879316166,0.00788608670162508,-0.0277236178668018,0.00318984200356856,0.119849721944936
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",36420,-0.0120710847525919,0.0077645499724685,-0.0272896026986301,0.00314743319344641,0.12005688038011
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,36743,0.0140594487048909,0.00904807916059949,-0.00367478644988414,0.0317936838596659,0.120242367572173
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR2,Complement factor H-related protein 2,36723,0.00801892196136108,0.00516445024927051,-0.00210340052720911,0.0181412444499313,0.120515719177084
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,36421,0.00545043306995651,0.00351462700458259,-0.00143823585902537,0.0123391019989384,0.120978257650466
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,39241,-0.0066516344952166,0.00429159227585504,-0.0150631553558925,0.00175988636545929,0.121180745010415
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRG,Histidine-rich glycoprotein,36737,-0.00448170476242432,0.00289217654714974,-0.0101503707948378,0.00118696126998917,0.12126312562321
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,36792,-0.00424104177826384,0.00274195502847072,-0.00961527363406646,0.00113319007753877,0.121954799578027
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,36391,0.0100895421865991,0.00652658321804035,-0.00270256092075998,0.0228816452939582,0.122150376182294
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,36430,0.0134232074453094,0.00869330222393466,-0.00361566491360251,0.0304620798042214,0.122592640387358
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,36391,-0.00589470490159047,0.00381766065753337,-0.0133773197903559,0.00158790998717493,0.122598555691601
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,39023,-0.0193852402950044,0.0125577303257566,-0.0439983917334873,0.00522791114347841,0.122684365494412
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL23,C-C motif chemokine 23,39162,-0.00578993814298844,0.00375087531291112,-0.0131416537562942,0.00156177747031735,0.122700320941958
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,36791,-0.00311570333888173,0.0020277108831502,-0.00709001666985613,0.000858609992092666,0.12442508899954
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,36631,0.00889749254032532,0.00579772337727658,-0.00246604527913677,0.0202610303597874,0.124893902023439
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,38727,-0.00475537263219092,0.00309937316275301,-0.0108301440311868,0.00131939876680498,0.124976796679107
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA4,Laminin subunit alpha-4,39162,0.00471659631140319,0.00308152729960042,-0.00132319719581363,0.01075638981862,0.125888100426308
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO1A,Coronin-1A,38775,-0.0124539305890153,0.00815162000023471,-0.0284311057894753,0.00352324461144476,0.126586894649908
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTO1,Protein LTO1 homolog,38841,-0.00561297754575364,0.00368086378288204,-0.0128274705602024,0.00160151546869516,0.127303228866674
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",38987,0.00800694220487921,0.00525760816232181,-0.00229796979327155,0.01831185420303,0.12779840735376
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",36421,-0.00676422294204988,0.00444942676841894,-0.015485099408151,0.00195665352405125,0.128474347366933
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",36430,0.00490750369681509,0.00323294175636153,-0.00142906214565352,0.0112440695392837,0.129047492469729
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36363,-0.00444490993702647,0.0029286850162753,-0.0101851325689261,0.00129531269487313,0.129111478757763
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,38832,-0.00855591095233066,0.00564067138047223,-0.0196116268580562,0.00249980495339491,0.12933200443945
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN1,Nectin-1,36430,-0.00444875357869841,0.00293492143697745,-0.0102011995951742,0.0013036924377774,0.12959510625534
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,36500,0.0122086447180008,0.00805708155817047,-0.00358323513601336,0.0280005245720149,0.129729338298723
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,38832,-0.00666832671464812,0.0044008704332259,-0.0152940327637709,0.00195737933447465,0.129735519824549
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1F,Protein phosphatase 1F,36792,0.00737665260967605,0.00487398190578704,-0.00217635192566656,0.0169296571450187,0.130183336301133
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENR,Density-regulated protein,36430,-0.00800858471891022,0.00529502038340892,-0.0183868246703917,0.00236965523257127,0.130438266914883
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,36420,0.00498036402000281,0.00329909268691745,-0.00148585764635539,0.011446585686361,0.131166520175025
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,38727,0.00650395609536061,0.00430999430321454,-0.00194363273893988,0.0149515449296611,0.131309675536016
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS27,Serine protease 27,39057,-0.00551798210181488,0.00366435798006203,-0.0127001237427365,0.0016641595391067,0.132125863056427
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK3,NT-3 growth factor receptor,39241,0.00292235090992574,0.00194241134653696,-0.000884775329286693,0.00672947714913817,0.132474128333544
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,36420,-0.00565314309680244,0.00376349429686142,-0.0130295919186508,0.00172330572504595,0.133096540138668
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,36538,0.009001184650183,0.005992737224031,-0.00274458030891775,0.0207469496092837,0.133117991742145
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,39106,0.0119694388302096,0.00797133403430832,-0.00365437587703476,0.0275932535374539,0.133231408854354
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCC1,Regulator of chromosome condensation,36731,-0.00694495718423453,0.00462976565019758,-0.0160192978586218,0.00212938349015273,0.133621658858998
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD1,Glutamate decarboxylase 1,36339,0.0035555611135688,0.00237063863083926,-0.00109089060287616,0.00820201283001375,0.133683066786341
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2,Prothrombin,36806,0.00200940727436132,0.00134023779136846,-0.000617458796720868,0.00463627334544351,0.133822382213222
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,39274,0.00492133754215259,0.00328284190744038,-0.00151303259643057,0.0113557076807357,0.133865860818068
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,36743,0.00734660131414336,0.0049013825392998,-0.00226010846288425,0.016953311091171,0.133928365175456
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRUNE2,Protein prune homolog 2,36538,-0.00390079633985967,0.00260449890277041,-0.00900561418928967,0.00120402150957033,0.134232281963517
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMT,Catechol O-methyltransferase,38658,-0.0116146431987036,0.00775765179353245,-0.0268196407140272,0.00359035431662004,0.134366344785506
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,38987,-0.0129111074552582,0.00862896789786911,-0.0298238845350816,0.00400166962456527,0.134608951904587
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR15L,Protein GPR15L,36743,-0.00836392332532894,0.0055910643544169,-0.0193224094599861,0.00259456280932818,0.134692550920306
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TG,Thyroglobulin,36731,-0.0148024076246334,0.00990169596323095,-0.0342097317125661,0.00460491646329922,0.134955506992046
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN2,Centrin-2,38741,-0.00924949410913558,0.00619714046485632,-0.021395889420254,0.0028969012019828,0.135578243538032
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,36363,-0.0101912929179621,0.00682900773714752,-0.0235761480827713,0.00319356224684701,0.135631755345996
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,36731,-0.0104714229231132,0.0070186695964352,-0.0242280153321262,0.0032851694858998,0.1357397944508
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,36792,-0.00436265617589443,0.00292856115543201,-0.0101026360405412,0.00137732368875231,0.136329441935119
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,38841,-0.00532345649308036,0.00357501036757379,-0.012330476813525,0.00168356382736427,0.136488822882251
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",36339,0.00661895478667052,0.00444503222643893,-0.00209330837714979,0.0153312179504908,0.136494761241024
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,38951,-0.0152102728101524,0.0102172026524298,-0.0352359900089148,0.00481544438861007,0.136589260679947
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,39043,-0.00261568233351864,0.00175805868312527,-0.00606147735244416,0.000830112685406886,0.136818017248096
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FADD,FAS-associated death domain protein,39106,0.0104452285923906,0.00702520259220982,-0.00332416848834065,0.0242146256731219,0.137082402443574
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD55,Complement decay-accelerating factor,38575,-0.00344945816991532,0.00232223106907983,-0.00800103106531177,0.00110211472548114,0.137457477700834
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,36792,0.00387000558609,0.00260537206553168,-0.00123652366235209,0.00897653483453209,0.137463701913612
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,36796,-0.00348473048390895,0.00234694997407537,-0.00808475243309668,0.00111529146527878,0.137623530846628
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1,Methionine aminopeptidase 1,38741,-0.004116002932104,0.00277362988296306,-0.00955231750271161,0.00132031163850361,0.137836203980262
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,36747,-0.00485317927861937,0.0032750763453108,-0.0112723289154285,0.0015659703581898,0.138404061002653
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",39147,-0.00833694089100405,0.00562614417126534,-0.0193641834666841,0.002690301684676,0.13840843240324
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,36538,-0.00797158069583037,0.00538789844283508,-0.0185318616437871,0.00258870025212639,0.139022410436486
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36311,0.00711659921211082,0.00481679105250902,-0.00232431125080685,0.0165575096750285,0.139578605442279
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL18,C-C motif chemokine 18,38963,0.00950290734724543,0.00645098803802758,-0.00314102920728862,0.0221468439017795,0.140746715688819
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR4,Proline-rich protein 4,36408,0.00935339554722641,0.00635646972908302,-0.00310528512177632,0.0218120762162291,0.141187387614451
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39023,-0.00313713452503652,0.00213249415041649,-0.00731682305985284,0.00104255400977981,0.141281988815863
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,36391,0.00911723918410058,0.00620169751907696,-0.00303808795329026,0.0212725663214914,0.141554379441172
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,36391,-0.00825156578866964,0.00561407801395464,-0.0192551586960207,0.00275202711868146,0.141641327912167
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTR,Methionine synthase,36391,0.00863023353301671,0.0058755820101082,-0.00288590720679537,0.0201463742728288,0.141903895671805
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,36363,0.00785538336944225,0.00534933127243586,-0.00262930592453203,0.0183400726634165,0.141999174848429
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSTB,Cystatin-B,38863,-0.0056906450199703,0.00387545875207219,-0.0132865441740318,0.00190525413409118,0.142022073169831
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDS,Iduronate 2-sulfatase,39291,0.00120611839557652,0.000821968811817558,-0.000404940475585891,0.00281717726673894,0.142300435341849
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDHB15,Protocadherin beta-15,36731,-0.00529830431177366,0.00361564980143669,-0.0123849779225896,0.00178836929904224,0.142841440845438
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,36538,0.00846491229700724,0.00580746799819569,-0.00291772497945631,0.0198475495734708,0.144978118052708
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36230,-0.00434370419343979,0.00298078284168384,-0.0101860385631401,0.00149863017626054,0.145076618450143
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM3,Junctional adhesion molecule C,36500,-0.00672814374803622,0.004627243102456,-0.01579754022885,0.00234125273277753,0.145963209436446
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,36731,0.0068433706269516,0.00470936712588366,-0.00238698893978037,0.0160737301936836,0.146209214418231
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,38882,0.0227246579568357,0.0156414951147727,-0.00793267246811877,0.0533819883817901,0.146287859781998
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLG4,Disks large homolog 4,36747,-0.00952640949082628,0.00655829787632633,-0.0223806733284259,0.00332785434677332,0.146366563819547
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINC1,Antithrombin-III,36779,0.00192681777643135,0.00132841224013533,-0.000676870214233907,0.0045305057670966,0.146952684192667
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,36743,-0.00357144070727799,0.00246529321708956,-0.00840341541277352,0.00126053399821755,0.147449070245784
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMCH,Pro-MCH,36391,0.0109642019535944,0.00758393324042168,-0.00390030719763206,0.0258287111048209,0.148282314961469
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLON5,IgLON family member 5,36339,0.0121726230730802,0.00843344317072136,-0.0043569255415337,0.028702171687694,0.148939896308336
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LXN,Latexin,38923,-0.00881361116003616,0.00610937380906998,-0.0207879838258133,0.003160761505741,0.149143434226423
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEF,Thyrotroph embryonic factor,36391,0.00558730781149537,0.00387367732420524,-0.0020050997439469,0.0131797153669376,0.149220696945005
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,36731,0.00702843344879958,0.00487807951794992,-0.00253260240638226,0.0165894693039814,0.149659929839595
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,38727,-0.010271050724638,0.00713972381901951,-0.0242649094099163,0.00372280796064022,0.150291129681263
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,36796,-0.00518365383099707,0.00360967837699761,-0.0122586234499124,0.00189131578791824,0.151014250029956
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39099,-0.00574224765001318,0.00399908724579867,-0.0135804586517786,0.00209596335175222,0.151054293858354
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRND,Prion-like protein doppel,36747,-0.00665526101925402,0.00463573082345228,-0.0157412934332205,0.00243077139471246,0.151127823223955
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,36792,-0.00433295329917923,0.00301826298270873,-0.0102487487452883,0.00158284214692988,0.151146516069037
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH1,Protocadherin-1,39252,-0.00272434500123725,0.00189895877029933,-0.00644630419102394,0.000997614188549442,0.151406605032002
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF6,SLAM family member 6,38727,-0.00494933009015695,0.00345042231819383,-0.0117121578338169,0.00181349765350296,0.151475517819062
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX1,Heme oxygenase 1,38941,0.00626114867519292,0.00436748917145556,-0.00229913010085997,0.0148214274512458,0.151712653604074
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,38987,0.00542223952478795,0.00378353465463149,-0.00199348839828977,0.0128379674478657,0.151845697799793
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNB2,Ephrin-B2,36421,0.00794695983489399,0.00555106682001293,-0.00293313113233135,0.0188270508021193,0.152280497960007
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLU,Clusterin,36806,0.00413492775688957,0.00289007399458604,-0.00152961727249906,0.0097994727862782,0.15253053853725
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",36792,-0.0114763676081186,0.00802155741749242,-0.0271986201464037,0.00424588493016654,0.152543041409226
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCLN,Nicalin,38841,0.00685085517498337,0.00479097190070987,-0.00253944975040798,0.0162411601003747,0.152751930312879
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,36743,0.0116331371322124,0.00814860292950689,-0.00433812460962109,0.0276043988740459,0.153424490720067
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,38977,-0.00622343950569131,0.00436448893090918,-0.0147778378102733,0.00233095879889068,0.15391026893704
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,36747,0.00512632260938113,0.0035961447308782,-0.00192212106314015,0.0121747662819024,0.154035470325909
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LUZP2,Leucine zipper protein 2,36731,-0.00567533481804112,0.00398442694054326,-0.0134848116215059,0.00213414198542366,0.154360978887151
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNPO1,Transportin-1,36538,-0.00457055029135253,0.00321051417878454,-0.0108631580817702,0.00172205749906518,0.154581283795398
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD1,Leiomodin-1,36767,-0.00454590850927418,0.00319859827541251,-0.0108151611290827,0.00172334411053433,0.155277274330166
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLTA,Clathrin light chain A,38832,-0.00603814353407814,0.00425203156923631,-0.0143721254097813,0.00229583834162502,0.155610790673302
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,39162,0.011432127073775,0.00806386954914892,-0.0043730572425569,0.0272373113901069,0.156299484924135
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPART,Spartin,36500,-0.0100903673965807,0.00711766899374447,-0.0240409986243198,0.00386026383115846,0.156317462445691
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",36391,0.00659468016096175,0.00465536894281072,-0.00252984296694727,0.0157192032888708,0.156632023530912
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLHL41,Kelch-like protein 41,36767,-0.00664691872392593,0.00470097401728698,-0.0158608277978084,0.00256699034995654,0.157402169912376
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM106A,Transmembrane protein 106A,36731,0.00920935926156566,0.00651745493285106,-0.00356485240682241,0.0219835709299537,0.157671088430501
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",36391,0.0051009385186415,0.00361432564916793,-0.00198313975372764,0.0121850167910106,0.158177680327194
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLINT1,Clathrin interactor 1,36339,0.00637473588227452,0.00452030946103246,-0.0024850706613491,0.0152345424258981,0.158492794811355
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX3,Syntaxin-3,36747,-0.00486859714308813,0.00345332930584499,-0.0116371225825443,0.00189992829636805,0.15861488355797
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA7A,Semaphorin-7A,39234,-0.0034654779184648,0.00245857623834255,-0.00828428734561619,0.00135333150868659,0.158693814879263
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,36420,-0.00782855136804949,0.00555760349010986,-0.0187214542086648,0.00306435147256583,0.15897231862424
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,38832,0.0144073875171717,0.0102500054208956,-0.0056826231077836,0.034497398142127,0.159864269103178
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,36339,0.018483981128439,0.0131859955957871,-0.00736057023930379,0.0443285324961817,0.161003191368471
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,39128,0.00287473321647269,0.00205442689785931,-0.00115194350333156,0.00690140993627695,0.161747198251969
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JUN,Transcription factor AP-1,38841,0.00659089567136754,0.00471128632745134,-0.00264322553043709,0.0158250168731722,0.161846027863113
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYAP1,Synapse-associated protein 1,36500,-0.00737263628195871,0.00527681277602053,-0.017715189322959,0.00296991675904154,0.162385170696578
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36339,0.0106895722794939,0.00765236800595848,-0.00430906901218478,0.0256882135711725,0.162469293610415
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,39021,0.00339429281120953,0.00244077642461447,-0.00138962898103483,0.00817821460345388,0.164348632103399
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1R,Complement C1r subcomponent,36806,-0.00246112815127919,0.00177093182978997,-0.00593215453766752,0.00100989823510915,0.164632881550568
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTN,Neuroplastin,38727,-0.0106014765998655,0.00763003897891877,-0.0255563529985463,0.00435339979881534,0.164719991349573
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE,Angiotensin-converting enzyme,36796,-0.00324025875137045,0.00233246828003264,-0.00781189658023443,0.00133137907749352,0.164796659747179
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAX,Protein max,38741,0.0133638796219852,0.00964676380869392,-0.00554377744305492,0.0322715366870253,0.165974619727612
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,38754,-0.0100126701919081,0.00722810337883104,-0.024179752814417,0.00415441243060071,0.165999320089111
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF2,Growth/differentiation factor 2,39106,-0.00445444920988205,0.00322372978634475,-0.0107729595911178,0.00186406117135365,0.167062950676498
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,36711,-0.00510449781244188,0.00369827674443421,-0.0123531202315329,0.00214412460664917,0.16753774260691
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,36339,-0.00527634058855559,0.00384321608072122,-0.0128090441067692,0.00225636292965801,0.16980897745577
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRXN3,Neurexin-3,36421,0.00439726214154148,0.00320872421333161,-0.00189183731658848,0.0106863615996714,0.170583987210602
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,36731,-0.00486397081173044,0.00355201952489029,-0.0118259290805154,0.00209798745705453,0.170912655124897
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2L,Ataxin-2-like protein,36767,-0.00601816666259211,0.00439540363958257,-0.014633157796174,0.00259682447098972,0.170962012252499
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB1,Beta-crystallin B1,36792,0.00832951168913468,0.00608354163831306,-0.00359422992195893,0.0202532533002283,0.17096432087591
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,36391,0.00634182313645999,0.00463227437203148,-0.00273743463272172,0.0154210809056417,0.171007650483658
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39023,0.00717244792069011,0.00524174910318435,-0.00310138032155121,0.0174462761629314,0.171228757959068
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPN3,Calpain-3,36731,-0.0047077757940056,0.00344071319233948,-0.011451573650991,0.00203602206297978,0.171255903473994
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,39093,-0.00377845593617507,0.00276315230181491,-0.0091942344477323,0.00163732257538215,0.171506365422911
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD82,CD82 antigen,36538,0.00526931874011878,0.00385514220278611,-0.00228675997734198,0.0128253974575796,0.17170326267251
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA6,Carbonic anhydrase 6,39058,-0.00793313012873317,0.00580469920791106,-0.0193103405762389,0.00344408031877251,0.171747800992361
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEFTY2,Left-right determination factor 2,39237,-0.00662469867496495,0.00485357027906074,-0.016137696421924,0.00288829907199409,0.172300527680476
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,39162,0.00326181461698422,0.00239221812634278,-0.00142693291064764,0.00795056214461607,0.172741725622787
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRC1,Macrophage mannose receptor 1,36796,0.00341678480656245,0.00250924767331453,-0.00150134063313403,0.00833491024625893,0.173323561256332
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA12,Carbonic anhydrase 12,39023,-0.00395158355003506,0.00290482631300047,-0.00964504312351598,0.00174187602344587,0.173739080107768
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39099,-0.00458662904068278,0.00337221168744204,-0.0111961639480692,0.00202290586670362,0.173810526481572
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,36421,0.00538413266973504,0.00396106291309824,-0.00237955063993751,0.0131478159794076,0.174087153618438
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFRC,Transferrin receptor protein 1,39151,0.00481971772617464,0.00355255130539005,-0.00214328283238985,0.0117827182847391,0.174899142616472
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPK2,Death-associated protein kinase 2,36430,-0.00660635211084764,0.00487080892030199,-0.0161531375946395,0.00294043337294426,0.175023266202318
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,38727,-0.00661310625648207,0.00488076648166604,-0.0161794085605475,0.00295319604758337,0.175459838861539
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,36391,0.00492639730260945,0.00363776730324088,-0.00220362661174267,0.0120564212169616,0.17568535332849
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROCR,Endothelial protein C receptor,36391,0.00452296542687541,0.00334245029194451,-0.00202823714533583,0.0110741679990867,0.176019816440554
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS9,Galectin-9,39092,0.00388075245587523,0.0028733689087532,-0.00175105060528105,0.0095125555170315,0.176845850442239
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIAE,Sialate O-acetylesterase,39111,-0.00582296388021672,0.00431595312659356,-0.0142822320083401,0.00263630424790667,0.177301698272775
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3,Interleukin-3,36339,0.00731588065668825,0.00542885074775858,-0.00332466680891856,0.0179564281222951,0.177813824227828
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,38841,-0.00485994501093655,0.00360720697422304,-0.0119300706804137,0.00221018065854061,0.177908020290792
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",38951,-0.00899575626765419,0.00668191664408443,-0.0220923128900597,0.0041008003547513,0.178231222853476
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,36767,0.0156235817460915,0.0116060490993771,-0.0071242744886876,0.0383714379808705,0.178275044535626
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FETUB,Fetuin-B,39145,-0.00412813665174821,0.00307214574331265,-0.010149542308641,0.00189326900514459,0.179055421754001
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,36796,-0.0058160572392072,0.00434552633057229,-0.0143332888471289,0.0027011743687145,0.180789241860162
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMP,Olfactory marker protein,36363,-0.00598550584907321,0.00448100128287739,-0.0147682683635129,0.00279725666536647,0.181654702256448
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,39241,-0.0117100608014983,0.00879228051038408,-0.0289429306018511,0.00552280899885446,0.182926901431025
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,38727,-0.00667911622465333,0.00501558739797474,-0.0165096675246838,0.00315143507537716,0.182988480707668
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,36792,-0.00486545935161384,0.00365634987819289,-0.0120319051128719,0.00230098640964422,0.183315295256505
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN5,Contactin-5,39135,0.00435305429182002,0.00328161682024341,-0.00207891467585706,0.0107850232594971,0.184695017555918
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,38841,-0.00815140044532505,0.00614617799227534,-0.0201979093101847,0.00389510841953461,0.184775403459635
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,36421,-0.00861578895702245,0.00649908658548375,-0.0213539986645706,0.00412242075052571,0.184965751927774
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XRCC4,DNA repair protein XRCC4,38741,-0.00450635385948925,0.00340152670196971,-0.0111733461953499,0.00216063847637139,0.18525673714141
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH3,Neurexophilin-3,36430,-0.0035966004182466,0.00271565901299285,-0.00891929208371259,0.00172609124721939,0.185396560093769
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,36767,0.00404326628971965,0.00305626748338746,-0.00194701797771978,0.0100335505571591,0.185877921602025
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP20,Centrosomal protein 20,38727,-0.00892421229025604,0.00676885349186196,-0.0221911651343055,0.00434274055379341,0.187382388074773
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,36767,-0.00772520972391897,0.00586177941822654,-0.019214297383643,0.00376387793580505,0.187562193053487
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,36430,0.00262155181225204,0.00199433316338473,-0.00128734118798202,0.0065304448124861,0.188701835226048
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,36743,-0.0168930023472645,0.0128617197725535,-0.0421019731014693,0.00831596840694024,0.189060601162963
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,38727,0.00896222892265834,0.00682505954859063,-0.00441488779257928,0.022339345637896,0.189157513870285
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,39197,-0.00356639324909012,0.00271755807856223,-0.00889280708307209,0.00176002058489184,0.189420975578671
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MILR1,Allergin-1,38841,-0.00592222775873465,0.00451355356854074,-0.0147687927530745,0.0029243372356052,0.189506939348931
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGN,Mimecan,39093,0.00473653572904268,0.0036138145923469,-0.00234654087195724,0.0118196123300426,0.189987414673045
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",38741,0.00326108687703678,0.00248850624643325,-0.0016163853659724,0.00813855912004596,0.190060631120412
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,36421,-0.00795148310895547,0.00606997229144016,-0.0198486288001782,0.00394566258226725,0.190229856518431
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM3,Dynamin-3,36767,-0.00657643054314435,0.00502071140461884,-0.0164170248961973,0.00326416380990858,0.190266412387432
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,36391,-0.00750796384206396,0.00573302226024911,-0.0187446874721522,0.00372875978802428,0.190355322529808
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36339,0.00761695685262843,0.00582053048193887,-0.00379128289197176,0.0190251965972286,0.190681714622023
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL2,Fc receptor-like protein 2,39224,-0.00551876930682957,0.00422608957899161,-0.0138019048816531,0.00276436626799399,0.191612643200696
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,39123,0.0142994373860321,0.010959431414116,-0.00718104818563531,0.0357799229576996,0.191993955195774
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM13A,Protein FAM13A,36743,-0.00806696253197763,0.00620106915787787,-0.0202210580814183,0.004087133017463,0.193316413318522
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOP56,Nucleolar protein 56,36391,0.0130320019919385,0.0100182690466002,-0.00660380533939784,0.0326678093232748,0.193342721229862
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC1,Hamartin,36430,0.00900473813318051,0.00692528413916144,-0.00456881877957592,0.0225782950459369,0.193532339379662
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B4,Protein ATP1B4,36339,0.0049664818415742,0.00382379420895352,-0.00252815480797469,0.0124611184911231,0.194024191911951
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL26,C-C motif chemokine 26,39099,-0.0101673397553839,0.00783402106133792,-0.0255220210356062,0.0051873415248384,0.194360479399253
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1B,Protein phosphatase 1B,36430,0.00750969446077176,0.00578644074452932,-0.0038317293985057,0.0188511183200492,0.194376815078784
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,38841,-0.00695486776447856,0.00536123081974308,-0.017462880171175,0.00355314464221788,0.194564447698319
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP1,Interstitial collagenase,38571,-0.0108767986963896,0.00838614239678504,-0.0273136377940882,0.0055600404013091,0.194652676421186
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,38841,-0.00445390875882186,0.00344121084632822,-0.0111986820176252,0.00229086449998144,0.195586828013931
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,38832,0.00377609806064258,0.0029188712154343,-0.00194488952160865,0.00949708564289382,0.195794424537469
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3A,Uroplakin-3a,36363,0.00569450842745763,0.00440781269755628,-0.00294480445975268,0.0143338213146679,0.196411319118488
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,38741,-0.00412064281266644,0.00319067200590233,-0.010374359944235,0.00213307431890213,0.1965623704809
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,36791,0.00970041951775851,0.0075401022416772,-0.0050781808759288,0.0244790199114458,0.198288043678414
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRGN,Neurogranin,36796,0.0107729279606975,0.00837840309429166,-0.00564874210411416,0.0271945980255091,0.198536833196214
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSM,Oncostatin-M,39019,0.0083623229081752,0.0065057718528317,-0.00438898992337494,0.0211136357397253,0.198682712884074
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM1,Myomesin-1,36363,0.0056041262427184,0.00437333906814961,-0.00296761833085483,0.0141758708162916,0.200066568326846
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX18,Sorting nexin-18,36743,-0.00530098756296473,0.0041467930741941,-0.0134287019883852,0.0028267268624557,0.201154630426227
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,38992,-0.00311737040414007,0.00244333194747145,-0.00790630102118411,0.00167156021290397,0.202021571959138
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,38741,0.00570452736769897,0.00447529323047997,-0.00306704736404177,0.0144761020994397,0.202445549424036
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH2,Growth hormone variant,38727,0.0191360814957481,0.0150267796376488,-0.0103164065940435,0.0485885695855398,0.202872910586497
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,36531,0.0115158016221721,0.00905891354302262,-0.00623966892215225,0.0292712721664964,0.203676494314424
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36339,-0.00788728594459588,0.006205568018303,-0.0200501992604698,0.004275627371278,0.203751824591964
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERVV_1,,36391,0.00553531176811052,0.00435672679069777,-0.00300387274165712,0.0140744962778782,0.203922785787542
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,36363,0.00717537147196405,0.00565193758015062,-0.00390242618513116,0.0182531691290593,0.204271491994978
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKAP12,A-kinase anchor protein 12,36500,0.00245067350901363,0.00193108767064617,-0.00133425832545286,0.00623560534348012,0.204441668139888
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,36538,-0.0060324026544284,0.00475562659956716,-0.01535343078958,0.00328862548072324,0.204650973167823
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA2,Adenosine deaminase 2,39025,0.00477971620765479,0.00376960154005896,-0.00260870281086078,0.0121681352261704,0.204830542309639
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,36430,0.0069051239108479,0.00544665887586954,-0.00377032748585639,0.0175805753075522,0.204902716386579
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,36421,0.00727369358658273,0.00574620562323866,-0.00398886943496504,0.0185362566081305,0.205599041654542
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,36791,0.00711319006037902,0.0056286801535391,-0.00391902304055762,0.0181454031613156,0.206346029516741
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36363,0.00376052545674211,0.00298233567076402,-0.00208485245795538,0.00960590337143959,0.207356516461938
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36339,0.00387892811129031,0.0030765680840596,-0.0021511453334665,0.00990900155604712,0.207405531454507
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,36391,0.00472630401684504,0.00375178113325821,-0.00262718700434105,0.0120797950380311,0.207783241391399
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC1,Syndecan-1,39106,0.00457891944468308,0.00363642560165851,-0.00254847473456759,0.0117063136239338,0.207984099678142
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX2,Transcription factor SOX-2,36748,0.00272370489891016,0.00217201096721932,-0.00153343659683971,0.00698084639466003,0.209864223339478
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,36391,-0.0111364094378803,0.0088814385401714,-0.0285440289766163,0.00627121010085559,0.209902824526599
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXDNL,Peroxidasin-like protein,36731,-0.0067554098809769,0.00539832163616933,-0.0173361202878688,0.003825300525915,0.210814685777379
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,38909,0.00433701937162601,0.00347032593795047,-0.00246481946675692,0.0111388582100089,0.211412476634105
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TF,Serotransferrin,36806,-0.0024862112452494,0.00199036347312906,-0.00638732365258235,0.00141490116208356,0.211642223643662
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,36796,0.00391079800926732,0.00313222670443899,-0.0022283663314331,0.0100499623499678,0.211845720883889
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF9,Fibroblast growth factor 9,36311,0.0046466001095675,0.00372225727837842,-0.00264902415605421,0.0119422243751892,0.211934228058079
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABO,Histo-blood group ABO system transferase,36796,0.0163203241736351,0.0130864903222617,-0.00932919685799778,0.0419698452052679,0.212378870136681
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F12,Coagulation factor XII,36806,-0.00471456622966505,0.00378111534211651,-0.0121255523002134,0.00269641984088331,0.21246705290992
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,36421,0.00767596785124045,0.00615991791497393,-0.00439747126210845,0.0197494069645894,0.212745315029503
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,38832,-0.00866608711207284,0.00695610816182159,-0.0223000591092432,0.00496788488509747,0.21284847847287
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,36421,0.00602314275199905,0.00483589618093931,-0.00345521376264199,0.0155014992666401,0.212968660705882
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF3,Fibroblast growth factor 3,36430,0.00350934967599145,0.00281896564989398,-0.00201582299780075,0.00903452234978365,0.213189197273583
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN1,Contactin-1,39283,0.00302018714743796,0.00242958738780929,-0.00174180413266824,0.00778217842754416,0.213854877221261
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD109,CD109 antigen,39093,-0.00382099644004524,0.00307588673102538,-0.00984973443285498,0.0022077415527645,0.214166320891944
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB9,Serpin B9,38987,0.00377063699746479,0.00303674490240726,-0.00218138301125344,0.00972265700618302,0.214377357309037
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC9,Histone deacetylase 9,36363,0.00727094665589813,0.00586029787915385,-0.00421523718724341,0.0187571304990397,0.214735139988975
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELP,P-selectin,39165,-0.00650691835725685,0.00525061776658823,-0.0167981291797698,0.00378429246525609,0.215265565968644
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,36363,0.0119685382046358,0.00966157817302742,-0.00696815501449791,0.0309052314237696,0.215451449783097
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBN,Ameloblastin,38841,0.00324475695992431,0.00262321781676507,-0.00189674996093523,0.00838626388078385,0.216129609351594
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36311,-0.00990112153814808,0.00803382553548974,-0.025647419587708,0.00584517651141182,0.217812053094466
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,36421,0.00574281475440667,0.00467837333557287,-0.00342679698331616,0.0149124264921295,0.21964877462184
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,36430,0.00327749968564391,0.00267015835524485,-0.00195601069063601,0.00851101006192382,0.219674546714264
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSD1,Tryptase delta,36767,-0.00406969413529311,0.00331703543616555,-0.0105710835901776,0.00243169531959138,0.219879910729221
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP2,Guanylate-binding protein 2,38841,0.00665313286542499,0.00542654380355666,-0.00398289298954606,0.017289158720396,0.220204759638053
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKCQ,Protein kinase C theta type,38841,-0.00482162987527583,0.00394023053877495,-0.0125444817312747,0.00290122198072307,0.221087561185497
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,38841,-0.00465393822044507,0.0038226790948291,-0.0121463892463101,0.00283851280541996,0.223450479053742
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,38987,0.00372585811504279,0.00306104153867725,-0.00227378330076463,0.00972549953085021,0.223552293657558
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,39106,-0.00631821451676193,0.00519233892479987,-0.0164951988093697,0.00385876977584581,0.223686219139903
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP8,Caspase-8,39211,-0.00686125471578114,0.00563863231855867,-0.0179129740601561,0.00419046462859386,0.22368776227209
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,36767,0.0127213538706861,0.0104634065305426,-0.00778692292917744,0.0332296306705496,0.224085386438739
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36363,0.00357822879137347,0.00294435915495411,-0.0021927151523366,0.00934917273508353,0.224281229224945
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,36391,0.00492903119446279,0.00407200807185795,-0.00305210462637878,0.0129101670153044,0.226122595979589
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,39291,-0.0074953205127084,0.00619361666058302,-0.0196348091674511,0.00464416814203433,0.22623273450397
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM2,Myomesin-2,36391,-0.0057008460868878,0.00472322321008113,-0.0149583635786468,0.00355667140487123,0.227461803042672
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,36430,0.00529324087580081,0.00438746337297014,-0.00330618733522066,0.0138926690868223,0.227667989140978
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,36421,0.0044772706345554,0.00372927782148335,-0.00283211389555198,0.0117866551646628,0.229939481087937
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,36767,0.00389517184246761,0.00324638330422535,-0.00246773943381408,0.0102580831187493,0.230219764317069
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTF,Ciliary neurotrophic factor,36363,0.00374901717462327,0.00312535165541739,-0.00237667206999481,0.00987470641924135,0.230336687418755
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,36538,0.0093964808145704,0.00784074631170467,-0.00597138195637074,0.0247643435855115,0.230777260708446
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,36363,0.00684436547081517,0.00571716058447243,-0.00436126927475079,0.0180500002163811,0.231266246615506
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,39147,0.00741876895435773,0.0062006965899842,-0.0047345963620113,0.0195721342707268,0.231542981681131
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAG,S-arrestin,36363,-0.00583768261222031,0.00487921461243388,-0.0154009432525907,0.00372557802815009,0.23154797982831
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCN,Decorin,38832,-0.00237080376795717,0.00198225277689083,-0.0062560192106632,0.00151441167474887,0.231709702816028
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MN1,Transcriptional activator MN1,36421,0.00640259005394649,0.0053788866163076,-0.00414002771401641,0.0169452078219094,0.233943595778796
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,36538,0.00383043309095649,0.00322320524399275,-0.0024870491872693,0.0101479153691823,0.234701051684314
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11,Coagulation factor XI,36610,-0.00341964319961084,0.00287908374008382,-0.00906264733017513,0.00222336093095344,0.234952471892512
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNG,Interferon gamma,38841,-0.012398410815675,0.0104391187165971,-0.0328590835002054,0.00806226186885535,0.234975380125122
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAP1,Antigen peptide transporter 1,36538,-0.00636692459131954,0.00536410323941173,-0.0168805669405665,0.00414671775792745,0.235269417765567
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,36339,-0.00668714062790156,0.00563390420573281,-0.0177295928711379,0.00435531161533475,0.235271476119537
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",38741,0.00537155323865598,0.00452707828436754,-0.0035015201987044,0.0142446266760164,0.235428600322529
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL21R,Interleukin-21 receptor,36430,-0.00589644961877652,0.00497390192911342,-0.0156452973998388,0.00385239816228578,0.235851052319172
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,38987,0.00534133051929577,0.00450601178366821,-0.00349045257669393,0.0141731136152855,0.235886358843851
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",36747,0.0115225277662874,0.00973218525338045,-0.0075525553303383,0.0305976108629131,0.236450339325008
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,36500,-0.00735197470080278,0.00621094467298677,-0.0195254262598569,0.0048214768582513,0.236549031269583
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAX,Apoptosis regulator BAX,38713,0.00991251846186962,0.00837599749904187,-0.00650443663625244,0.0263294735599917,0.236652429639363
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,36420,-0.00506561653303037,0.00430199214596785,-0.0134975211391274,0.00336628807306661,0.239016382175218
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,38832,-0.00369785696396393,0.00314152802331409,-0.00985525188965954,0.00245953796173167,0.239178838902136
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,39045,-0.00370560421865765,0.00315146558260709,-0.00988247676056756,0.00247126832325225,0.23967916467091
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,36767,-0.00779314646798427,0.00663205436645659,-0.0207919730262392,0.00520568009027064,0.239987282115556
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,36421,0.00451687335574752,0.00385672732746777,-0.0030423122060893,0.0120760589175843,0.241553708224347
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB2,Beta-crystallin B2,36747,-0.00601203007060035,0.00514158883863436,-0.0160895441943237,0.00406548405312299,0.242306741059674
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,36391,0.00497372651679454,0.00425829203057133,-0.00337252586312526,0.0133199788967143,0.242825062833212
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,38841,0.00661499768580522,0.00566931555955154,-0.00449686081091579,0.0177268561825262,0.243306849015416
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,36339,-0.00686446014942958,0.00588419169151826,-0.0183974758648054,0.00466855556594621,0.243396837322252
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,36731,0.00892363983875876,0.00765517429804517,-0.00608050178540978,0.0239277814629273,0.243757194316542
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTKN2,Rhotekin-2,36391,0.00549435462074827,0.00471772423102395,-0.00375238487205867,0.0147410941135552,0.244195133162215
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,39093,0.00300604062524341,0.00258164867946849,-0.00205399078651483,0.00806607203700165,0.244285062222939
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1,Integrin beta-1,39098,0.00230991221309558,0.00198657102204526,-0.00158376699011314,0.0062035914163043,0.244943691653969
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7,Complement component C7,36512,-0.00340912783741195,0.00293446102790703,-0.00916067145210973,0.00234241577728583,0.245356488950598
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,36430,0.00314404438484086,0.00270979746472309,-0.0021671586460164,0.00845524741569812,0.245968789151105
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELENOP,Selenoprotein P,36806,0.00234900058430993,0.00202776354801923,-0.00162541596980775,0.00632341713842761,0.246714304469757
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_E,,39099,0.00289326179173072,0.00249807884488169,-0.0020029727442374,0.00778949632769883,0.246802722804326
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39162,-0.00452039799160599,0.00390474198756385,-0.0121736922872311,0.00313289630401915,0.2470172880908
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC2,Mucin-2,36791,-0.00952852494276365,0.00823896213406595,-0.0256768907255329,0.00661984084000561,0.247489866389692
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,39062,-0.00300546484191946,0.00260138516966978,-0.00810417977447223,0.00209325009063331,0.247972448769973
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSB,Arylsulfatase B,39023,-0.00583536523837234,0.00505143122933421,-0.0157361704478674,0.00406543997112271,0.248030638047755
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,38832,0.00601582692661319,0.00520858320990129,-0.00419299616479334,0.0162246500180197,0.24811567445647
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,36339,0.00420517514141755,0.00364149331624619,-0.00293215175842498,0.0113425020412601,0.248196849903441
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,38841,-0.00640307479206423,0.00554683637130074,-0.0172748740798137,0.00446872449568522,0.248368896333754
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,36731,-0.0113593832101664,0.00984999709154529,-0.0306653775095951,0.00794661108926241,0.248834448077172
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39093,0.00266691684450714,0.00231689962741698,-0.00187420642523015,0.00720804011424443,0.249720939620051
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,36792,0.0103598736745913,0.00900611626778674,-0.00729211421027066,0.0280118615594534,0.250035286505195
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",36391,0.00651723623160486,0.00567072879239226,-0.00459739220148398,0.0176318646646937,0.250463855171473
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,36767,-0.00281442506004535,0.00245106826118337,-0.00761851885196475,0.00198966873187406,0.250889023209367
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",36743,0.0107338783181125,0.00935087475919611,-0.00759383620991184,0.0290615928461369,0.25103075761091
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,36430,0.0021117719662321,0.00183995240372625,-0.00149453474507136,0.00571807867753555,0.251101123741492
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,38841,-0.00299426627428492,0.00261768918242627,-0.0081249370718404,0.00213640452327057,0.252700560908106
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",39162,0.0114960681903694,0.0100543799447209,-0.00821051650128345,0.0312026528820223,0.252894973475783
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,36743,0.0123650652824086,0.010850916066432,-0.00890273020779813,0.0336328607726153,0.254498705265238
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",36391,-0.0042204674369682,0.00370727829510802,-0.0114867328953799,0.00304579802144352,0.254963794427207
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,36792,-0.00847890942113366,0.00747093612017091,-0.0231219442166686,0.00616412537440133,0.256430177001796
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,36791,0.00266643189227735,0.00235525390779194,-0.00194986576699485,0.00728272955154954,0.257604652396591
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTPBP2,GTP-binding protein 2,36421,-0.00839432529882333,0.00744238190791202,-0.0229813938383309,0.00619274324068423,0.25938013632897
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,38741,-0.00764242907737058,0.00679498522455414,-0.0209606001174967,0.00567574196275553,0.260727510733214
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,38960,-0.00339047349239974,0.00301499829306523,-0.00929987014680759,0.00251892316200811,0.260803670868126
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS8,Galectin-8,39241,-0.00627726469883654,0.00559711491450004,-0.0172476099312566,0.00469308053358354,0.262084974973377
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TST,Thiosulfate sulfurtransferase,38707,0.00783702522188586,0.00698917085539661,-0.00586174965469149,0.0215358000984632,0.262174184574943
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN10,Ataxin-10,38741,0.00747593181347538,0.00667059125426797,-0.00559842704488985,0.0205502906718406,0.262420889372207
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12B,Interleukin-12 subunit beta,39291,-0.0053488716029187,0.00477438765496066,-0.0147066714066416,0.0040089282008042,0.262592215003103
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2,Ataxin-2,36363,0.0114020450355384,0.0102115161908869,-0.0086125266985999,0.0314166167696768,0.26419245988178
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",36731,0.00370270435079506,0.0033355280696829,-0.00283493066578341,0.0102403393673735,0.266985118590064
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,36363,0.0059927313567665,0.00540519171905274,-0.00460144441257688,0.0165869071261099,0.267581322951012
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36363,-0.00596327598508055,0.00538502898544698,-0.0165179327965566,0.00459138082639553,0.268150765039966
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,38987,0.0111027849392223,0.0100539197379528,-0.00860289774716518,0.0308084676256097,0.26947017759135
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,36731,0.00492004273009805,0.00445780643665382,-0.00381725788574343,0.0136573433459395,0.269747651264457
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,36363,0.00731145825312905,0.00662718161322456,-0.00567781770879109,0.0203007342150492,0.269938527825949
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,39093,0.0043175718659375,0.00391689420387765,-0.0033595407736627,0.0119946845055377,0.270350971736946
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICA1,Islet cell autoantigen 1,38841,-0.00809942506654639,0.00735018699017388,-0.0225057915672872,0.00630694143419442,0.270507825273383
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39117,0.00295299654208032,0.00268108056057438,-0.00230192135664547,0.00820791444080611,0.270731151950946
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF22,Kinesin-like protein KIF22,36391,-0.0122035278446129,0.0110940303813633,-0.033947827392085,0.00954077170285916,0.271349544719885
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,36679,0.00284249205509012,0.00258964122968585,-0.00223320475509415,0.00791818886527439,0.272382630338937
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL14,C-C motif chemokine 14,39083,-0.00389930035888424,0.00355509467799319,-0.0108672859277509,0.0030686852099824,0.272737261387935
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,36767,-0.00526028412165861,0.00480183964985328,-0.014671889835371,0.00415132159205382,0.273330051220493
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,38741,-0.00396231925719858,0.00361818985749153,-0.011053971377882,0.00312933286348481,0.273485764984311
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39191,-0.00276900966484397,0.00253637709284648,-0.00774030876682306,0.00220228943713513,0.27497402973274
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",38727,0.00505585454706634,0.00463695375971286,-0.00403257482197086,0.0141442839161035,0.275581226111884
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF75D,Zinc finger protein 75D,36538,0.00592499694189507,0.00543520502799158,-0.00472800491296842,0.0165779987967586,0.275683336876641
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,39255,0.0055645303644527,0.00510557141458732,-0.00444238960813846,0.0155714503370439,0.275777010061648
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YWHAQ,14-3-3 protein theta,36500,-0.0073738884458318,0.00678151393182877,-0.0206656557522162,0.00591787886055258,0.276902288872755
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],38841,0.00541748819093044,0.00498308198608778,-0.00434935250180162,0.0151843288836625,0.276976433393089
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRX,Cone-rod homeobox protein,38832,0.0106991758065128,0.00984132452528173,-0.00858982026303943,0.029988171876065,0.276979950290393
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,38727,-0.00599653558040802,0.00551656715706429,-0.016809007208254,0.00481593604743799,0.27705226301577
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLA2,Src-like-adapter 2,36767,-0.010458748667024,0.00962246982750126,-0.0293187895289265,0.00840129219487844,0.277097343632191
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,38741,0.0111596385954091,0.0102895463807902,-0.00900787231093977,0.031327149501758,0.27813379774069
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDNRB,Endothelin receptor type B,36430,0.00451798035503851,0.00418289973555807,-0.0036805031266553,0.0127164638367323,0.280115144348199
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATOX1,Copper transport protein ATOX1,39147,0.0071654051251431,0.00663487242681486,-0.00583894483141402,0.0201697550817002,0.280176473794204
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTF1,Cardiotrophin-1,38832,0.00833653925400577,0.00775187714013343,-0.00685713994065575,0.0235302184486673,0.282203164041578
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,36430,-0.00633992563094261,0.00590067671023543,-0.0179052519830041,0.00522540072111883,0.282645953341558
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,36767,-0.00233944655481804,0.00217804816962089,-0.00660842096727498,0.0019295278576389,0.282796912091939
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,39093,0.00510631500192999,0.00475415709017781,-0.00421183289481851,0.0144244628986785,0.282806673007022
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,39283,0.00704186528592816,0.00655630392109919,-0.00580849039942626,0.0198922209712826,0.282812491863542
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,36587,0.00132139734175221,0.00123154649929852,-0.00109243379687289,0.00373522848037731,0.283310423681489
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL6B,Myosin light chain 6B,36421,-0.00908141836692541,0.00846934807157591,-0.0256813405872142,0.00751850385336337,0.283619880785656
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,36731,-0.00354800026200374,0.00331110704585001,-0.0100377700718698,0.00294176954786228,0.283944531457306
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,36430,-0.00770137297148206,0.00721001623712369,-0.0218330047962445,0.00643025885328038,0.285473734629659
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,39147,0.00968035192220468,0.00907205821583241,-0.00810088218082684,0.0274615860252362,0.285965501752063
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,36767,0.0112582654453346,0.010554108777736,-0.00942778775902789,0.0319443186496971,0.28611882177843
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH1,Neurexophilin-1,38741,0.0036339685974817,0.0034123389479797,-0.00305421574055851,0.0103221529355219,0.286916069842706
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,38727,0.00477392825814097,0.00449205243179272,-0.00403049450817275,0.0135783510244547,0.287912648426486
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,36339,-0.00384910249472707,0.00362243086020723,-0.0109490669807332,0.00325086199127909,0.287995538918705
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,38727,-0.00331066638211015,0.00311658109436736,-0.00941916532707017,0.00279783256284988,0.288128085992247
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP1,Dipeptidase 1,38951,0.00455940115229601,0.00430417746364614,-0.00387678667645043,0.0129955889810424,0.289481613710917
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,36391,-0.00498018355638977,0.00471110228143211,-0.0142139440279967,0.00425357691521716,0.290478838690264
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,39216,-0.00598328381281699,0.00567110810695824,-0.0170986557024551,0.00513208807682116,0.291420572395806
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP350,Centrosome-associated protein 350,36339,0.00348458847998707,0.00330496542930485,-0.00299314376145043,0.00996232072142457,0.291743369958078
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,36391,0.00331647090615374,0.00314807344200476,-0.00285375304017559,0.00948669485248307,0.292135766882915
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,36363,0.00671886228062367,0.00637774544273899,-0.00578151878714475,0.0192192433483921,0.292138899219176
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B2M,Beta-2-microglobulin,36806,0.00293556691024911,0.00278942820005229,-0.00253171236185337,0.0084028461823516,0.292640203753589
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,36500,0.00241005107072442,0.00229037548763967,-0.00207908488504934,0.00689918702649818,0.292704286480505
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN1,Cerebellin-1,36363,0.00926185779371037,0.00881050696799462,-0.00800673586355909,0.0265304514509798,0.293173881292959
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,36339,-0.00348681573678383,0.00332283984408315,-0.00999958183118681,0.00302595035761915,0.29403824892236
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,38741,0.00813115367365932,0.00776728999571094,-0.00709273471793412,0.0233550420652528,0.295187779191955
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,39033,-0.00248410255890239,0.00237388427295475,-0.0071369157338937,0.00216871061608892,0.295379442932827
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18BP,Interleukin-18-binding protein,39165,-0.00282375118787648,0.00270354484116471,-0.0081226990765593,0.00247519670080635,0.296287959033617
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH6,Cadherin-6,39106,-0.00363004910209951,0.00347664020157521,-0.0104442638971869,0.0031841656929879,0.296443829192934
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB6,Serpin B6,39202,0.00573843550876967,0.00549830796161731,-0.00503824809600026,0.0165151191135396,0.296653154954982
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,38727,0.00307173488555667,0.00294654795804769,-0.00270349911221681,0.00884696888333016,0.297203381442631
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,36430,0.00355229076780946,0.0034240934310147,-0.00315893235697935,0.0102635138925983,0.299550898833344
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,36421,-0.00648496593335438,0.00625274269473759,-0.0187403416150401,0.0057704097483313,0.299690850672894
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,38987,0.00750952875974327,0.00725775369480621,-0.00671566848207691,0.0217347260015634,0.300830017110946
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRDT,Bromodomain testis-specific protein,36391,0.00344471237272295,0.0033302648650451,-0.00308260676276544,0.00997203150821134,0.300985106519752
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRTN,Neurturin,38841,-0.00466631670118697,0.00451228870655141,-0.0135104025660277,0.00417776916365379,0.301089643427417
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,38727,0.00436093628676797,0.00423258024150395,-0.00393492098657977,0.0126567935601157,0.302873890263305
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,39095,-0.00230484462662525,0.00223757709622085,-0.0066904957352181,0.00208080648196761,0.302996942192528
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39095,-0.00280543153703423,0.00272423992708569,-0.00814494179412218,0.00253407872005373,0.303118653071115
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EREG,Proepiregulin,38951,0.00751881271536554,0.00730167947381904,-0.00679247905331978,0.0218301044840509,0.303149779289115
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,39093,-0.00268009700400904,0.00261232991512205,-0.00780026363764825,0.00244006962963018,0.304935570932821
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,36420,-0.00718475112327006,0.00703258206550459,-0.0209686119716591,0.00659910972511894,0.306972073903952
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39099,-0.0138589043632562,0.0135705311618595,-0.0404571454405008,0.0127393367139884,0.307152241079475
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBN2,Fibrillin-2,36421,0.00563988881116885,0.00552403667884931,-0.0051872230793758,0.0164670007017135,0.307287193102883
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECM1,Extracellular matrix protein 1,36470,-0.00337813322669044,0.00330948774120785,-0.00986472919945783,0.00310846274607694,0.307396259275141
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS2,Podocin,36430,0.00952202424326282,0.00934408278330555,-0.00879237801201606,0.0278364264985417,0.308202059029854
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH1,Acid ceramidase,36698,-0.00439813824152828,0.0043215489551201,-0.0128683741935637,0.00407209771050711,0.308828960210527
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL20,C-C motif chemokine 20,39291,-0.00776289552743122,0.00764363668041497,-0.0227444234210446,0.00721863236618212,0.309834699130479
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,36430,0.00625756064471587,0.00616259441828853,-0.00582112441512964,0.0183362457045614,0.309929921988222
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,36743,0.00461587589249469,0.00455056878915245,-0.0043032389342441,0.0135349907192335,0.310434147781736
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,36420,-0.00394766673694548,0.00389233594781989,-0.0115766451946725,0.00368131172078151,0.310499558104697
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,38727,0.0050412882307063,0.00497627505235123,-0.0047122108719021,0.0147947873333147,0.31104577936155
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,36430,0.0100886320596767,0.00996154301330569,-0.00943599224640249,0.0296132563657558,0.311195275315967
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,36391,-0.00442556643588681,0.00437046088004024,-0.0129916697607657,0.00414053688899206,0.311266683908609
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,36591,0.00516741885870428,0.00510363773489626,-0.00483571110169239,0.0151705488191009,0.31131963225291
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,36731,0.00409002165838421,0.00404002347950448,-0.00382842436144457,0.012008467678213,0.311377475841231
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,38727,-0.00313014448961595,0.00309940495361383,-0.00920497819869905,0.00294468921946716,0.312551070086174
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS53,Serine protease 53,36747,-0.00344198462922809,0.0034102552646044,-0.0101260849478527,0.00324211568939652,0.312847763065419
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR4,Toll-like receptor 4,36430,0.00252064986103009,0.00250183262958774,-0.00238294209296187,0.00742424181502206,0.313703682941095
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,36363,0.00693296211220415,0.00688555285796312,-0.00656272148940356,0.0204286457138119,0.314009371347389
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39140,0.00704184360652419,0.00699385992990279,-0.00666612185608528,0.0207498090691337,0.314017601860474
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD22,B-cell receptor CD22,39291,-0.00366849248136457,0.00365110079847826,-0.0108246500463819,0.00348766508365282,0.315026542662319
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAGE2A,G antigen 2A,36339,0.00559206084890137,0.00557509043551345,-0.005335116404705,0.0165192381025077,0.315859094960698
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKZF2,Zinc finger protein Helios,38727,0.00858417213839411,0.00855897162455239,-0.00819141224572857,0.0253597565225168,0.315904041128362
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,36421,-0.00592747744114127,0.00591712825132535,-0.017525048813739,0.00567009393145641,0.316484120568582
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,36339,-0.00509819800033449,0.00510425658106699,-0.0151025408992258,0.00490614489855682,0.317904637798062
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,39241,-0.00416802048334784,0.00417782388975518,-0.012356555307268,0.0040205143405723,0.318463119921475
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,36339,-0.00391005272777286,0.00392633292463528,-0.011605665260058,0.0037855598045123,0.319340598262491
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM3,Paralemmin-3,36391,0.0068654456560099,0.0069023865328909,-0.00666323194845626,0.0203941232604761,0.319926650172487
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,39180,0.00218089601210713,0.00219426823574626,-0.00211986972995554,0.0064816617541698,0.320284408988857
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF830,Zinc finger protein 830,36731,-0.00732225479543268,0.00737320097571434,-0.0217737287078328,0.00712921911696742,0.320684591432289
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,38727,0.00355831763525918,0.00359725713793376,-0.00349230635509099,0.0106089416256094,0.322593516493904
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL1,Chordin-like protein 1,39140,0.00275619919469962,0.00279116332434565,-0.00271448092101786,0.0082268793104171,0.323426313006351
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,36767,-0.00816858899332931,0.00827835779792588,-0.024394170277264,0.00805699229060542,0.32378848056175
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,39023,-0.00193634481609065,0.00196435710296749,-0.00578648473790693,0.00191379510572563,0.324276582555332
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,36785,-0.00432661973016584,0.00440107869990763,-0.0129527339819848,0.00429949452165311,0.325585653972298
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX33,Testis-expressed protein 33,36538,0.00359200146365688,0.00366029633691808,-0.00358217935670255,0.0107661822840163,0.326442987084639
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRSF1,G-rich sequence factor 1,36258,0.00725421109487358,0.00740406567155355,-0.00725775762137138,0.0217661798111185,0.327223471210365
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLM2,Protein GOLM2,39241,-0.00197341383348779,0.00201556998775376,-0.00592393100948515,0.00197710334250957,0.327553506206582
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB2,Calretinin,38741,0.00260997482897782,0.00266693073067414,-0.00261720940314348,0.00783715906109913,0.327771992157586
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,36339,0.00289609708354498,0.0029647449849473,-0.00291480308695172,0.00870699725404168,0.328664701509317
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX9,Sorting nexin-9,39106,-0.00618309824734845,0.00633703306082494,-0.0186036830465653,0.00623748655186844,0.329224323770074
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",36420,0.00447844012861294,0.00459793177089147,-0.00453350614233435,0.0134903863995602,0.330069402743723
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFB,Complement factor B,36584,0.00291766512716749,0.00299998684370236,-0.00296230908648914,0.00879763934082412,0.330790863083041
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,36703,-0.0039811169057716,0.0040969965173466,-0.0120112300797709,0.00404899626822774,0.331210174586846
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,39069,0.00392665093246112,0.00404873864379894,-0.00400887680938479,0.011862178674307,0.332138934706683
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,38960,0.00205209467285241,0.00211632062479998,-0.00209589375175555,0.00620008309746036,0.332235480270949
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,39099,-0.00314930807758106,0.00325488659153911,-0.00952888579699773,0.0032302696418356,0.333277981275654
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,36391,-0.00391025177975614,0.0040443825935223,-0.0118372416630598,0.00401673810354756,0.333645043227193
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,39162,-0.00177881345788876,0.00184205027461862,-0.00538923199614125,0.00183160508036372,0.334224387754491
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLGAP5,Disks large-associated protein 5,36767,-0.00459684927161469,0.00476729971770991,-0.0139407567183261,0.00474705817509675,0.334940715505034
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,36398,0.00342244746054809,0.00355082104868502,-0.00353716179487454,0.0103820567159707,0.335141334447899
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,38841,0.00265823567926727,0.00276085311045678,-0.00275303641722802,0.00806950777576256,0.335647751064662
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",36420,-0.00852480291021257,0.00885768195180123,-0.025885859535743,0.00883625371531783,0.335857615970318
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL1,Fc receptor-like protein 1,39106,0.00385574893138202,0.00400711468659537,-0.00399819585434489,0.0117096937171089,0.335951477983806
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,39147,-0.0035807793988418,0.00373379442830551,-0.0108990164783206,0.00373745768063701,0.33756439463343
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,39023,-0.00269537357994642,0.00281193954318087,-0.00820677508458093,0.0028160279246881,0.337802758629621
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,36421,0.00373731301264825,0.00391447327478543,-0.00393505460593119,0.0114096806312277,0.339726432332201
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,36718,0.00313789001779808,0.00329158679245882,-0.0033136200954212,0.00958940013101736,0.340452883665797
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGN,Cingulin,36421,-0.00340097641208678,0.00357128059984091,-0.010400686387775,0.00359873356360139,0.340956666149249
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM2,Isthmin-2,36791,0.00386533237457187,0.00406086712535223,-0.00409396719111851,0.0118246319402623,0.341191350465129
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GKN1,Gastrokine-1,38391,-0.00243149714301987,0.00255881252184174,-0.00744676968582969,0.00258377539978994,0.342003912085365
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN2,Prefoldin subunit 2,38741,-0.0048506825514688,0.00511464277277573,-0.0148753823861092,0.00517401728317162,0.342945703202374
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,36507,0.00439814152875837,0.0046525697149682,-0.00472089511257929,0.013517178170096,0.344516406731751
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,36339,0.00512779592380763,0.00545749385232154,-0.00556889202674259,0.0158244838743578,0.347447102038855
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3G,Semaphorin-3G,36500,0.00374489534409073,0.00398809407781931,-0.00407176904843512,0.0115615597366166,0.347739031178729
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMA,Granzyme A,39291,-0.00287993486705892,0.00308575014192504,-0.008928005145232,0.00316813541111416,0.350678985579805
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,36363,0.0025863333504301,0.00277591305572841,-0.00285445623879757,0.00802712293965778,0.351506753968011
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,36517,0.00447166782960454,0.00480436587018201,-0.00494488927595219,0.0138882249351613,0.352000188215307
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD83,CD83 antigen,39099,0.00278991059196769,0.00299961230891196,-0.00308932953349975,0.00866915071743513,0.35233901729832
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,36538,-0.00549736863889993,0.00591354949587218,-0.0170879256508094,0.00609318837300955,0.352584275532203
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,36767,-0.0101375223710384,0.0109103617095026,-0.0315218313216636,0.0112467865795867,0.352821142902396
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP1,Retinol-binding protein 1,36421,0.00597683862573927,0.00643731256750278,-0.00664029400656618,0.0185939712580447,0.353182708294222
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK2,Docking protein 2,39106,-0.0104055392529729,0.0112093132126369,-0.0323757931497412,0.0115647146437954,0.353269732770524
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,39099,-0.00958497732387987,0.0103265983675223,-0.0298251101242235,0.0106551554764638,0.353327137496248
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,36430,0.00239817749112685,0.00258760819518471,-0.00267353457143517,0.00746988955368887,0.354051747841845
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,38741,0.00622734301183039,0.00672464229523081,-0.006952955886822,0.0194076419104828,0.35443594035238
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,36538,0.00703554791392876,0.00759840869522533,-0.00785733312871288,0.0219284289565704,0.354503174822184
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,36538,-0.00373369674128187,0.00403249237091795,-0.011637381788281,0.0041699883057173,0.354514021739725
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXOSC10,Exosome component 10,36391,0.00516487701107739,0.00558119418807816,-0.0057742635975558,0.0161040176197106,0.354771981373332
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,36391,0.00390395158004542,0.00422013187947418,-0.00436750690372397,0.0121754100638148,0.354943097869472
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12A_IL12B,Interleukin-12,39023,-0.00621359475933039,0.00672996542774208,-0.0194043269977049,0.00697713747904409,0.355879693183339
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,36420,0.00217782757629271,0.00237180448564822,-0.0024709092155778,0.00682656436816321,0.358523701789851
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESPL1,Separin,36339,0.00447015842915447,0.00488663531075703,-0.0051076467799293,0.0140479636382382,0.360328875210051
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,36391,-0.00317675744424672,0.00347369977825972,-0.00998520900963578,0.00363169412114233,0.360462854060462
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKIV2L,Helicase SKI2W,36391,0.00338118022063088,0.00369795854704744,-0.0038668185315821,0.0106291789728439,0.360557401694662
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,36363,0.00769177021992175,0.00842389914200807,-0.00881907209841406,0.0242026125382576,0.361213305307231
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36363,0.00550057784520508,0.00604065771158725,-0.00633911126950594,0.0173402669599161,0.3625276572537
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39113,0.00474163153663911,0.00520769716763294,-0.00546545491192145,0.0149487179851997,0.362570914705161
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL3,Insulin-like 3,36747,0.00604343470018037,0.00664020574042228,-0.0069713685510473,0.019058237951408,0.362772227608267
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMD,Osteomodulin,39162,0.00360616852153639,0.0039628643625159,-0.00416104562899479,0.0113733826720676,0.362841906424663
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,39162,0.00711504769282472,0.00782923533167607,-0.00823025355726037,0.0224603489429098,0.363480901464625
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1A,Protein phosphatase 1A,38727,0.00252335946798877,0.00278661308914595,-0.00293840218673729,0.00798512112271482,0.365199782282311
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,36538,0.00595319830429972,0.0065779924161678,-0.00693966683138916,0.0188460634399886,0.365473309592399
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,36724,0.00586642001841086,0.00649828642477207,-0.00687022137414241,0.0186030614109641,0.366667985186596
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBR1,T-box brain protein 1,36421,-0.00399658447877326,0.00442747257087715,-0.0126744307176925,0.00468126176014597,0.366713838147856
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,36363,0.00408884403111107,0.00453261339451963,-0.00479507822214741,0.0129727662843696,0.367024233147841
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,36731,-0.00420240544841574,0.00466557485512483,-0.0133469321644604,0.00494212126762892,0.367750774591322
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO4,Roundabout homolog 4,36420,-0.00146559288588182,0.00162896348019887,-0.00465836130707161,0.00172717553530796,0.368292452715668
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,38832,-0.00433450444234975,0.00481942341703693,-0.0137805743397421,0.00511156545504264,0.368463492334784
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,36339,-0.00608699642399739,0.00678080040586979,-0.0193773652195022,0.00720337237150739,0.369372902314696
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,36747,0.00291691319192322,0.00325208453194258,-0.00345717249068423,0.00929099887453067,0.369769577662556
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,H2AP,Huntingtin-interacting protein M,36339,-0.00409210659644631,0.00457344828954266,-0.0130560652439499,0.0048718520510573,0.370936394605136
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,36538,0.00686913185739868,0.00767939545648111,-0.0081824832373043,0.0219207469521017,0.37107749557172
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESR1,Estrogen receptor,36430,0.00481981394702975,0.00539732102098018,-0.00575893525409139,0.0153985631481509,0.371873645527605
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",36767,-0.00382673779531788,0.00428556363216151,-0.0122264425143544,0.00457296692371868,0.371907626443511
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,36500,0.00428830377168724,0.00480521210965518,-0.00512991196323692,0.0137065195066114,0.372180787415251
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP6,Guanylate-binding protein 6,36391,0.00375527912312803,0.0042144348122274,-0.00450501310883768,0.0120155713550937,0.372918565916515
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,36420,-0.00594156137744608,0.00667536901474711,-0.0190252846463504,0.00714216189145826,0.373444087241939
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC2,Stanniocalcin-2,39068,-0.0021391872619956,0.00240447574929872,-0.0068519597306211,0.0025735852066299,0.373657777983464
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAL,Integrin alpha-L,36430,-0.00346360599091063,0.00389599402501189,-0.0110997542799339,0.00417254229811268,0.374010808100949
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,36420,-0.00825109936870669,0.00933139616233656,-0.0265406358468864,0.010038437109473,0.376589053684011
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,36430,-0.00715282740882005,0.00809142404461853,-0.0230120185362724,0.00870636371863226,0.376712549480408
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,36791,-0.00264269156153444,0.0029930496818542,-0.00850906893796867,0.00322368581489979,0.377283609984606
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,36538,0.00526617780468895,0.00597333035882593,-0.00644154969860989,0.0169739053079878,0.37800173982806
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,36538,0.00315528239922241,0.00358536894055266,-0.00387204072426081,0.0101826055227056,0.378852158666207
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,36791,0.00200553148613785,0.00228065867821466,-0.00246455952316289,0.00647562249543859,0.379219727570487
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTTG1,Securin,36538,0.00336871178275967,0.00383381717146688,-0.00414556987331542,0.0108829934388348,0.379589575331663
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36339,0.0043668179969546,0.00497875539669389,-0.00539154258056542,0.0141251785744746,0.380454484689976
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,36698,-0.00384820570795435,0.0044007140111609,-0.0124736051698297,0.00477719375392101,0.381889430238173
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,39093,-0.00699506750875057,0.00800055745424097,-0.0226761601190629,0.00868602510156174,0.381956425586631
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN3,Centrin-3,36743,0.00631607411700866,0.00722463727557705,-0.00784421494312235,0.0204763631771397,0.38200331873743
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,36421,-0.00493753866189383,0.00565337944818435,-0.0160181623803351,0.00614308505654749,0.382473636877426
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMFG,Glia maturation factor gamma,36792,0.00574487890724554,0.00658162225678015,-0.00715510071604354,0.0186448585305346,0.382751944677058
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,36421,-0.00289823057704056,0.00332871153095786,-0.00942250517771798,0.00362604402363685,0.383947506196655
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCL2,Phosducin-like protein 2,36339,0.0042461727343986,0.0048818657693635,-0.00532228417355386,0.0138146296423511,0.384434738691859
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",36391,0.00315650840101602,0.00363315027043,-0.00396446612902678,0.0102774829310588,0.38496903979298
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA11,Annexin A11,39062,0.00525380723369191,0.00608209719857895,-0.00666710327552282,0.0171747177429066,0.387703115086128
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",36538,-0.00393809312894785,0.0045598962497664,-0.01287548977849,0.0049993035205943,0.387803909628054
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLASP1,CLIP-associating protein 1,36339,-0.0057384465158985,0.0066586799703397,-0.0187894592577643,0.00731256622596732,0.388814465307129
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK6,Kallikrein-6,39123,0.0023266628662777,0.00270176322807889,-0.00296879306075693,0.00762211879331232,0.389160918560869
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1A,Lithostathine-1-alpha,39046,-0.00362855095920867,0.00424164746969731,-0.0119421799998154,0.00468507808139805,0.392311182120289
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,36363,0.00346075220339108,0.00406336205357751,-0.00450343742162085,0.011424941828403,0.394398744237004
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CABP2,Calcium-binding protein 2,36421,0.00512503534284445,0.00601810929242936,-0.00667045887031709,0.016920529556006,0.394451131882889
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCT,Secretin,36421,-0.00345422241181932,0.00406350022654521,-0.0114186828558479,0.0045102380322093,0.395307464612586
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX1B,Syntaxin-1B,36421,0.0033051310174541,0.00389708384768867,-0.00433315332401569,0.0109434153589239,0.3963964121337
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSB,Lupus La protein,38741,-0.00473736368873729,0.0055896763998775,-0.0156931294324972,0.00621840205502261,0.396718860440081
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",39057,0.00848998561556276,0.0100197250850238,-0.0111486755510838,0.0281286467822093,0.396826112683674
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",36767,-0.00304249819226827,0.00359576797739969,-0.0100902034279717,0.00400520704343513,0.397494201440443
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2,T-cell surface antigen CD2,36391,0.00297200582711549,0.00351762231225492,-0.00392253390490416,0.00986654555913514,0.398188085356512
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36339,0.00439526478812134,0.00520912627545034,-0.00581462271176132,0.014605152288004,0.398818374641694
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,36430,0.00701400455314578,0.00833180578812476,-0.00931633479157874,0.0233443438978703,0.399896412007122
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,38630,0.00947092655658442,0.0112687264547866,-0.0126157772947973,0.0315576304079661,0.400663492353566
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,36430,0.00524076605513299,0.00623693860939531,-0.00698363361928182,0.0174651657295478,0.400768178321864
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX7,Syntaxin-7,36430,0.00376273378880336,0.00448747810574103,-0.00503272329844905,0.0125581908760558,0.401767968921031
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSTN,Osteocrin,36421,-0.00316160176831793,0.00377170268167038,-0.0105541390243919,0.00423093548775602,0.401910430242353
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTN,Titin,36391,-0.00524031691491575,0.00625280168458893,-0.01749580821671,0.00701517438687854,0.402004554528241
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,38741,0.00603636845715292,0.00723420127428845,-0.00814266604045245,0.0202154029547583,0.404057260344159
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,36538,0.00261713469040477,0.00313843053962091,-0.00353418916725221,0.00876845854806176,0.404353503698534
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB1,Lamin-B1,36712,-0.00441408401949953,0.00529546165970924,-0.0147931888725296,0.00596502083353058,0.404544571735861
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,39099,-0.00283549717912742,0.00340306566890438,-0.00950550589018,0.00383451153192516,0.404734584866861
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36363,0.00467419953128187,0.00562015486062119,-0.00634130399553566,0.0156897030580994,0.405602548766821
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EP300,Histone acetyltransferase p300,36430,0.0022502591216644,0.00271358235808881,-0.00306836230018967,0.00756888054351846,0.406974336018945
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,36747,0.0029124551248586,0.00351331946602809,-0.00397365102855646,0.00979856127827366,0.407133726788107
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,39023,-0.0034959646080451,0.00421913213694698,-0.0117654635964612,0.00477353438037099,0.407344941143296
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,36391,0.00661510288977259,0.00800187077914769,-0.00906856383735689,0.0222987696169021,0.408425956982385
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1,Allograft inflammatory factor 1,38727,-0.00398929485763638,0.0048307319336982,-0.0134575294476849,0.00547893973241209,0.408921829483458
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP12,Macrophage metalloelastase,39130,0.00378355837806662,0.004582126015465,-0.00519740861224477,0.012764525368378,0.408975189970942
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPLX2,Complexin-2,36339,0.00226975579923733,0.00274969539445263,-0.00311964717388983,0.00765915877236448,0.409127864359682
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,38832,-0.00241226795027836,0.00293458240610839,-0.00816404946625082,0.00333951356569409,0.411081994257949
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERC2,ERC protein 2,36421,-0.00564173130944652,0.00686995198022859,-0.0191068371906946,0.00782337457180152,0.411537435287001
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRNN,Cornulin,38645,0.00485572401277805,0.00591440873662967,-0.0067365171110161,0.0164479651365722,0.411660040852688
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,36391,-0.00332417531175313,0.00405248374677025,-0.0112670434554228,0.00461869283191656,0.412071553148187
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHPK,Sedoheptulokinase,36538,0.00315881209214581,0.00385505380636836,-0.00439709336833618,0.0107147175526278,0.412576448441462
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGM2,Phosphoglucomutase-2,36421,-0.00457359523767817,0.00558518485360567,-0.0155205575507453,0.00637336707538894,0.412870512643105
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSCA,Prostate stem cell antigen,36743,0.0189814412696441,0.0231851274765556,-0.026461408584405,0.0644242911236931,0.412978218719302
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,38741,-0.00483311874329687,0.00590720849285965,-0.0164112473893018,0.00674500990270804,0.413271486477157
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,38713,0.00382286746917066,0.00468449016105445,-0.00535873324649607,0.0130044681848374,0.414473727181717
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRLB,Fc receptor-like B,38727,-0.00431895579493872,0.00529526812854704,-0.0146976813268909,0.00605976973701347,0.414727418344584
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,36321,-0.00462589668910963,0.00567471628304216,-0.0157483406038723,0.00649654722565301,0.414986732946473
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP9,Caspase-9,36430,-0.00472472724088415,0.00580025486684062,-0.0160932267798918,0.00664377229812346,0.415332574243713
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX8,Syntaxin-8,39099,-0.00361633780489612,0.00444292745152958,-0.0123244756098941,0.00509180000010186,0.415684120465198
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFP,Properdin,36806,-0.00172694356389571,0.0021229312692444,-0.00588788885161474,0.00243400172382332,0.415962880984304
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC5,Glypican-5,38987,-0.00414828005109164,0.00510171977181669,-0.0141476508038524,0.00585109070166907,0.416165466069725
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,39023,0.00863206184042019,0.0106828399174704,-0.0123063043978218,0.0295704280786621,0.419085627340421
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,36420,-0.00304221668925797,0.00376669443048223,-0.0104249377730031,0.0043405043944872,0.419300368009441
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDK2,Protein sidekick-2,36500,-0.00273259107641376,0.00339045065506333,-0.00937787436033788,0.00391269220751036,0.420277084645979
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",36363,0.00610914086792505,0.00759004172940588,-0.00876734092171048,0.0209856226575606,0.420899059092447
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP7,Retinoid-binding protein 7,36743,-0.00441222748303204,0.00549460725519805,-0.0151816577032202,0.00635720273715613,0.421983462543716
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAV,Integrin alpha-V,39255,0.0012103856094209,0.00150923165809396,-0.00174770844044327,0.00416847965928507,0.422572305343758
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,38727,0.00257424283251793,0.00321292257357143,-0.00372308541168207,0.00887157107671792,0.423019800097347
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,36420,0.00450402660904065,0.00563677599643299,-0.006544054343968,0.0155521075620493,0.424280567265729
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,36731,0.00354200201599309,0.00443308380330954,-0.0051468422384936,0.0122308462704798,0.424309333471967
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMB,RGM domain family member B,39241,0.0018572704631308,0.00233011891814533,-0.00270976261643405,0.00642430354269564,0.425422039665373
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN1,Transcobalamin-1,36591,0.00248753579607971,0.00312192197320272,-0.00363143127139763,0.00860650286355704,0.425584218117934
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,36391,-0.00469249674352904,0.0058992851660311,-0.01625509566895,0.00687010218189192,0.426375687289746
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",36430,0.00215886118983633,0.00271643708280301,-0.00316535549245757,0.00748307787213024,0.426779767658789
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,39067,0.00200135930865676,0.00251952046528858,-0.00293690080330887,0.00693961942062238,0.42700912870485
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,36743,-0.00307609954178712,0.00387337279838305,-0.0106679102266179,0.00451571114304366,0.427113643549513
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUCB2,Nucleobindin-2,39222,0.00272411134012251,0.00343110045746613,-0.0040008455565111,0.00944906823675612,0.427238647681308
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMS,Spermine synthase,36363,-0.00468911534657079,0.00591351713465089,-0.0162796089304865,0.00690137823734496,0.427822795370875
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,36792,0.00516491643510701,0.00652595715715552,-0.00762595959291781,0.0179557924631318,0.428700638046689
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPP,Lipoma-preferred partner,36391,-0.00486291560716216,0.00615267963858806,-0.0169221676987947,0.00719633648447043,0.429324567268066
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAB2,Disabled homolog 2,39255,0.00804028733332779,0.0101817883850909,-0.0119160179014504,0.027996592568106,0.429730698679893
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,39023,0.00190516711875615,0.00241869245378515,-0.00283547009066274,0.00664580432817505,0.430893450636094
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACYBP,Calcyclin-binding protein,36466,0.00744484456171607,0.00946297507007858,-0.0111025865756379,0.0259922756990701,0.431452365282586
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,36743,-0.0105161331064501,0.0133693310427829,-0.0367200219503045,0.0156877557374043,0.431538529607303
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,36430,0.0066504525920405,0.00846390909444157,-0.00993880923306498,0.023239714417146,0.432033204135198
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,36363,0.00295620637857579,0.0037649068275373,-0.00442301100339732,0.0103354237605489,0.432350954100301
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36363,0.00346738983120251,0.00442045066881821,-0.00519669347968118,0.0121314731420862,0.43282184804897
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,38727,-0.00214201985020043,0.00273314373955142,-0.00749898157972122,0.00321494187932036,0.433216815516927
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39093,-0.00269458287158949,0.00343999798253899,-0.00943697891736591,0.00404781317418694,0.433457602771763
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB2,Carboxypeptidase B2,36779,0.00161327898214191,0.00206198698884898,-0.00242821551600209,0.00565477348028591,0.433999469019261
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COLEC12,Collectin-12,39095,-0.00177513561087536,0.00226967383917646,-0.00622369633566122,0.00267342511391051,0.43416182523883
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17C,Interleukin-17C,38841,-0.00471764946925032,0.00603233513588713,-0.0165410263355891,0.00710572739708846,0.434191531567869
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,36731,0.00675129061655612,0.00864056500580365,-0.010184216794819,0.0236867980279313,0.434612052013903
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,36391,-0.00467105079493086,0.00599103859520637,-0.0164134864415353,0.00707138485167362,0.435598123731246
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL21,C-C motif chemokine 21,39162,-0.00279669847029744,0.00358852222423423,-0.00983020202979653,0.00423680508920165,0.435788300477627
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",39093,0.00267203227836649,0.00343015478982194,-0.00405107110968451,0.00939513566641749,0.436001828128907
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA8,Carbonic anhydrase-related protein,36430,-0.0018539937253288,0.00238095866943347,-0.00652067271741841,0.0028126852667608,0.436185662645487
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164,Sialomucin core protein 24,39093,-0.00183260614222836,0.00235517318945386,-0.00644874559355792,0.00278353330910121,0.436510663918582
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,39051,-0.00281116684199667,0.00361817849113434,-0.00990279668461998,0.00428046300062664,0.437196607346319
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,38727,0.00347181225613933,0.00448125537499466,-0.00531144827885021,0.0122550727911289,0.438505041789882
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,39106,0.00241123654836232,0.00311600701693433,-0.00369613720482897,0.0085186103015536,0.439047723870458
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_A,,36767,0.00228471261567121,0.00295356033225793,-0.00350426563555434,0.00807369086689676,0.43921391672961
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB3,Plexin-B3,39051,0.0033600315910196,0.00435323874164496,-0.00517231634260453,0.0118923795246437,0.440217421125828
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,39106,0.00197977958658024,0.00257249006670405,-0.00306230094415971,0.00702186011732019,0.441551150728415
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",38727,0.00569607822257493,0.00741136144341218,-0.00883019020651294,0.0202223466516628,0.442166585084184
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39147,0.0051020340735978,0.00663876316446301,-0.00790994172874969,0.0181140098759453,0.4421891291212
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPB,Natriuretic peptides B,38832,0.0088451991555726,0.0115172133947132,-0.0137285390980652,0.0314189374092104,0.442500366558696
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHIT1,Chitotriosidase-1,39144,0.0105014100427696,0.0137703594020532,-0.0164884943852548,0.037491314470794,0.445707950108289
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN15,Lipocalin-15,36767,-0.0042591477049999,0.00559192734743088,-0.0152193253059644,0.00670102989596462,0.446276836704663
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MB,Myoglobin,39283,-0.00360713103238139,0.0047502977168291,-0.0129177145573664,0.00570345249260364,0.447655769511044
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINH1,Serpin H1,36538,-0.0089245116605129,0.0117813695537685,-0.0320159959858991,0.0141669726648733,0.448758129996824
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGMN,Legumain,39162,0.0024811852036023,0.00328359771284633,-0.0039546663135765,0.0089170367207811,0.449882646767273
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,36743,0.00199630974711842,0.00265185446786584,-0.00320132500989863,0.00719394450413546,0.45158528884434
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,36339,0.00380948386076891,0.00506107641652348,-0.0061102259156171,0.0137291936371549,0.451643025651355
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,36731,0.0031640622108012,0.00420432654763838,-0.00507641782257003,0.0114045422441724,0.45172037243558
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPO,Myeloperoxidase,39093,-0.00310915831322326,0.00413542686520963,-0.0112145949690341,0.00499627834258763,0.452161957077868
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,39095,-0.00192010653728914,0.00255439099134528,-0.0069267128803259,0.00308649980574761,0.452249971356349
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,39095,-0.00354593133768618,0.00472564896738686,-0.0128082033137644,0.00571634063839207,0.453050346734389
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,38741,-0.00425643599068184,0.00568747084765802,-0.0154038788520916,0.00689100687072787,0.454237873967084
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,39241,-0.00184600802080904,0.00247078276032605,-0.00668874223104809,0.00299672618943001,0.454993558716951
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,36430,-0.00202375468622421,0.00271000972835442,-0.00733537375379887,0.00328786438135045,0.455216213690639
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,38841,0.00233511602664837,0.00313194721386055,-0.00380350051251831,0.00847373256581506,0.45593309288872
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,36421,-0.00394619544839049,0.00531139956769935,-0.0143565386010812,0.00646414770430023,0.457515458034509
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,36420,0.00317280977280678,0.00427151518662555,-0.00519935999297929,0.0115449795385929,0.457626832371831
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",36420,-0.00219551201124941,0.00295628008534093,-0.00798982097851762,0.00359879695601881,0.457701228081355
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,39045,0.00768320046198018,0.0104161565506811,-0.0127324663773547,0.0280988673013151,0.460754749780907
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,39095,-0.0198298090523687,0.0269116625050123,-0.0725766675621928,0.0329170494574554,0.461226037427116
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,36538,-0.00272371184728247,0.0037003651691642,-0.0099764275788443,0.00452900388427937,0.46170433877529
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK1,Kallikrein-1,38961,-0.00844377399149775,0.011486596832718,-0.0309575037836249,0.0140699558006294,0.462291247359312
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,36421,0.0019498776958905,0.00265707328974588,-0.00325798595201143,0.00715774134379244,0.463057424434794
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39171,0.00753264745365581,0.0102698538512321,-0.0125962660947592,0.0276615610020708,0.463281995141312
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL2,Interferon lambda-2,36363,0.00419290952033332,0.00571753452231803,-0.00701345814341002,0.0153992771840767,0.463363473398343
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC8,Histone deacetylase 8,36430,0.00421281740454508,0.00575196772943511,-0.00706103934514773,0.0154866741542379,0.463930027127029
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBX2,Chromobox protein homolog 2,36391,0.00268846705816576,0.00367448253108499,-0.00451351870276082,0.00989045281909234,0.464390601281363
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRN1,Secernin-1,39099,-0.00374285411387823,0.00513299232797732,-0.0138035190767138,0.00631781084895731,0.465905299838767
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DXO,Decapping and exoribonuclease protein,36747,-0.00302053702250378,0.00415485947699324,-0.0111640615974105,0.00512298755240297,0.467245916526141
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XCL1,Lymphotactin,39255,-0.00364209926416942,0.00501189974145679,-0.0134654227574247,0.00618122422908589,0.467426704544471
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APP,Amyloid-beta precursor protein,39067,0.00441665662991246,0.00608579235970278,-0.00751149639510499,0.0163448096549299,0.468014010207769
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,36743,-0.0112720930175408,0.0155428714058464,-0.0417361209729998,0.0191919349379181,0.468326623938591
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,39291,0.00500823662275488,0.00690909123835825,-0.00853358220442729,0.0185500554499371,0.468538901210996
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,36747,-0.00294109824968032,0.0040611510982811,-0.0109009544023113,0.00501875790295064,0.468954197037994
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRKL,Crk-like protein,39114,-0.00707461376923039,0.00977121201366191,-0.0262261893160077,0.012076961777547,0.469060737140433
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,36767,0.00516716068140165,0.00713805699083341,-0.00882343102063182,0.0191577523834351,0.469147025301884
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,36430,-0.00257684118622505,0.00357759198020589,-0.0095889214674286,0.0044352390949785,0.471370614647178
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP3,Caspase-3,39283,0.00581169952905279,0.00811593892327578,-0.0100955407605677,0.0217189398186733,0.473949904371763
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,36339,0.00301673156895102,0.00421570781625463,-0.00524605575090806,0.0112795188888101,0.474256002985307
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,36339,-0.00533973601657339,0.00748284927308193,-0.020006120591814,0.00932664855866719,0.47548998778651
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCG22,Protein PBMUCL2,36391,0.00355108294375664,0.00498084706884824,-0.00621137731118591,0.0133135431986992,0.475891460929629
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD1,Bromodomain-containing protein 1,36538,0.00200606641348619,0.00281551552397682,-0.00351234401350839,0.00752447684048077,0.476165772728127
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH22,Cadherin-22,36538,0.00189792626682316,0.00267122246563404,-0.00333766976581956,0.00713352229946588,0.477401931317999
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBLN2,Fibulin-2,36791,0.00195577593039402,0.00275389894945441,-0.00344186601053663,0.00735341787132467,0.477602632462002
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,36796,-0.00172042524432259,0.00242327749726971,-0.00647004913897122,0.00302919865032604,0.477742979105182
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GC,Vitamin D-binding protein,36806,0.00167442068491245,0.00236117247956834,-0.0029534773750415,0.00630231874486639,0.478245423854521
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,36791,-0.00256581919872577,0.00362401137032828,-0.00966888148456919,0.00453724308711765,0.478954737329961
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,36420,0.0026383833400001,0.00372663328276627,-0.00466581789422179,0.00994258457422199,0.478970563684899
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,39093,0.00253848481029361,0.00358735629928829,-0.00449273353631143,0.00956970315689865,0.479192139222014
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,36320,0.00307408807138464,0.00436224404983901,-0.00547591026629982,0.0116240864090691,0.481008026724916
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,36538,0.00470207841805637,0.00669270036491653,-0.00841561429718004,0.0178197711332928,0.482337787913284
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR1B,Cornifin-B,36538,0.00565807337232186,0.00805376969908611,-0.0101273152378869,0.0214434619825306,0.482357066302215
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL19,Interleukin-19,38677,-0.00440567340997982,0.00627698618317205,-0.016708566328997,0.0078972195090374,0.482766780877788
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,39162,0.00180758859559524,0.00257597710325226,-0.00324132652677918,0.00685650371796966,0.482870779446193
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGRN,Neugrin,36747,-0.00135614023860494,0.00193359258971026,-0.00514598171443705,0.00243370123722716,0.483092417235523
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,38727,-0.00237832099136119,0.00339294782131896,-0.00902849872114635,0.00427185673842397,0.483338896228634
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAD,Chondroadherin,36500,-0.00320009892078955,0.00456753058077848,-0.0121524588591154,0.00575226101753627,0.483553684810568
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39023,0.00566346155178303,0.00809584056071361,-0.0102043859472156,0.0215313090507817,0.484217851606757
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IST1,IST1 homolog,36655,0.00636923741745064,0.00912078018591744,-0.0115074917469476,0.0242459665818488,0.48498881209241
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,36391,-0.00382629388915933,0.0054921021819794,-0.014590814165839,0.0069382263875203,0.486009602344711
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",36747,0.00350946208696598,0.00504745728320866,-0.00638355418812299,0.013402478362055,0.486884190894852
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,36500,0.0080090458435402,0.0115320685926042,-0.014593808597964,0.0306119002850444,0.487380149570783
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",38832,0.00590960646787641,0.00851649686650734,-0.010782727390478,0.0226019403262308,0.487755004888648
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36339,0.00192657335009479,0.00278182998163601,-0.00352581341391179,0.00737896011410137,0.488601049145291
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,36743,-0.00349753145488098,0.00505226245499478,-0.0133999658666707,0.00640490295690877,0.488780048692188
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL3,Fc receptor-like protein 3,38841,-0.00328864958791333,0.00475775438386179,-0.0126138481802824,0.00603654900445578,0.489438720448032
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,39162,-0.0015743662815015,0.00228052168673288,-0.00604418878749795,0.00289545622449495,0.489982339541423
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,36391,0.0029590059405038,0.00429295060719097,-0.0054551772495905,0.0113731891305981,0.49066556756226
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,38705,0.00300470599211807,0.00436405836707114,-0.00554884840734136,0.0115582603915775,0.491141256449812
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCB,Tubulin-folding cofactor B,38987,0.00633406871709189,0.00921611306396242,-0.0117295128882744,0.0243976503224582,0.491915569357103
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAVL4,ELAV-like protein 4,36363,-0.00531295546243378,0.00778085160739159,-0.0205634246129213,0.00993751368805374,0.49473044999133
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO2,Gamma-enolase,39241,0.00412119218467396,0.00604780707900305,-0.00773250969017201,0.0159748940595199,0.495606043606751
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRAS,GTPase Hras,36531,0.00611687305068791,0.00897694699943883,-0.0114779430682122,0.023711689169588,0.495632188975433
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_DRA,,39035,0.00220117856150389,0.00323339507992829,-0.00413627579515557,0.00853863291816335,0.496031299051207
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",36320,0.00158024613000232,0.0023218240144829,-0.00297052893838416,0.0061310211983888,0.496133809968041
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,36430,-0.00231503191742558,0.00340828431122327,-0.00899526916742318,0.00436520533257202,0.497000379474267
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINK1,Misshapen-like kinase 1,36747,-0.00575652504829715,0.00847539911476527,-0.0223683073132371,0.0108552572166428,0.497020806239082
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPSE,Heparanase,36665,0.00583828433470556,0.00860276320164488,-0.0110231315405184,0.0226997002099295,0.497370512331892
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXTL1,Exostosin-like 1,36391,-0.00294991322512068,0.00435554470135009,-0.0114867808397669,0.00558695438952549,0.498242290544776
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,36391,-0.00283763527317501,0.0042001150734487,-0.0110698608171345,0.00539459027078444,0.499301433897568
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,38841,-0.00526682542135754,0.00779917283345539,-0.0205532041749301,0.010019553332215,0.499492022468048
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MITD1,MIT domain-containing protein 1,38987,-0.00596024926297381,0.00885170522788044,-0.0233095915096195,0.0113890929836719,0.50073827502644
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTNNA1,Catenin alpha-1,36363,0.00212393137252217,0.00316085886282406,-0.00407135199861299,0.00831921474365733,0.501629502531986
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,39255,-0.00181985570728393,0.00271469776572166,-0.00714066332809839,0.00350095191353052,0.502631125514385
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,38705,-0.00255094345894675,0.00380537953933621,-0.0100094873560457,0.00490760043815222,0.502643908217958
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRC,Chymotrypsin-C,39089,-0.00376699718675265,0.00562819413023816,-0.0147982576820194,0.00726426330851415,0.503308963732674
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39046,-0.00164000069301759,0.00245207718675503,-0.00644607197905744,0.00316607059302226,0.503619841632962
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39099,0.00612657086364206,0.00918272714620966,-0.0118715743429289,0.024124716070213,0.504664556549596
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEBP1,Heme-binding protein 1,38832,0.00325788643669036,0.0048859646506922,-0.00631860427866636,0.0128343771520471,0.504919946957236
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36363,-0.00353290096816304,0.00530869320095928,-0.0139379396420432,0.00687213770571714,0.505747157799861
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPB2,Coatomer subunit beta',36391,-0.00260405837918712,0.00391368791774778,-0.0102748866979728,0.00506676993959854,0.505824831845566
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",36538,0.00426553277320513,0.00641971735848971,-0.00831711324943469,0.016848178795845,0.506419251207127
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",36391,0.00391376995644752,0.00589070739344117,-0.00763201653469717,0.0154595564475922,0.506448299834401
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO6,Unconventional myosin-VI,36767,0.00233346077872803,0.00351796622724754,-0.00456175302667715,0.00922867458413321,0.507151414698484
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",36747,-0.00362071241070907,0.00547074454246006,-0.0143433717139308,0.00710194689251264,0.508090892172721
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRAS,Ras-related protein R-Ras,36421,-0.0080231822921106,0.0121250335349223,-0.0317882480205583,0.0157418834363371,0.50817312623037
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD2,Glutamate decarboxylase 2,36430,0.0027985518553523,0.00423349433264929,-0.00549909703664031,0.0110962007473449,0.508592299586373
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39006,-0.00171619399589567,0.002599219519212,-0.00681066425355119,0.00337827626175984,0.509088811383678
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,36767,-0.00455175594204026,0.00692441116586162,-0.018123601827129,0.00902008994304852,0.510968147892463
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST6,Cystatin-M,38773,-0.00281897055405944,0.0042888117679375,-0.0112250416192169,0.00558710051109806,0.511007986604546
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAGLN3,Transgelin-3,36339,0.00361525842396301,0.00550350059448145,-0.00717160274122063,0.0144021195891466,0.511256294298201
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,36743,0.00525672425531261,0.00806954071914161,-0.0105595755542049,0.0210730240648302,0.514781901797645
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,36767,0.00459120667915751,0.00705913998373125,-0.00924470768895574,0.0184271210472708,0.515450756610798
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,39234,-0.00125129055856789,0.00192618651794696,-0.00502661613374392,0.00252403501660815,0.515946989353729
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,36391,-0.0041322444749105,0.00636646664224418,-0.0166105190937091,0.00834603014388809,0.516308887769654
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",36792,-0.00438297939885112,0.00677021329003814,-0.0176525974473259,0.00888663864962364,0.51739000506579
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR3,Folate receptor gamma,39093,0.0111733724441833,0.0172786289236362,-0.0226927402461436,0.0450394851345102,0.517862723652337
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",36430,-0.00353134613753941,0.00546544624823757,-0.014243620784085,0.00718092850900622,0.518212016628442
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK1,Docking protein 1,36747,-0.00807315096589992,0.012517616682319,-0.0326076796632451,0.0164613777314453,0.518975516828777
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN9,Septin-9,39023,0.00166466193670563,0.00258202827577259,-0.00339611348380865,0.00672543735721991,0.519124263731147
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD8,Frizzled-8,36363,-0.00251649552337685,0.00390425159949999,-0.0101688286583968,0.00513583761164313,0.519228984631465
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGLL,Monoglyceride lipase,39140,0.0051254407168102,0.00797715923247454,-0.0105097913788399,0.0207606728124603,0.520548798077155
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP1,Caspase-1,38741,0.00388414296168555,0.00610197107277649,-0.00807572034095638,0.0158440062643275,0.524434918095374
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,36421,-0.0035642430715251,0.00562539766082058,-0.0145900224867334,0.00746153634368324,0.526354468343976
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,39023,0.00376387844207453,0.00594972615515247,-0.00789758482202431,0.0154253417061734,0.52699545956573
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCOR1,REST corepressor 1,38832,-0.00260562219802567,0.00412077037024913,-0.010682332123714,0.00547108772766262,0.52719115051231
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,39023,0.00488109076611096,0.00772185306197864,-0.0102537412353672,0.0200159227675891,0.527321973996283
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GL3,Endophilin-A3,36456,0.00478453161155425,0.00758146309175206,-0.0100751360482798,0.0196441992713883,0.52799778102649
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,39165,-0.00157472978698506,0.00249783036653647,-0.00647047730539654,0.00332101773142643,0.528416785524684
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1S,Complement C1s subcomponent,36806,0.00120167905902377,0.00190829683872493,-0.0025385827448771,0.00494194086292463,0.528893580381416
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,38832,-0.00176160990667096,0.00280012635009888,-0.00724985755286477,0.00372663773952285,0.529281401462993
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP10,Bone morphogenetic protein 10,36500,-0.00162182642229934,0.00257794535614929,-0.00667459932035195,0.00343094647575328,0.529284548687828
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,36538,-0.00258636905002489,0.00412416222167001,-0.0106697270044981,0.00549698890444834,0.530587987394575
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP9,Fatty acid-binding protein 9,39099,0.00316433630404621,0.00506211235280201,-0.00675740390744573,0.0130860765155382,0.531913507894647
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD3,Extracellular superoxide dismutase,36796,-0.00344070701833502,0.00555633216643292,-0.0143311180645435,0.00744970402787351,0.535768708739666
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,39092,0.00285505863260661,0.00461402364110991,-0.00618842770396881,0.011898544969182,0.536071540350801
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",36391,-0.00218220174026205,0.00354386681575199,-0.00912818069913594,0.00476377721861185,0.538058469037499
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,36796,-0.00122684600028788,0.00199361882192345,-0.00513433889125784,0.00268064689068208,0.53831036652072
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,38741,-0.00359341593035562,0.00585808541574789,-0.0150752633452215,0.00788843148451024,0.53961377584629
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,36391,-0.00375052228480672,0.00612267217900245,-0.0157509597556515,0.00824991518603809,0.540176461671805
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASC3,Protein CASC3,36421,-0.0023724098184416,0.00387317402756343,-0.00996383091246592,0.00521901127558272,0.540202593092295
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC1,Sialoadhesin,39162,0.00233326864692177,0.00381028635310498,-0.00513489260516399,0.00980142989900754,0.540308405329504
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD69,Early activation antigen CD69,39024,0.00490812991245025,0.00801928838254764,-0.0108096753173431,0.0206259351422436,0.540520085807727
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,36743,0.00119064263547456,0.00195011300916535,-0.00263157886248952,0.00501286413343864,0.541507916581029
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,39099,0.00228118861882563,0.00374544260595609,-0.0050598788888483,0.00962225612649956,0.542495634343667
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD63,CD63 antigen,38960,-0.0028487560520732,0.00469143715460296,-0.012043972875095,0.0063464607709486,0.543710998998538
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHDC3L,KH domain-containing protein 3,36339,0.00371243683233523,0.00612088913979891,-0.00828450588167063,0.0157093795463411,0.544181064667197
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,36339,0.00280392287960558,0.00463178832248768,-0.00627438223247028,0.0118822279916814,0.544947460839363
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL17,C-C motif chemokine 17,39069,-0.0049853474184882,0.00825009764318566,-0.0211555387991321,0.0111848439621557,0.54566825377281
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,39106,0.00147704724089443,0.00244578052902991,-0.0033166825960042,0.00627077707779306,0.545908137186419
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",36420,0.0025290960644178,0.00419490157218029,-0.00569291101705557,0.0107511031458912,0.546587702259275
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASQ2,Calsequestrin-2,36391,-0.00269447340038542,0.00447573521246334,-0.0114669144168136,0.00607796761604273,0.547173012288866
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARTN,Artemin,38841,0.00245643334956666,0.00409193419453865,-0.00556375767172909,0.0104766243708624,0.548308030446042
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS6,Growth arrest-specific protein 6,39184,-0.00139470666697218,0.00232649703444017,-0.00595464085447492,0.00316522752053055,0.548856483968494
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,36391,-0.00535790578984835,0.00899930671736775,-0.0229965469558892,0.0122807353761924,0.551607776099761
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,36767,-0.00456243244706221,0.00772727655708552,-0.0197078944989498,0.0105830296048254,0.554911304514475
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,36430,0.00168544287178039,0.00286479230630663,-0.00392955004858061,0.00730043579214138,0.556321473468538
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHD3,EH domain-containing protein 3,36420,0.0062803493827873,0.0106958583066504,-0.0146835328982474,0.027244231663822,0.557096183907475
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,36538,0.00205061426725501,0.00349311603786307,-0.00479589316695661,0.00889712170146663,0.557184329771568
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PER3,Period circadian protein homolog 3,36430,-0.00632625670970182,0.0107811121578849,-0.0274572365391562,0.0148047231197526,0.55735479910666
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GJA8,Gap junction alpha-8 protein,36339,0.0032007621161499,0.0054864714814875,-0.0075527219875656,0.0139542462198654,0.559640163525361
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,39162,-0.00564695816297442,0.00971664841210567,-0.0246915890507015,0.0133976727247527,0.561139049098958
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39197,0.00182583130726312,0.00314304501734579,-0.00433453692673463,0.00798619954126086,0.561308570317854
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTH3,Cytohesin-3,36339,-0.00383637570881319,0.00663396204878453,-0.0168389413244309,0.00916618990680449,0.563076562498317
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RA,Interleukin-17 receptor A,39093,-0.00231379372098517,0.00401347837611473,-0.01018021133817,0.00555262389619971,0.564281842016789
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSP90B1,Endoplasmin,38667,0.00351346036632207,0.00613935729617714,-0.00851967993418512,0.0155466006668293,0.5671377887677
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,36430,-0.00477439295119994,0.00834789610738186,-0.0211362693216684,0.0115874834192685,0.567381189861488
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL33,Interleukin-33,38841,0.00204167566337161,0.0035792210146118,-0.00497359752526753,0.00905694885201074,0.568398313434786
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARK7,Parkinson disease protein 7,39093,-0.00273151125110177,0.00479112902301498,-0.0121221241362111,0.0066591016340076,0.5686057423001
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBNL,Drebrin-like protein,39162,-0.00482048240827093,0.00849196138957259,-0.0214647267318332,0.0118237619152913,0.570279335412541
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,38727,-0.00184526996575482,0.00325494687670455,-0.00822496584409573,0.00453442591258609,0.570782211908713
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2,Interleukin-2,38841,-0.00160527821334934,0.00283548522426692,-0.00716282925291251,0.00395227282621383,0.571307906642278
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,36391,-0.0026224106661671,0.00463399564701856,-0.0117050421343235,0.00646022080198927,0.571467122591945
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRN1,Neuritin,36767,-0.00180848351954347,0.0032159882979159,-0.00811182058345864,0.0044948535443717,0.573893168989729
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36363,0.00240308290187561,0.00427565937113554,-0.00597720946555005,0.0107833752693013,0.574100226364727
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD9,COMM domain-containing protein 9,36731,-0.00201889812081374,0.00359331179066524,-0.00906178923051761,0.00502399298889012,0.574228784781942
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,38294,-0.00182953955380744,0.00327113816709963,-0.00824097036132271,0.00458189125370784,0.575967346730523
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,36430,0.00456545239391097,0.00816910979578769,-0.0114460028058329,0.0205769075936548,0.576261904288903
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTDH,Protein LYRIC,36430,-0.00473590152645823,0.00847914824061727,-0.0213550320780681,0.0118832290251516,0.576489022927103
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,36430,-0.00411161480493701,0.00736329248771978,-0.0185436680808678,0.0103204384709938,0.576585643135083
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",36430,-0.00141378869213569,0.00254261586336291,-0.00639731578432699,0.00356973840005562,0.578195405756655
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THTPA,Thiamine-triphosphatase,36708,0.00446025199622928,0.00806150692880067,-0.01134030158422,0.0202608055766786,0.580082896992256
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,39291,-0.00182935102751989,0.0033129866728777,-0.00832280490636019,0.00466410285132041,0.580835917927097
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,36792,-0.00147374534948254,0.00266958308304425,-0.00670612819224926,0.00375863749328418,0.580923121510127
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB37,Ras-related protein Rab-37,38841,-0.00420695995585422,0.00762421950736587,-0.0191504301902913,0.0107365102785829,0.581101200219502
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT1,Angiopoietin-1,39031,-0.00425539346302272,0.00771844450356171,-0.0193835446900037,0.0108727577639582,0.581417065483482
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",36421,0.00425762738623985,0.00773349039049964,-0.0109000137791394,0.0194152685516192,0.581956039073322
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36066,0.00245153495720616,0.00445335785934113,-0.00627704644710246,0.0111801163615148,0.581992485780019
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,39099,-0.00423428667632964,0.00770669236157862,-0.0193394037050237,0.0108708303523644,0.582718558260567
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,36747,0.0050021221086253,0.00914576606705051,-0.0129235793827937,0.0229278236000443,0.584434170411012
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIF,Macrophage migration inhibitory factor,39064,-0.00339783998316377,0.0062157969513528,-0.0155808020078153,0.00878512204148771,0.584630043407906
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",36791,0.00308720424888424,0.00565450959174784,-0.00799563455094153,0.01417004304871,0.585094561889761
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,36538,0.00431722926900701,0.00790754769294693,-0.011181564209169,0.019816022747183,0.58510090716992
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRING1,SREBP regulating gene protein,36339,0.00298552242992029,0.00547804435508674,-0.00775144450604973,0.0137224893658903,0.585764731581325
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",36430,0.00247432818423613,0.00454226671406151,-0.00642851457532442,0.0113771709437967,0.585945979017772
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,36500,-0.0016299188093185,0.00299290548987544,-0.00749601356947437,0.00423617595083736,0.586042289067827
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,39147,0.00276108676986978,0.00507447300522374,-0.00718488032036875,0.0127070538601083,0.586371645350026
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,36430,0.00111967859915253,0.00206799897641717,-0.00293359939462512,0.00517295659293017,0.588220192023601
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,36421,0.0049613613207837,0.00917538997495032,-0.0130224030301189,0.0229451256716863,0.588706839170857
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,38727,-0.00233915511588596,0.00432698051342967,-0.0108200369222081,0.00614172669043619,0.588793097364683
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,36339,-0.0014650332074754,0.00271211205755385,-0.00678077284028094,0.00385070642533015,0.589081395460909
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP73,Tumor protein p73,36421,-0.0017120575875398,0.00317430586432025,-0.00793369708160749,0.00450958190652788,0.589655864439304
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAG1,Dystroglycan,39162,0.0023895534486793,0.00444083890861314,-0.00631449081220246,0.0110935977095611,0.59052547164865
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGF,Beta-nerve growth factor,38987,0.000604345354054103,0.00112404688094113,-0.00159878653259051,0.00280747724069871,0.590825662151544
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,38741,-0.00229656106628966,0.00429840236037137,-0.0107214296926176,0.00612830756003823,0.593154094371168
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCIN,Adseverin,36363,-0.00360403962782087,0.00679728295818337,-0.0169267142258603,0.00971863497021854,0.595970427326565
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,36538,0.00330436591533427,0.00623592461747739,-0.00891804633492142,0.01552677816559,0.596196164975825
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10,Interleukin-10,38841,0.00378621194092196,0.00716887952175567,-0.0102647919217192,0.0178372158035631,0.597406129008044
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP5,Fatty acid-binding protein 5,39208,-0.00327894353785763,0.00622408157851913,-0.0154781434317551,0.00892025635603985,0.598329232457347
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,36731,-0.00402970315754182,0.0076595856666834,-0.0190424910642413,0.0109830847491576,0.598828234161797
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORN4,MORN repeat-containing protein 4,36339,-0.00383182296598353,0.00734429961946507,-0.0182266502201351,0.010563004288168,0.60185986365135
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAP,Prosaposin,36705,0.00133507149677727,0.00255996427396688,-0.00368245848019782,0.00635260147375236,0.602013859801867
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPT,Microtubule-associated protein tau,38741,-0.00250909890062926,0.00481685003289705,-0.0119501249651075,0.00693192716384897,0.602443937532041
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRY2,Protein sprouty homolog 2,38841,0.00440164199356849,0.00848446376517154,-0.0122279069861677,0.0210311909733047,0.603915920590849
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCC,Netrin receptor DCC,36421,-0.00107670635204318,0.00207910989692477,-0.00515176175001572,0.00299834904592937,0.604558863640816
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,39147,0.00160077677855949,0.0030983764191629,-0.0044720410029998,0.00767359456011878,0.605407843629317
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39121,0.00110262216551696,0.00213730032709546,-0.00308648647559014,0.00529173080662406,0.605935346668212
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",36421,-0.00361502357024022,0.00702144297578996,-0.0173770518027885,0.0101470046623081,0.606663552306028
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD72,B-cell differentiation antigen CD72,36500,0.00194771986304891,0.00378428935442574,-0.00546948727162554,0.00936492699772335,0.606781621186843
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD177,CD177 antigen,39080,-0.00585845053393253,0.0114038147642632,-0.0282099274718883,0.0164930264040233,0.607450146667504
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL11,Interleukin-11,38841,-0.00291595945443883,0.0056994893519553,-0.0140869585842712,0.00825503967539355,0.60892615808354
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,36391,0.00467894400549707,0.00914684197177315,-0.0132488662591783,0.0226067542701725,0.608984413840105
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL1,Growth-regulated alpha protein,39075,0.00442462870675804,0.00865133173813632,-0.0125319814999891,0.0213812389135052,0.609051093215879
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YY1,Transcriptional repressor protein YY1,36430,0.00128837385716854,0.00252853970619235,-0.00366756396696848,0.00624431168130555,0.610387774835398
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLNK,B-cell linker protein,36430,-0.00182730845990481,0.00359075466752774,-0.00886518760825917,0.00521057068844955,0.610836442841429
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171A2,Protein FAM171A2,36767,0.00728758468142992,0.0143740850503447,-0.0208856220172457,0.0354607913801055,0.612167211233297
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,36731,0.0027674135890711,0.00546443968905815,-0.00794288820148288,0.0134777153796251,0.612556121270452
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,39266,-0.00122541614258886,0.00242278174741885,-0.0059740683675298,0.00352323608235208,0.613012080191676
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF174,Zinc finger protein 174,36430,-0.00175597628416087,0.00347245424845218,-0.00856198661112713,0.0050500340428054,0.613084997583967
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,38727,-0.00336320432154138,0.00665224002304456,-0.0164015947667087,0.00967518612362595,0.613162734252989
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAPPA,Pappalysin-1,38841,-0.00218162863555037,0.00433166984684615,-0.0106717015353688,0.00630844426426808,0.614517494953394
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,38741,0.00178110505409799,0.00354161127903177,-0.00516045305280427,0.00872266316100025,0.615036317854208
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA6C,Semaphorin-6C,36430,-0.00118465506741957,0.00235723647705588,-0.0058048385624491,0.00343552842760996,0.615281775002833
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D23,TBC1 domain family member 23,39023,-0.00410707927480152,0.00822308170922317,-0.0202243194248789,0.0120101608752759,0.617464414637446
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,P4HB,Protein disulfide-isomerase,39016,-0.00177347295168381,0.00356357032726675,-0.00875807079312665,0.00521112488975903,0.61872567543501
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,36430,0.00274381284983893,0.0055177494251143,-0.00807097602338509,0.013558601723063,0.619007158307733
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL19,C-C motif chemokine 19,39241,0.00522787420986616,0.010526052272175,-0.0154031882435969,0.0258589366633292,0.619435591396828
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,36430,-0.00185813378719587,0.00375691858008851,-0.00922169420416935,0.00550542662977761,0.62089831396392
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL9,Interleukin-9,36538,0.00259058147887579,0.00524934602974722,-0.00769813673942876,0.0128792996971803,0.621663957161191
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,36339,0.00217770822213246,0.00441919190433224,-0.00648390791035873,0.0108393243546237,0.622173702219027
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5,Interleukin-5,38841,0.0064268438254423,0.0131129589817004,-0.0192745557786905,0.0321282434295751,0.624060460674746
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALCAM,CD166 antigen,39283,0.00086813880993901,0.00177219582235114,-0.00260536500186923,0.00434164262174725,0.62423555905142
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",36792,-0.00241437736565273,0.00493440773793411,-0.0120858165320036,0.00725706180069814,0.624641685319441
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,36500,0.00502756652176726,0.0103036842100644,-0.015167654529959,0.0252227875734935,0.625601708229991
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM25,RNA-binding protein 25,36339,-0.00203864270996621,0.00419456431750218,-0.0102599887722705,0.00618270335233806,0.626961425089971
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",38841,0.00538295730505177,0.0110942753683767,-0.0163618224169666,0.0271277370270701,0.627540624675716
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,39023,0.00115395629458257,0.00238743386032886,-0.003525414071662,0.00583332666082714,0.628857155288956
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PF4,Platelet factor 4,36743,-0.00422491880864552,0.00881147381711893,-0.0214954074901986,0.0130455698729076,0.631605869430413
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,39216,0.00175758589299875,0.00367525111809724,-0.00544590629847183,0.00896107808446934,0.632499022687252
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,36731,-0.00164953278594906,0.00345162865347637,-0.00841472494676275,0.00511565937486463,0.632729610297612
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36363,-0.00235413300826359,0.00494124985317941,-0.0120389827204952,0.00733071670396806,0.633780234436489
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39218,0.00122022737282733,0.00256784352395215,-0.0038127459341189,0.00625320067977355,0.634654479278164
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,36731,-0.00208932769809703,0.00440564503358483,-0.0107243919639233,0.00654573656772924,0.63533769157594
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNG,Uracil-DNA glycosylase,36731,0.00148927225018702,0.00314630458295764,-0.00467748473240996,0.007656029232784,0.635978556877512
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,36420,-0.00398617732487564,0.00842694603341564,-0.0205029915503703,0.012530636900619,0.636201770490529
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,36767,0.00367629816459263,0.00780589172366426,-0.0116232496137893,0.0189758459429746,0.63767402062469
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,38832,0.00136349727492596,0.00290986086625978,-0.00433983002294321,0.00706682457279513,0.639378007144733
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,36747,0.00230636402593377,0.0049308459474629,-0.00735809403109351,0.011970822082961,0.639976970844698
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL1,Interferon lambda-1,38741,0.00190490364414565,0.00407284118547284,-0.00607786507938112,0.00988767236767241,0.639999699645795
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,36538,0.00187305888394052,0.00400605182942052,-0.0059788027017237,0.00972492046960475,0.64010922376981
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX2,Sorting nexin-2,36731,0.00342056284597039,0.00733223521008845,-0.010950618165803,0.0177917438577437,0.640858211418867
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,39054,0.00108393219962196,0.00232414165094409,-0.00347138543622846,0.00563924983547238,0.640950513817521
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAG,Myelin-associated glycoprotein,36421,0.00196735821469835,0.00422325152363084,-0.0063102147716181,0.0102449312010148,0.641338324386691
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH7B,Myosin-7B,36339,0.00188277831094105,0.00404375141088488,-0.00604297445439332,0.00980853107627542,0.641508613360015
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,36430,-0.00380995307205019,0.00822234438989995,-0.0199257480762541,0.0123058419321537,0.643110220930336
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY2,Protein canopy homolog 2,38832,-0.00252452937704878,0.00547590958952017,-0.0132573121725083,0.00820825341841076,0.644787606968681
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIAPIN1,Anamorsin,39147,-0.00264741889844734,0.00576654987056196,-0.0139498566447488,0.00865501884785409,0.646169400705077
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP2,Caspase-2,39099,0.00285698574040915,0.00625328294358051,-0.00939944882900866,0.015113420309827,0.647765441173187
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,36339,0.00138300382760894,0.00302755284397931,-0.0045509997465905,0.00731700740180838,0.647818557017197
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOS,Proto-oncogene c-Fos,36311,0.00147815837795213,0.0032375110542367,-0.00486736328835181,0.00782368004425607,0.647986343955102
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,36731,-0.00253695738084551,0.00556224647178728,-0.0134389604655486,0.00836504570385756,0.648323598246721
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,39147,-0.00325377192708285,0.0071758156974329,-0.0173183706940513,0.0108108268398856,0.650241379089773
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCA,Tubulin-specific chaperone A,36500,-0.00357400232843252,0.0078866678508256,-0.0190318713160507,0.0118838666591857,0.65043401516101
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMOD4,Tropomodulin-4,36339,-0.00169423587053564,0.00373890553931579,-0.00902249072759458,0.0056340189865233,0.650458081960847
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,38832,-0.00137896472071767,0.00304938000489111,-0.00735574953030426,0.00459782008886891,0.651123172302102
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,36430,-0.00169868559295877,0.00375674662475923,-0.00906190897748686,0.00566453779156932,0.651154805821793
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",38741,-0.00224736686282992,0.00497446561673156,-0.0119973194716238,0.00750258574596393,0.651433659957774
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,39283,-0.00128843881816088,0.00285884415276202,-0.00689177335757444,0.00431489572125268,0.652222768643161
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF12,Fibroblast growth factor 12,36430,-0.00192182352232532,0.00426517293865897,-0.0102815624820969,0.00643791543744626,0.652296354103779
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,38922,0.00130970139779089,0.00291250578250865,-0.00439880993592607,0.00701821273150786,0.652946229918139
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICOSLG,ICOS ligand,39023,0.000772799582631047,0.00171870688031583,-0.00259586590278797,0.00414146506805007,0.652976375493895
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39099,-0.00134028516229875,0.00299332057639267,-0.00720719349202839,0.00452662316743088,0.654333757888653
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,39271,-0.00211577344271828,0.00476963761468503,-0.0114642631675009,0.00723271628206437,0.657343764516203
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF3,Neurotrophin-3,39099,-0.00136471972687135,0.00307707168457367,-0.00739578022863574,0.00466634077489305,0.65740138307316
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300C,CMRF35-like molecule 6,39241,0.00134685421171663,0.00303833960300753,-0.00460829141017812,0.00730199983361139,0.657564924580659
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK10,Kallikrein-10,39092,-0.00159001540311632,0.00359541691027906,-0.00863703254726328,0.00545700174103063,0.658326203808008
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,39028,0.00180255675940863,0.00410345532514935,-0.00624021567788409,0.00984532919670136,0.660466527730913
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,39106,0.00514758576495131,0.011722144854619,-0.017827818150102,0.0281229896800046,0.66057107526731
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEC31A,Protein transport protein Sec31A,36420,-0.00307884462712564,0.0070124990218821,-0.0168233427100146,0.0106656534557633,0.660632143715865
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,36430,0.00182256746528218,0.00416372909675663,-0.00633834156436082,0.00998347649492518,0.661593314039612
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,36538,0.00207761912782986,0.00475732519031969,-0.00724673824519674,0.0114019765008565,0.662321849604086
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFAP1,Actin filament-associated protein 1,36500,0.00338418465107079,0.00775568569956179,-0.0118169593200703,0.0185853286222119,0.662591086135014
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYZL2,Lysozyme-like protein 2,36339,0.00144058533643992,0.00331418518454067,-0.0050552176252598,0.00793638829813964,0.663807639473394
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDC,Nuclear migration protein nudC,39291,-0.00254394613449067,0.00585812563967494,-0.0140258723882535,0.00893798011927221,0.664106153395864
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL8,C-C motif chemokine 8,39229,0.00238825179784239,0.00550545409185127,-0.00840243822218609,0.0131789418178709,0.664441641945104
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,36421,-0.00139900584563378,0.00323397813732414,-0.00773760299478909,0.00493959130352153,0.665315758733136
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,36391,0.00133065442704623,0.00308867406844248,-0.00472314674710103,0.00738445560119349,0.666608581373073
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39095,0.00146385570121385,0.00340939266625431,-0.0052185539246446,0.0081462653270723,0.667667572250295
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,36421,0.00184803629931251,0.00430908477691836,-0.00659776986344748,0.0102938424620725,0.6680253382844
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL25,Interleukin-25,36286,0.00134586330969605,0.00314383830355905,-0.0048160597652797,0.0075077863846718,0.668588947662271
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,36743,0.00355475255056434,0.00831033422894268,-0.0127335025381633,0.019843007639292,0.668839672092061
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,39050,-0.00348745745191245,0.00817288466908937,-0.0195063114033276,0.0125313964995027,0.669596093246303
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,36767,0.00107996992189522,0.00253674156260243,-0.00389204354080554,0.00605198338459598,0.67031085415023
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C3,Complement C3,36195,0.00175848195667905,0.00420826151609949,-0.00648971061487595,0.010006674528234,0.676053660447628
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL4,Early placenta insulin-like peptide,36731,-0.00202599621026766,0.00485600882461469,-0.0115437735065125,0.00749178108597713,0.676528641896348
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR2,Toll-like receptor 2,36538,-0.000864164462755684,0.00207969667060105,-0.00494036993713374,0.00321204101162238,0.677765176681313
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAM,Basal cell adhesion molecule,39093,0.000881096842721461,0.00215718409666669,-0.00334698398674525,0.00510917767218817,0.682950774767232
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,38841,-0.00216902800587717,0.00531929824318471,-0.0125948525625192,0.00825679655076487,0.683451437053369
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",39095,-0.00347945978683675,0.00855203750202873,-0.0202414532908131,0.0132825337171396,0.684118437366971
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENG,Endoglin,39283,-0.000627151110558252,0.00154481603969226,-0.00365499054835508,0.00240068832723858,0.684769256236432
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,39162,0.00243845714568635,0.00603787640466367,-0.00939578060745444,0.0142726948988271,0.686321269300379
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,36414,-0.00220531587433128,0.00547246035434218,-0.012931338168842,0.00852070642017939,0.686966600435971
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDSN,Corneodesmosin,39227,-0.00154369108652271,0.00384464473132535,-0.00907919475992039,0.00599181258687497,0.688044941729445
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F3,Tissue factor,39160,0.000989791457490009,0.0024682599402964,-0.00384799802549093,0.00582758094047095,0.688419990330025
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,38823,0.00123700288392793,0.00309213890034847,-0.00482358936075507,0.00729759512861093,0.689127135631336
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,36421,0.00183457546349679,0.00459340818711194,-0.00716850458324261,0.0108376555102362,0.689610379154628
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,36731,-0.00245121421532314,0.00614709089432258,-0.0144995123681954,0.00959708393754911,0.690076638075621
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,36363,0.00352253085334567,0.00884140619067953,-0.0138066252803862,0.0208516869870775,0.690332605885491
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,36731,0.00103018576829316,0.0025860854574088,-0.00403854172822809,0.0060989132648144,0.690373507988149
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,36743,-0.000903293973256504,0.0022850671599719,-0.00538202560680142,0.00357543766028841,0.692625808196791
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,38841,0.00237128632212067,0.00601692829888055,-0.00942189314368522,0.0141644657879265,0.693510994744573
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,36420,0.00325064494171184,0.00836088203696042,-0.0131366838507306,0.0196379737341543,0.697436530689792
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,36767,0.000908159362654203,0.00233714983069965,-0.00367265430551711,0.00548897303082552,0.697596539814365
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL22,C-C motif chemokine 22,38925,-0.00178234551288519,0.00460139296705365,-0.0108010757283103,0.00723638470253996,0.698503238233617
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,36421,-0.00193294069545866,0.00500267865817241,-0.0117381908654766,0.00787230947455926,0.699220958495659
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRADD,Death domain-containing protein CRADD,38951,0.00268031810373016,0.00695734629836629,-0.0109560806410678,0.0163167168485281,0.700057584641684
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARD3,Partitioning defective 3 homolog,36538,-0.00260986526926538,0.00677512531268513,-0.0158891108821282,0.0106693803435975,0.700086192775132
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,36792,-0.00257617448299,0.00668851400608424,-0.0156856619349151,0.0105333129689351,0.700122284119666
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TWF2,Twinfilin-2,36791,-0.00297308228219864,0.00773178581965677,-0.0181273824887259,0.0121812179243286,0.700594031729885
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31,Interleukin-31,36430,0.00201557373988288,0.00524497233755689,-0.00826457204172863,0.0122957195214944,0.700772376180611
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,36391,-0.0023685606842554,0.00621721079859826,-0.014554293849508,0.00981717248099718,0.703233174832525
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,39161,0.00279270054862811,0.00734652064557794,-0.0116064799167047,0.0171918810139609,0.703847358213486
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN4,Prefoldin subunit 4,36339,-0.00188446674530772,0.00495879562942183,-0.0116037061789745,0.00783477268835906,0.70393325968601
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,38727,0.00109127871908705,0.00287396093422947,-0.00454168471200271,0.00672424215017681,0.704164308433247
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,38741,-0.0048853919432004,0.0129461349813987,-0.0302598165067419,0.0204890326203411,0.705909263463303
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,39023,0.00133684745343541,0.00354568525189793,-0.00561269564028452,0.00828639054715535,0.706152868055133
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO6,Coronin-6,36363,-0.00131393565751322,0.00348504975898619,-0.00814463318512616,0.00551676187009971,0.706164671921167
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,39226,0.000871751631123696,0.00232137357831783,-0.00367814058237924,0.00542164384462664,0.707269533547206
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,39260,0.00121402022239196,0.00325159168830058,-0.00515909948667717,0.00758713993146109,0.708884303442981
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN2,CCN family member 2,39114,-0.001996323092669,0.00535385336519788,-0.0124898756884568,0.00849722950311884,0.7092459625718
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,36401,-0.00124287241747472,0.00333847111343936,-0.00778627579981587,0.00530053096486642,0.709684793390145
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX2,Neuronal pentraxin-2,36791,0.00114415760612714,0.00307610698689926,-0.0048850120881954,0.00717332730044968,0.709936265540653
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN1,Prorelaxin H1,36767,-0.00270877539729907,0.00732130074293891,-0.0170585248534593,0.0116409740588612,0.711399336251046
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,39093,-0.00112305520925275,0.00303872221816971,-0.00707895075686539,0.00483284033835989,0.711699549987221
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,38992,0.000776370228482316,0.00210277791301429,-0.00334507448102569,0.00489781493799032,0.71197509441389
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,39283,0.00235452947957583,0.00638215450343096,-0.0101544933471489,0.0148635523063005,0.712189495050783
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,36363,0.00135099191385982,0.0036636877196168,-0.00582983601658911,0.00853181984430875,0.712318882054788
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39106,-0.00164573705551287,0.00446389120076963,-0.0103949638090213,0.00710348969799559,0.712373105902328
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,39093,-0.000893364008591807,0.0024232359358931,-0.00564290644294229,0.00385617842575868,0.712382030285839
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPN1,Epsin-1,36538,0.00145373270090786,0.00395246393199272,-0.00629309660579786,0.00920056200761358,0.713025402290023
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3,Galectin-3,39139,0.000988735752185725,0.00268832770777857,-0.00428038655506028,0.00625785805943172,0.713036112086598
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,36430,-0.00129473402556771,0.00352951870483117,-0.0082125906870368,0.00562312263590138,0.713751859644528
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,36731,0.00174154241612021,0.00478075598030097,-0.00762873930526968,0.0111118241375101,0.715653569726808
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBH,Dopamine beta-hydroxylase,36782,-0.00361589814394155,0.00995044451238399,-0.0231187693882142,0.0158869731003311,0.716319056425103
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6,Seizure protein 6 homolog,36421,0.00103291482932973,0.00284446231663988,-0.00454223131128443,0.00660806096994389,0.716512512740439
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,36767,0.00225570881268517,0.00624528561292632,-0.00998505098865042,0.0144964686140208,0.717966428464444
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHISA5,Protein shisa-5,36791,0.000751473014112508,0.00208281799408614,-0.00333085025429633,0.00483379628252134,0.718257626793947
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,36421,0.00135153512354624,0.00374850438388268,-0.00599553346886382,0.0086986037159563,0.718439568216005
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,36339,0.00209665108243205,0.00582457422644256,-0.00931951440139537,0.0135128165662595,0.7188783436188
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,39241,-0.000879698926647408,0.00244533037821457,-0.00567254646794797,0.00391314861465315,0.71904169006882
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,36538,-0.00219948490869342,0.00611598230762774,-0.0141868102316438,0.00978784041425695,0.719130546030806
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,39140,-0.00169736596949491,0.00476424624133889,-0.0110352886025191,0.00764055666352932,0.721642041448989
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39099,0.0031259232308501,0.00879338895655713,-0.0141091191240019,0.0203609655857021,0.722230744164622
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",36747,-0.00317895155390814,0.00895111472752436,-0.0207231364198559,0.0143652333120396,0.722486115686913
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,36767,-0.000961040098847367,0.00271267293923129,-0.0062778790597407,0.00435579886204597,0.723136408492182
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,38832,-0.00127989360828671,0.00361728407889095,-0.00836977040291297,0.00580998318633954,0.723473347080175
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH23,Cadherin-23,36747,-0.000863109751190502,0.00245127961630306,-0.00566761779914451,0.0039413982967635,0.7247646821579
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,36430,-0.0024569495422567,0.00698213027804444,-0.0161419248872238,0.0112280258027104,0.724925828652181
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",36510,0.00206283094851426,0.00589123840890131,-0.00948399633293231,0.0136096582299608,0.726230197813553
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY75,Lymphocyte antigen 75,39099,-0.00123416582875236,0.00352852839792397,-0.00815008148868334,0.00568174983117861,0.726517754331102
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL24,Interleukin-24,38841,0.00150835662767363,0.0043129213241385,-0.00694496916763782,0.00996168242298508,0.726546487530107
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,36538,0.00146176927809106,0.00418832497575338,-0.00674734767438557,0.00967088623056769,0.727087243586859
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPGN,Epigen,36731,0.00157506205929136,0.00451697036135849,-0.00727819984897128,0.010428323967554,0.727321162982753
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,36355,0.00109246220408232,0.00314536030500991,-0.00507244399373711,0.00725736840190175,0.728353036264928
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,39023,0.000709522996682273,0.00204670736820021,-0.00330202344499014,0.00472106943835468,0.728847382228573
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,38727,0.00147679169551863,0.00427163958420467,-0.00689562188952252,0.00984920528055978,0.729557963224787
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB2,Lamin-B2,36747,-0.0008645817249785,0.00250365621613561,-0.0057717479086043,0.0040425844586473,0.729853696020608
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,36339,0.00116973555405043,0.00339288387542378,-0.00548031684178017,0.00781978794988103,0.730279528991625
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,36363,-0.00313881431285678,0.00913410105939563,-0.0210416523892722,0.0147640237635587,0.731125137264808
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLLT1,Protein ENL,36339,-0.00224596047316662,0.0065541508234401,-0.0150920960871092,0.010600175140776,0.731846810862127
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,36421,0.00166098088860443,0.00484938285568298,-0.0078438095085342,0.0111657712857431,0.731969938847719
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",36421,-0.00122769711544121,0.00359975295257545,-0.0082832129024891,0.00582781867160667,0.733071358711667
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI3,Elafin,38840,0.0016428467209234,0.00482028371238099,-0.00780490935534334,0.0110906027971901,0.733244243496457
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,36500,-0.00223301139852302,0.00659013261575023,-0.0151496713253935,0.0106836485283474,0.734734652942566
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,36538,0.00228326445415367,0.00675225317400185,-0.01095115176689,0.0155176806751973,0.735256863183699
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,36420,-0.00106780655977497,0.00315920591479095,-0.00725985015276524,0.0051242370332153,0.735370038877567
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,38741,-0.00161546110778846,0.00478336099640997,-0.010990848660752,0.00775992644517508,0.735575115854926
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,36791,0.00416941111833148,0.0123658770600766,-0.0200677079194186,0.0284065301560816,0.735993714358617
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,39283,-0.000959493658000057,0.00285380454596073,-0.0065529505680831,0.00463396325208298,0.736712850519508
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,36421,0.00240607872537932,0.00717866234573558,-0.0116640994722624,0.0164762569230211,0.737501768561829
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHH,Sonic hedgehog protein,36430,-0.00133784153832973,0.00399689492871476,-0.00917175559861067,0.00649607252195121,0.737841734130822
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VGF,Neurosecretory protein VGF,36767,0.000890177308811648,0.00266713150369901,-0.00433740043843841,0.0061177550560617,0.738567365402389
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,38741,0.0011698174921702,0.00350675338785473,-0.00570341914802507,0.00804305413236547,0.738693745198385
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39099,-0.003084615734311,0.00925735358716322,-0.0212290287651509,0.0150597972965289,0.738982560074074
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,36421,-0.00253253706494007,0.00761183902150244,-0.0174517415470848,0.0123866674172047,0.739358543954501
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,36339,0.000765461085484196,0.00234645360037277,-0.00383358797124644,0.00536451014221483,0.744263061116808
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,36538,-0.0015933963559727,0.00488663350159833,-0.0111711980191054,0.00798440530716002,0.74437495375196
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,39291,0.00108933700458647,0.00334413951355913,-0.00546517644198943,0.00764385045116237,0.744621648274571
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC1,Glypican-1,39255,0.000858475853170808,0.00265274935408033,-0.00434091288082664,0.00605786458716825,0.746232107616593
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",38832,-0.00127330430381684,0.00394197468868517,-0.00899957469363978,0.00645296608600609,0.746690823350999
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPS,Calcyphosin,36747,-0.002541695834047,0.00792535963962936,-0.0180754007277206,0.0129920090596266,0.748439791869263
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36339,-0.000765692335296955,0.0023978388672327,-0.00546545651507305,0.00393407184447915,0.749484650859832
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,36747,-0.00693092394428092,0.021806168319331,-0.0496710138501697,0.0358091659616079,0.750609668751676
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALB,Ras-related protein Ral-B,36430,-0.000840758273017222,0.00266091248900309,-0.00605614675146327,0.00437463020542882,0.752033447771994
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD7,FERM domain-containing protein 7,36421,-0.000962587427738376,0.0030734113875159,-0.00698647374726954,0.00506129889179279,0.7541351590672
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS1,Nephrin,36430,-0.000975730233425188,0.00312881626724917,-0.00710821011723356,0.00515674965038318,0.75515753807193
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,36792,0.000970676709962095,0.00311600906968665,-0.00513670106662373,0.00707805448654793,0.755415835218797
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHCY,Adenosylhomocysteinase,39106,0.0019282116843593,0.00620023150204087,-0.0102242420596408,0.0140806654283594,0.755812268321979
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF6,Fibroblast growth factor 6,36430,-0.00114901776879859,0.00372618898157022,-0.00845234817267623,0.00615431263507904,0.757811455787547
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD226,CD226 antigen,36430,-0.00118236519476523,0.0038399707198983,-0.00870870780576591,0.00634397741623544,0.75815595560937
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,36363,-0.0014833488364289,0.00483535804288216,-0.0109606506004779,0.00799395292762012,0.759022600693495
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,38741,0.00132246832913424,0.00431365158779613,-0.00713228878294617,0.00977722544121465,0.759169304767747
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,36538,-0.00205319837700733,0.0067240999693589,-0.0152324343169508,0.0111260375629361,0.76010523989397
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEB,Nebulin,36391,-0.00103765663770176,0.00341884735614265,-0.00773859745574136,0.00566328418033784,0.761505759211415
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,36743,0.000914700719377369,0.00301696054019104,-0.00499854193939707,0.00682794337815181,0.761752881508114
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX9,Transcription factor SOX-9,36421,-0.00075185951115688,0.00248029316319727,-0.00561323411102352,0.00410951508870976,0.761793279336996
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,38741,-0.00232272890509986,0.00768494169348776,-0.0173852146243359,0.0127397568141361,0.762470150955394
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSPN,Claspin,38705,0.000952581978077831,0.00315265693778689,-0.00522662561998447,0.00713178957614013,0.762540334763569
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDRG1,Protein NDRG1,38741,-0.00189964919134841,0.0063266542078336,-0.0142998914387023,0.0105005930560054,0.763982071635797
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,36421,-0.00140996849762352,0.00472708855695367,-0.0106750620692527,0.00785512507400566,0.765498837265535
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,39283,0.000948384079596473,0.003183844715036,-0.00529195156187409,0.00718871972106703,0.765803460260729
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP4,Guanylate-binding protein 4,38741,-0.00133468198783625,0.00448212058325753,-0.010119638331021,0.00745027435534852,0.765875897800637
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHC1,SHC-transforming protein 1,36339,0.00315262899681555,0.0105944477897319,-0.017612488671059,0.02391774666469,0.766033505785239
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,39099,0.00282106563276933,0.00954446010844798,-0.0158860761797887,0.0215282074453274,0.767561749135727
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSAP,Gamma-secretase-activating protein,38727,-0.00236587795874868,0.00800896180896409,-0.0180634431043183,0.0133316871868209,0.767689536398079
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA3,Annexin A3,39218,0.00187961785422255,0.00637330531781412,-0.0106120605686931,0.0143712962771382,0.768058662083814
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,38741,-0.00174328910428987,0.00591571633303591,-0.0133380931170403,0.00985151490846051,0.768236536694786
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,36792,0.00239757161533412,0.00813954783742739,-0.0135559421460236,0.0183510853766918,0.768336026523699
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,39023,-0.00145227904626267,0.00493134235371622,-0.0111177100595465,0.00821315196702113,0.768380092727811
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,38741,0.001299377825228,0.00441482834786862,-0.0073536857365945,0.00995244138705049,0.768516536716313
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL6,Fc receptor-like protein 6,39099,-0.00177235175160533,0.00604168550078961,-0.013614055333153,0.0100693518299423,0.769255685163239
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,39147,0.00224377020197685,0.00765514205969887,-0.0127603082350329,0.0172478486389866,0.76944489622025
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,39099,-0.0016181577160174,0.00552362922603248,-0.0124444709990411,0.00920815556700627,0.769562901006951
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA2,Integrin alpha-2,36500,-0.000894395140309362,0.003071410428554,-0.00691435958027521,0.00512556929965648,0.770903035218779
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI1,Neuroserpin,36466,-0.000816222462625488,0.00280780227783555,-0.00631951492718316,0.00468707000193219,0.771287095449748
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAP3,Cytosol aminopeptidase,38841,-0.00128119082151903,0.00442305962891533,-0.00995038769419307,0.00738800605115501,0.77207909420917
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,36743,-0.00125790190206927,0.0043427766433614,-0.00976974412305762,0.00725394031891907,0.772085739789625
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAP,Cartilage-associated protein,36421,0.00130339953238285,0.00451494580287044,-0.00754589424124322,0.0101526933060089,0.772826798797425
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HK2,Hexokinase-2,38832,-0.00071993792218015,0.00249403613470395,-0.0056082487461999,0.0041683729018396,0.772842671498285
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,36391,0.00176527315485875,0.00614169813836755,-0.0102724551963417,0.0138030015060592,0.773792226494714
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,36394,-0.00222175292940872,0.00781397115663612,-0.0175371363964155,0.0130936305375981,0.776161556294586
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,39023,-0.00146181964146449,0.00517554671889667,-0.011605891210502,0.00868225192757298,0.777604339822299
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,36731,0.00108613993496778,0.00384607368289853,-0.00645216448351334,0.0086244443534489,0.777639616181527
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLN,Mesothelin,39001,0.00135428255657342,0.00481675591146784,-0.00808655902990355,0.0107951241430504,0.77859097331713
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2,Microtubule-associated protein 2,36747,-0.00118427282549382,0.00422134339072538,-0.00945810587131557,0.00708956022032793,0.779064628203655
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,36375,-0.00214820740616454,0.00766055304785998,-0.0171628913799701,0.012866476567641,0.779156412734534
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,36421,0.00165680760750913,0.00592374115919539,-0.00995372506451383,0.0132673402795321,0.779720417093899
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,36430,0.00104157441232808,0.00372468836649914,-0.00625881478601024,0.0083419636106664,0.779757789551009
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,36391,-0.00132832843548824,0.00475906384215955,-0.010656093566121,0.00799943669514446,0.780160802307601
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,39023,-0.000531253911175467,0.00190715395564161,-0.00426927566423303,0.0032067678418821,0.780587476850751
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",38336,-0.000735833369133982,0.00264529965279341,-0.00592062068860907,0.0044489539503411,0.780888631644244
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A3,Protein S100-A3,36731,0.00112800486659335,0.0040815631226924,-0.00687185885388376,0.00912786858707046,0.782271482247057
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36363,-0.00139079251616712,0.00505098720866849,-0.0112907274451574,0.00850914241282312,0.783051419226082
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX5,Syntaxin-5,36430,-0.00101207659688605,0.0036775724796094,-0.00822011865692048,0.00619596546314837,0.783165303168551
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,36421,0.00090457824740471,0.00329337801617418,-0.00555044266429669,0.00735959915910611,0.783577539686331
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,38727,0.00121641229275242,0.00442966806554622,-0.00746573711571816,0.00989856170122301,0.783622968807075
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POMC,Pro-opiomelanocortin,36420,0.00177493453734815,0.00647342526700989,-0.0109129789859912,0.0144628480606875,0.783944776087714
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH3,Cadherin-3,39241,0.000864842694103564,0.00316619300306055,-0.00534089559189512,0.00707058098010225,0.784742290380996
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,36391,0.000987573698519755,0.00362553067199094,-0.00611846641858249,0.008093613815622,0.78532338358499
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCP11,T-complex protein 11 homolog,36538,0.00146910106267221,0.005425585200701,-0.00916504593070174,0.0121032480560462,0.786570165467209
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39093,0.00102812005830816,0.00380278628228724,-0.00642534105497483,0.00848158117159114,0.786887223660085
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,36767,0.000946927456892182,0.00354029830547254,-0.005992057221834,0.00788591213561836,0.789110741851313
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRELP,Prolargin,39095,0.000535466100328764,0.00202646573913292,-0.00343640674837175,0.00450733894902928,0.791601304797685
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",39093,0.00187461038213557,0.00710280202955357,-0.0120468815957894,0.0157961023600606,0.791840917275986
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,36743,-0.00140745301169842,0.00533803357561166,-0.0118699988198973,0.00905509279650044,0.792042228196511
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTN3,Myeloblastin,38677,0.00110840069330819,0.0042064997100108,-0.00713633873831297,0.00935314012492936,0.792171082526204
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,36339,0.00130943027371884,0.00497243731629929,-0.00843654686622777,0.0110554074136655,0.792294641744028
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,39055,-0.000478235035722227,0.00182088915312855,-0.00404717777585418,0.00309070770440973,0.79283302048181
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,36363,-0.00278558904269927,0.0106541478945104,-0.0236677189159396,0.018096540830541,0.79374531699392
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",36420,0.000616167760427345,0.00236353114668919,-0.00401635328708346,0.00524868880793815,0.79432970928909
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,36430,-0.00103402055187907,0.00396932803784639,-0.00881390350605799,0.00674586240229986,0.794480323134347
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRAXIN,Draxin,38987,-0.000984307980294211,0.00381473226865381,-0.00846118322685567,0.00649256726626725,0.79638875893926
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,36500,-0.00156786191638872,0.00610498540024334,-0.0135336333008657,0.0103979094680882,0.797324493919378
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1A,Interleukin-1 alpha,38841,0.00125353843370205,0.00490301275805215,-0.00835636657208017,0.0108634434394843,0.798211509013065
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,36726,-0.000862078929748766,0.00337308575166006,-0.00747332700300248,0.00574916914350494,0.798282528804818
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,36743,-0.00179290681387433,0.00701552034602355,-0.0155433266920805,0.0119575130643318,0.798292438814375
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,36430,-0.00150714226539367,0.00590529233524896,-0.0130815152424816,0.0100672307116943,0.798558203065873
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,36538,0.00136411472615692,0.00536106404221286,-0.00914357079658029,0.0118718002488941,0.799153209561574
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOB,Elongin-B,36391,-0.000908749993228782,0.00359177300529524,-0.00794862508360744,0.00613112509714988,0.80026560294814
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,36430,0.000740578647334304,0.00292868685357437,-0.00499964758567146,0.00648080488034006,0.800372384812099
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WNT9A,Protein Wnt-9a,38841,0.000647983621075544,0.00256641418072246,-0.00438218817314047,0.00567815541529156,0.800668906925004
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,36747,0.00111018374786864,0.00442116058123334,-0.00755529099134871,0.00977565848708598,0.801735496407169
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",36391,0.00145238065738486,0.00581043394872451,-0.00993606988211517,0.0128408311968849,0.802621769117546
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,38841,-0.000820104425034336,0.00328997671913733,-0.0072684587945435,0.00562824994447483,0.803152548636034
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,36500,0.000551798165621572,0.00223269499920045,-0.00382428403281132,0.00492788036405446,0.804800452368402
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,38841,0.00102610337109234,0.00416464740069646,-0.00713660553427272,0.0091888122764574,0.805388201727078
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13,Interleukin-13,38841,0.00109240682037423,0.00447818699779711,-0.0076848396953081,0.00986965333605656,0.807280995592818
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEG1,Protein LEG1 homolog,36102,-0.00154266304841962,0.0063743207108827,-0.0140363316417497,0.0109510055449105,0.808774803902106
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,37339,-0.000676327976477736,0.00281225014689359,-0.00618833826438918,0.00483568231143371,0.809951332751329
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF2,Fibroblast growth factor 2,39099,-0.00146580025599605,0.00609658255383098,-0.0134151020615048,0.0104835015495127,0.8100002959499
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,36339,0.000895651978418372,0.0037262164306117,-0.00640773222558055,0.00819903618241729,0.810051264273351
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,36743,-0.000560676858432187,0.00233498732674209,-0.00513725201884668,0.00401589830198231,0.81024114947128
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FST,Follistatin,39140,-0.00112514064056694,0.00469058605250372,-0.0103186893034742,0.00806840802234036,0.810432642301817
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPBP,Platelet basic protein,36729,0.00186613192452688,0.00778223990402001,-0.0133870582873523,0.0171193221364061,0.810494027864735
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,36339,0.00191830486314254,0.0080293923799042,-0.0138193042014697,0.0176559139277548,0.811179030805264
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX6,Syntaxin-6,38727,-0.00147750192651145,0.00620288642828176,-0.0136351593259437,0.0106801554729208,0.811732463280297
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LF,CMRF35-like molecule 1,39255,0.00128021983730925,0.00544678204193022,-0.00939547296487397,0.0119559126394925,0.814179646757704
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAFB2,Scaffold attachment factor B2,36767,-0.000584444529346145,0.00251324965406801,-0.00551041385131945,0.00434152479262716,0.816118152598018
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBZ,Hemoglobin subunit zeta,36792,-0.00223061203209303,0.00961211620880069,-0.0210703598013424,0.0166091357371563,0.816493117095836
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD9,Enhancer of filamentation 1,36430,0.000698569725057956,0.00304080080633443,-0.00526139985535753,0.00665853930547345,0.818303644252511
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOT,Angiomotin,36500,0.00086068368679696,0.00376303303794707,-0.0065148610675793,0.00823622844117322,0.819089676957815
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD3,Bromodomain-containing protein 3,36391,0.00096703440820701,0.00424798560327441,-0.00735901737421083,0.00929308619062485,0.819925631504814
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,39023,0.00151261097669007,0.00664957417923301,-0.0115205544146066,0.0145457763679868,0.820057580097139
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,36731,0.00128264093229126,0.00570711565139327,-0.00990330574443956,0.0124685876090221,0.822181873608561
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPT1,Translationally-controlled tumor protein,38841,0.00131382539650234,0.00595234896778692,-0.01035277858036,0.0129804293733647,0.825310465659397
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,38727,-0.00137866313859441,0.00625178092341233,-0.0136321537484826,0.0108748274712938,0.825466683896236
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,36421,0.000762877330819984,0.00346733378928919,-0.00603309689618684,0.00755885155782681,0.825860378046494
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,38727,0.00242012305236633,0.0110172190820298,-0.0191736263484121,0.0240138724531447,0.826133269257016
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN1,Neuroligin-1,36421,0.00135860802615134,0.00618747592190792,-0.0107688447807882,0.0134860608330909,0.826206612344752
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",36420,-0.00125962139150136,0.00576664721553744,-0.0125622499339547,0.010043007150952,0.827095934318807
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHB,Lutropin subunit beta,38727,0.0017504685392031,0.00805368820776967,-0.0140347603480255,0.0175356974264316,0.827938633928853
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,36391,0.000661988683469069,0.00304715186925386,-0.0053104289802685,0.00663440634720663,0.828018351676129
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,36792,0.000547945512272253,0.00252450459300238,-0.00440008349001241,0.00549597451455692,0.828172250561487
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,36743,0.00128502430210296,0.00594550823026565,-0.0103681718292177,0.0129382204334236,0.828887004691185
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB5,Integrin beta-5,39147,-0.000748479850640918,0.00348014947219295,-0.0075695728161391,0.00607261311485726,0.829714692795946
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,36391,0.00109803553872591,0.00515212622173214,-0.00900013185586909,0.0111962029333209,0.831234652455772
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",36767,0.0012635141970537,0.0059319432948122,-0.0103630946607782,0.0128901230548856,0.831328975559053
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD2,Leiomodin-2,36363,-0.00125519373376263,0.00589667235480553,-0.0128126715491815,0.0103022840816562,0.831435921775339
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP13,Collagenase 3,38741,0.00062037812314397,0.00292177920222823,-0.00510630911322337,0.00634706535951131,0.831853369527379
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN4,Contactin-4,39093,-0.000461964856139952,0.00217940617384492,-0.00473360095687599,0.00380967124459609,0.832134660470837
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36363,0.00140362690696018,0.00662560601190998,-0.0115825608763834,0.0143898146903037,0.832228422275862
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,39255,-0.000486624184335835,0.00230142259981101,-0.00499741247996541,0.00402416411129374,0.832542884119413
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36339,-0.000837348382252554,0.00397616629837398,-0.00863063432706556,0.00695593756256045,0.833209178332491
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD2,Bromodomain-containing protein 2,36363,0.000650362840098257,0.00311234262984298,-0.00544982871439398,0.0067505543945905,0.83448093137729
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,36538,-0.00131212737712435,0.00629178529273948,-0.0136440265508937,0.011019771796645,0.834805929971409
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,36792,-0.00171522007741085,0.00828208129659997,-0.0179480994187468,0.0145176592639251,0.835934924682653
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USO1,General vesicular transport factor p115,39023,-0.00167724243157399,0.00817670152427537,-0.0177035774191537,0.0143490925560057,0.837477549370539
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,38741,0.000999714728873075,0.0049043456783917,-0.00861280280077465,0.0106122322585208,0.838479264469232
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,38741,0.00128530546852891,0.00630643423966234,-0.0110753056412093,0.0136459165782671,0.83850586701044
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPE,Coatomer subunit epsilon,38741,0.00087993952693058,0.00432203491113737,-0.00759124889889866,0.00935112795275982,0.838673719580302
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,39023,-0.000613806005127271,0.00302120578494796,-0.00653536934362527,0.00530775733337073,0.83900808766276
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,38832,0.00110338461174183,0.00547644034824702,-0.00963043847082232,0.011837207694306,0.840327229877951
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBN1,Drebrin,36430,0.000959050711257691,0.00477854603370011,-0.00840689951479452,0.0103250009373099,0.840936975873399
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED8,Protein TMED8,36743,0.00189747716176259,0.00946086676732865,-0.0166458217022015,0.0204407760257267,0.841045330717147
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARC,SPARC,39147,-0.00126661124112735,0.00642210444535937,-0.0138539359540317,0.011320713471777,0.843652665110407
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYGD,Gamma-crystallin D,36747,0.00172695599375458,0.00878719124361907,-0.0154959388437388,0.018949850831248,0.844197624747034
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17D,Interleukin-17D,38841,0.000602938500939123,0.00307168408342531,-0.00541756230257448,0.00662343930445273,0.844386453765911
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBQLN3,Ubiquilin-3,36391,0.000843844805973089,0.00430920180026993,-0.00760219072255598,0.00928988033450216,0.844751159123719
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD244,Natural killer cell receptor 2B4,39291,-0.000473784037620509,0.00243061120964517,-0.00523778200852504,0.00429021393328402,0.845455147344941
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,39106,-0.00143118004349077,0.00738465888115879,-0.015905111450562,0.0130427513635805,0.846331553581961
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,36538,-0.000932744665681779,0.00483723951870461,-0.0104137341223428,0.00854824479097926,0.847098471974335
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39106,0.00146334572272193,0.00761389256573086,-0.0134598837061106,0.0163865751515544,0.847592676217991
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,36538,-0.00134649958542967,0.00702858260750548,-0.0151225214961404,0.0124295223252811,0.848078320500005
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,38727,0.00145858680261186,0.00776719490128589,-0.0137651152039085,0.0166822888091322,0.851045324431792
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,36538,0.00114417635373877,0.00626131342609266,-0.0111279979614028,0.0134163506688804,0.855006963509691
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",36339,-0.00154918855304575,0.00848366061436236,-0.018177163357196,0.0150787862511045,0.855108179530189
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABHD14B,Protein ABHD14B,38927,0.000952604423895185,0.00524529701209773,-0.00932817771981636,0.0112333865676067,0.855890340720391
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD48,CD48 antigen,39140,-0.000480777955729915,0.00264940337258843,-0.00567360856600324,0.00471205265454341,0.856003833085533
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,36363,0.000971386872093895,0.00536307619530573,-0.00954024247070533,0.0114830162148931,0.856272442280141
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,36538,-0.00130701266279592,0.00721676862691652,-0.0154518791715523,0.0128378538459605,0.856285903742992
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN2,Prorelaxin H2,36472,-0.0022843693906929,0.0127634115847259,-0.0273006560967556,0.0227319173153698,0.85795788117141
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CERT,Ceramide transfer protein,38741,-0.00100313854115693,0.00563986420042692,-0.0120572723739937,0.0100509952916798,0.858830849197179
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,36792,-0.00101053624112733,0.00569104029704225,-0.0121649752233301,0.0101439027410755,0.85906647403826
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN6,Prefoldin subunit 6,36421,0.0010392937802484,0.00605957606039886,-0.0108374752981334,0.0129160628586302,0.863823469134187
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D2,DCN1-like protein 2,36339,0.00123781937626415,0.00734008187956285,-0.013148741107679,0.0156243798602073,0.866083838219532
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE1,Ribonuclease pancreatic,36796,0.000339358667765927,0.00204437869410636,-0.00366762357268254,0.00434634090821439,0.868162699095176
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,39241,0.00103252438615717,0.00626899128789551,-0.011254698538118,0.0133197473104324,0.869179579148776
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,36731,0.000620841264805952,0.00378290465149335,-0.00679365185212102,0.00803533438173293,0.869641137127875
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,38727,-0.000600034786606286,0.00368680369396266,-0.00782617002677309,0.00662610045356052,0.870715890798068
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,36420,0.000400200028970205,0.0025259979083084,-0.00455075587131427,0.00535115592925467,0.874118594977484
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRV1,Acrosomal protein SP-10,36430,0.0010599796158763,0.0067041499576982,-0.0120801543012122,0.0142001135329648,0.874374251322323
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN6,Dynactin subunit 6,38741,0.00102496170242004,0.00648512732605703,-0.0116858878566517,0.0137358112614918,0.874421083656511
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK3,Prostate-specific antigen,36791,0.00113960556127409,0.00723092204399248,-0.0130330016449512,0.0153122127674993,0.874773129604168
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,38605,0.00121048557152837,0.00777051889375708,-0.0140197314602355,0.0164407026032922,0.876209162946099
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",36747,-0.000357021803237252,0.00230895687279237,-0.0048825772739103,0.0041685336674358,0.877119604358854
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYDGF,Myeloid-derived growth factor,36792,0.0014178912747418,0.00924600148635201,-0.0167042716385081,0.0195400541879917,0.878123219993424
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG4,Desmoglein-4,38960,0.00068194081668887,0.00448293481696072,-0.00810461142455414,0.00946849305793188,0.879094890252589
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,36538,0.000707062716540049,0.00467147472454466,-0.00844902774356748,0.00986315317664758,0.879696124654758
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF5,Fibroblast growth factor 5,38841,-0.000453940671186564,0.00301351143468558,-0.0063604230831703,0.00545254174079717,0.880265579964847
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,36421,-0.0010843653852465,0.00720367459028735,-0.0152035675822097,0.0130348368117167,0.880349311612201
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,36421,0.000728561858789341,0.00486031494678137,-0.00879765543690214,0.0102547791544808,0.880845813200308
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,36363,0.000667257007826564,0.00446004124039421,-0.00807442382334608,0.00940893783899921,0.881076458169613
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI16,Peptidase inhibitor 16,36796,0.000323559609828686,0.0021813696671061,-0.00395192493769927,0.00459904415735664,0.882085720850803
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,36339,0.00114547487145541,0.00793092719346717,-0.0143991424277402,0.0166900921706511,0.885162160105011
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDHB,Succinate dehydrogenase,36743,-0.000929082627045602,0.00644170460126613,-0.0135548236455272,0.011696658391436,0.885321650760264
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD302,CD302 antigen,39023,-0.000376146838986493,0.002640950007521,-0.00555240885372764,0.00480011517575466,0.88674335749735
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4,Interleukin-4,38841,-0.00117216395173491,0.00825980103358382,-0.0173613739775592,0.0150170460740894,0.887151513075675
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP7,Caspase-7,36747,0.0010790771906406,0.00770839979696831,-0.0140293864114173,0.0161875407926985,0.888672303034316
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,39099,0.000544258357719482,0.00398759413844555,-0.0072714261536338,0.00835994286907277,0.891437390864205
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN7,Tetraspanin-7,36363,0.00117801977812943,0.00865325958388458,-0.0157823690062844,0.0181384085625432,0.891715993946544
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",36391,-0.000499698649456715,0.00369961801236617,-0.00775094995369442,0.00675155265478099,0.892560569789121
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR5,Proline-rich protein 5,36430,-0.00058095000845973,0.00432210739580907,-0.00905228050424551,0.00789038048732605,0.89307768108484
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,36538,-0.000860388940628588,0.00650547696847155,-0.0136111237988328,0.0118903459175757,0.894783836949058
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,38832,-0.000732043537142787,0.00559294492736828,-0.0116942155947846,0.010230128520499,0.895866491969403
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BID,BH3-interacting domain death agonist,39099,-0.000774810151848643,0.00603669531848353,-0.0126067329760764,0.0110571126723791,0.897873651360276
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",36743,-0.00168482884512496,0.013466768931752,-0.0280796959513588,0.0247100382611089,0.900438337361874
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,39274,-0.000572241693096363,0.00458081563500261,-0.00955064033770148,0.00840615695150875,0.90058744152881
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANPEP,Aminopeptidase N,39128,-0.00031485962122833,0.00255463971788095,-0.005321953468275,0.00469223422581834,0.901910669827427
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53BP1,TP53-binding protein 1,36430,-0.000964065371212335,0.00801201839802604,-0.0166676214313434,0.0147394906889187,0.904225720014277
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFP,Alpha-fetoprotein,38939,-0.000733533664782704,0.00613349666534174,-0.0127551871288525,0.0112881197992871,0.904805815331903
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD7,T-cell antigen CD7,36414,0.000462754007699295,0.00389205170330393,-0.0071656673307764,0.00809117534617499,0.905358711025382
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,36421,-0.00040047886371917,0.00337140488806654,-0.00700843244432958,0.00620747471689124,0.905446056811835
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,36430,-0.00073303130369134,0.00619362061314651,-0.0128725277054585,0.0114064650980758,0.905790146889121
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,36500,0.000900829785129797,0.0078597152794276,-0.0145042121625483,0.0163058717328079,0.9087532681743
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPJ,Centromere protein J,36538,-0.000746479328669616,0.00659821247758418,-0.0136789757847346,0.0121860171273954,0.909926452636931
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,36391,-0.000632599176355607,0.00563071206493627,-0.0116687948236307,0.0104035964709195,0.910549292556993
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,36339,0.000541559928507884,0.00483384075219739,-0.008932767945799,0.0100158878028148,0.91079736210551
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,39283,0.000227361555463026,0.00207345032655639,-0.0038366010845875,0.00429132419551355,0.912685426392582
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,36500,-0.00060112593269416,0.00553178273824117,-0.0114434200996468,0.0102411682342585,0.913467811665886
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL7,C-C motif chemokine 7,39099,-0.000575972896311637,0.00532170273971147,-0.0110065102661461,0.00985456447352285,0.913813926484202
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",36500,0.000992500479437056,0.0095310356435316,-0.0176883293818849,0.019673330340759,0.917065026780231
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,39147,0.000222429446357994,0.00213702102191302,-0.00396613175659152,0.00441099064930751,0.917104146173552
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,36391,-0.000485495266153605,0.00467197440150933,-0.00964256509311189,0.00867157456080468,0.917237269402118
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300A,CMRF35-like molecule 8,36500,-0.000270776443978404,0.00263115764635619,-0.00542784543083654,0.00488629254287973,0.918034823779342
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLMH,Bleomycin hydrolase,39283,-0.000297952872880934,0.00292197676298045,-0.00602502732832262,0.00542912158256075,0.918782111236189
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,36500,0.000765740563280631,0.00756659594957292,-0.0140647874978823,0.0155962686244436,0.919393191363463
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCC,Tubulin-specific chaperone C,38987,-0.000745818008891279,0.00741526786446228,-0.0152797430232373,0.0137881070054548,0.919886238065047
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,38987,-0.00084530286843659,0.0086462630317649,-0.0177919784106958,0.0161013726738226,0.922120106980931
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,36391,0.00105924714685934,0.0109332869415579,-0.0203699952585941,0.0224884895523127,0.922821039699096
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTBDN,Retbindin,39023,0.000258958392472474,0.00267941586811368,-0.00499269670903033,0.00551061349397528,0.92300774493906
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,36430,0.000377541994998546,0.00393307886383261,-0.00733129257811338,0.00808637656811047,0.923528882863237
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,39099,0.000399426661084715,0.00426122325777074,-0.00795257092414594,0.00875142424631537,0.92532073138282
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFIC,Nuclear factor 1 C-type,36767,-0.000352410446854766,0.00384198501149285,-0.00788270106938075,0.00717788017567122,0.926917053408616
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39023,0.000284603550527316,0.00311082561747954,-0.00581261465973259,0.00638182176078722,0.927105963462679
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,36391,-0.000379757861802028,0.00418131969673628,-0.00857514446740514,0.00781562874380108,0.927635091973699
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2BP,LRP2-binding protein,36421,0.000640225857466797,0.00730138711141739,-0.0136704928809113,0.0149509445958449,0.930128033842773
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,36420,0.000451197793370185,0.00519501271087594,-0.00973102711994666,0.010633422706687,0.930790454158937
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRL,Prolactin,39241,-0.000542256116626059,0.00692791527934462,-0.0141209700641415,0.0130364578308894,0.93761335883486
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSR,Insulin receptor,36430,-0.000118911485456686,0.00152147801405966,-0.00310100839301361,0.00286318542210024,0.937705807157397
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,36343,0.000397220820574153,0.00508595812279595,-0.00957125710010591,0.0103656987412542,0.937748587351471
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,36420,-0.00182941636427078,0.0235123935507543,-0.0479137077237493,0.0442548749952077,0.937983238424924
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",38939,-0.000283063035287979,0.00366109866057288,-0.00745881641001083,0.00689269033943487,0.938372855937589
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDAN1,Codanin-1,36747,0.000157643181060053,0.00204771374974932,-0.00385587576844861,0.00417116213056871,0.938636697003747
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOMO1,Nodal modulator 1,39093,-0.000164960156295791,0.00216969947144507,-0.00441757112032812,0.00408765080773654,0.939396997165342
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,36806,0.00011480860243327,0.00155742951986956,-0.00293775325651106,0.00316737046137761,0.941236929865262
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,38727,-0.000317378830091121,0.0043065559128592,-0.00875822841929515,0.00812347075911291,0.941252739970768
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD2,Polycystin-2,36391,-0.000401112629870309,0.0054519866783193,-0.0110870065193761,0.0102847812596355,0.941352262103801
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT1,Diamine acetyltransferase 1,36391,0.000333439748244015,0.00454759094442725,-0.00857983850283339,0.00924671799932142,0.94155083076772
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,39283,-0.000208613731879887,0.00286872895956482,-0.00583132249262694,0.00541409502886717,0.942029942004972
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAX,Integrin alpha-X,36538,0.000347089009306734,0.00481072778129209,-0.00908193744202577,0.00977611546063924,0.942484500866844
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,39106,-0.000191967520746879,0.00269280875182286,-0.00546987267431969,0.00508593763282593,0.943168720910852
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,39106,-0.000416309194595322,0.00609282261411806,-0.0123582415182667,0.0115256231290761,0.945525586811502
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,39291,-0.000348191489148336,0.00510950080200579,-0.0103628130610797,0.00966643008278301,0.945670381740522
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,36731,0.000279153199582356,0.00411176955365018,-0.00777991512557199,0.00833822152473671,0.945873253921764
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39093,0.000162088562388074,0.00250642226688571,-0.00475049908070792,0.00507467620548406,0.948438158801478
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB116,Beta-defensin 116,36363,-0.000453072425228093,0.00707908356791449,-0.0143280762183405,0.0134219313678843,0.948970004033482
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,36430,-0.000236505356075266,0.00379918062985558,-0.0076828993905922,0.00720988867844167,0.950363401682205
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,36761,0.000335383684627155,0.00563115199012665,-0.0107016742160211,0.0113724415852754,0.952508092688868
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,39283,-0.00014807679036074,0.00249804936092047,-0.00504425353776486,0.00474809995704338,0.952732274242916
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,39237,-0.00034714660449362,0.00598341692494457,-0.012074643777385,0.0113803505683977,0.953734948592468
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,36363,-0.000180982535990502,0.00316029819554106,-0.00637516699925098,0.00601320192726998,0.954332984119339
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,38832,0.000140499269738417,0.00245807324065969,-0.00467732428195457,0.00495832282143141,0.954419864178217
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,36806,-9.45767077078032e-05,0.00174741608392635,-0.00351951223220344,0.00333035881678783,0.956837406985109
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",36430,-0.000221002062224863,0.0041365393196609,-0.00832861912876023,0.00788661500431051,0.957392700773348
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,36339,0.000443486543532995,0.00840280151380974,-0.0160260044235341,0.0169129775106001,0.957909304846104
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",38741,-0.000197309011994272,0.00399954776161148,-0.00803642262475276,0.00764180460076422,0.960654718442324
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN4,Alpha-actinin-4,38841,0.0001400739649816,0.00285551079617942,-0.00545672719553006,0.00573687512549326,0.960876988866258
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,39291,-0.000204358114448475,0.0041738861636828,-0.00838517499526676,0.00797645876636981,0.960950919290258
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,36767,0.000296616471697201,0.00607061531475166,-0.0116017895452161,0.0121950224886105,0.961030807264929
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39162,0.000114887133907957,0.00240266275319484,-0.00459433186235392,0.00482410613016984,0.961863040744189
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39106,0.000129824067226371,0.0028044354061712,-0.00536686932886917,0.00562651746332192,0.963077796901201
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK1,Dickkopf-related protein 1,39241,0.000249768879454361,0.0054559302704378,-0.0104438544506037,0.0109433922095125,0.963486721231484
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL,Podocalyxin,39023,-5.14066817577114e-05,0.00137081404829197,-0.00273820221640997,0.00263538885289455,0.970086162052707
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",36430,-0.000153259535208288,0.00418420284035809,-0.00835429710231014,0.00804777803189357,0.970782093873314
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,36420,-8.69562482590232e-05,0.00242329492561744,-0.0048366143024692,0.00466270180595115,0.971375840894586
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDM1,Nuclear protein MDM1,36421,-9.58355442503478e-05,0.00287968614751465,-0.00574002039337907,0.00554834930487837,0.973451945132041
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE4,Ribonuclease 4,36418,-7.85501682132699e-05,0.00238300258505801,-0.00474923523492697,0.00459213489850043,0.973704866818842
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANG,Angiogenin,39083,-0.000100252490248475,0.0030776164849712,-0.00613238080079202,0.00593187582029507,0.9740141580045
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,39106,-0.000115363420982998,0.00356523677250235,-0.00710322749508761,0.00687250065312162,0.974187093839362
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,38727,-0.000215432874413965,0.00700234698160478,-0.0139400329583593,0.0135091672095314,0.975456720420934
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,36796,-0.000124514094323939,0.00424171114000338,-0.00843826792873056,0.00818923974008268,0.976582166191209
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB1,Calbindin,39023,-0.000112059127955988,0.00384264043256604,-0.00764363437578542,0.00741951611987344,0.976735761839382
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX5,Sorting nexin-5,36420,7.40387326036712e-05,0.00278366770562998,-0.00538194997043109,0.00553002743563844,0.978781152340651
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM,Paralemmin-1,36667,-6.58923526833382e-05,0.00259837957591584,-0.00515871632147839,0.00502693161611172,0.979768995116855
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,39088,-0.000173218598492363,0.00716860691765394,-0.0142236881570941,0.0138772509601094,0.980722512878797
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,39283,4.47929108286871e-05,0.00214009395434255,-0.00414979123968272,0.00423937706134009,0.983301488621224
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,38832,-0.000129208197912632,0.00716236482859272,-0.0141674432619544,0.0139090268661291,0.985607279780514
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,36391,8.94949438947389e-05,0.00539013807041552,-0.0104751756741197,0.0106541655619092,0.986753228286815
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,36519,8.16896409235996e-05,0.00499682226318276,-0.00971208199491461,0.00987546127676181,0.986956767877101
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,38741,-0.000102585602555605,0.0064065858231531,-0.0126594938159357,0.0124543226108245,0.987224615767217
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,38741,-8.29048593835082e-05,0.00519100215680269,-0.0102572690867168,0.0100914593679498,0.987257839251069
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAM,Signal transducing adapter molecule 1,36731,5.14539809823335e-05,0.00332417755952039,-0.00646393403567764,0.00656684199764231,0.987650509197203
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP4,Caspase-4,36538,0.00020323259301907,0.01510382801612,-0.0294002703185761,0.0298067355046142,0.989264439643143
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB1,Heat shock protein beta-1,38869,-6.28124903697521e-05,0.00632177419412145,-0.0124534899108478,0.0123278649301083,0.992072564546641
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE2,Glia-derived nexin,36792,-4.03758703535652e-05,0.00590907321060405,-0.0116221593631375,0.0115414076224304,0.994548314267038
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,36469,2.48764393744355e-05,0.00445134611897029,-0.00869976195380733,0.00874951483255621,0.995541117334679
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTB,Lymphotoxin-beta,36731,-1.7100633002403e-05,0.0031047461539241,-0.00610240309469363,0.00606820182868882,0.995605438781057
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,36420,9.07542281534485e-06,0.00190491072198223,-0.00372454959226982,0.00374270043790051,0.996198788667913
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEFL,Neurofilament light polypeptide,38692,-1.60296798781722e-05,0.00396837555562723,-0.00779404576890754,0.0077619864091512,0.996777123648901
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,36391,1.64107177967783e-05,0.00515476906689132,-0.0100869366533102,0.0101197580889038,0.997459910454676
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSND,Barttin,36339,-7.54413296715357e-06,0.00307014962621594,-0.0060250374003504,0.00600994913441609,0.99803943738719
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36339,-1.14411167792129e-05,0.00530471249960758,-0.0104086776160101,0.0103857953824516,0.998279171495124
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,36421,8.84950271937051e-06,0.00469699514181096,-0.00919726097523011,0.00921495998066886,0.998496754484662
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,39182,3.2630871497598e-06,0.00184181407624283,-0.00360669250228618,0.0036132186765857,0.998586435488613
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBD,Thrombomodulin,39106,2.34576723358649e-06,0.00248089477939642,-0.0048602080003834,0.00486489953485057,0.999245586509774
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,36538,-6.35654387329049e-07,0.00337134506740011,-0.00660847198649153,0.00660720067771688,0.999849564845054
